UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended May 3, 2020
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___ to ___

Commission file number 0-15451

graphic

PHOTRONICS, INC.
(Exact name of registrant as specified in its charter)

Connecticut
 
06-0854886
(State or other jurisdiction of incorporation or organization)
 
(IRS Employer Identification No.)

15 Secor Road, Brookfield, Connecticut
 
06804
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code
 
(203) 775-9000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
Trading Symbol(s)
Name of each exchange on which registered
COMMON
PLAB
NASDAQ Global Select Market
PREFERRED STOCK PURCHASE RIGHTS
N/A
N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes   No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes   No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated Filer
Accelerated Filer
Non-Accelerated Filer
Smaller Reporting Company
Emerging growth company
   

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act ((§15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report

Yes   No

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes   No

The registrant had 65,622,399 shares of common stock outstanding as of June 8, 2020.




Index

Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements made by or on behalf of Photronics, Inc. (“Photronics”, the “Company”, “we”, “our”, or “us”). These statements are based on management’s beliefs, as well as assumptions made by, and information currently available to, management. Forward-looking statements may be identified by words like “expect,” “anticipate,” “believe,” “plan,” “project,” “could,” “estimate,” “intend,” “may,” “will”,“in our view” and similar expressions, or the negative of such terms, or other comparable terminology. All forward-looking statements involve risks and uncertainties that are difficult to predict. In particular, any statement contained in this quarterly report on Form 10-Q or in other documents filed with the Securities and Exchange Commission in press releases or in the Company’s communications and discussions with investors and analysts in the normal course of business through meetings, phone calls, or conference calls regarding, among other things, the consummation and benefits of transactions, joint ventures, business combinations, divestitures and acquisitions, expectations with respect to future sales, financial performance, operating efficiencies, or product expansion, are subject to known and unknown risks, uncertainties, and contingencies, many of which are beyond the control of the Company. Various factors may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements expressed or implied by forward-looking statements. Factors that might affect forward-looking statements include, but are not limited to, overall economic and business conditions; economic and political conditions in international markets; pandemics affecting our labor force, customers or suppliers; the demand for the Company’s products; competitive factors in the industries and geographic markets in which the Company competes; the timing of orders received from customers; the gain or loss of significant customers; competition from other manufacturers; changes in accounting standards; federal, state and international tax requirements (including tax rate changes, new tax laws and revised tax law interpretations); changes in the jurisdictional mix of our earnings; interest rate and other capital market conditions, including changes in the market price of the Company’s securities; foreign currency exchange rate fluctuations; changes in technology; technology or intellectual property infringement, including cybersecurity breaches, and other innovation risks; unsuccessful or unproductive research and development or capital expenditures; the timing, impact, and other uncertainties related to transactions and acquisitions, divestitures, business combinations, and joint ventures as well as decisions the Company may make in the future regarding the Company’s business, capital and organizational structures and other matters; the seasonal and cyclical nature of the semiconductor and flat panel display industries; management changes; changes in laws and government regulation impacting our operations or our products, including laws relating to export controls and import laws, rules and tariffs; the occurrence of regulatory proceedings, claims or litigation; damage or destruction to the Company’s facilities, or the facilities of its customers or suppliers, by natural disasters, labor strikes, political unrest, or terrorist activity; acts of war, construction of new facilities and acquisition of new equipment; dilutive issuances of the Company’s stock; the ability of the Company to (i) place new equipment in service on a timely basis; (ii) obtain additional financing; (iii) achieve anticipated synergies and cost savings; (iv) fully utilize its tools; (v) achieve desired yields, pricing, product mix, and market acceptance of its products and (vi) obtain necessary import and export licenses. Any forward-looking statements should be considered in light of these factors. Accordingly, there is no assurance that the Company’s expectations will be realized. The Company does not assume responsibility for the accuracy and completeness of the forward-looking statements and does not assume an obligation to provide revisions to any forward-looking statements, except as otherwise required by securities and other applicable laws.

2

Index

PHOTRONICS, INC.

INDEX

PART I.
FINANCIAL INFORMATION
 
 
 
 
Item 1.
4
 
 
 
 
4
 
 
 
 
5
 
 
 
 
6
 
 
 
 
7
 
 
 
 
9
 
 
 
 
10
 
 
 
Item 2.
24
 
 
 
Item 3.
31
 
 
 
Item 4.
32
 
 
 
 
 
 
PART II.
OTHER INFORMATION
 
 
 
 
Item 1.
32
     
Item 1A.
33
 
 
 
Item 2.
33
 
 
 
Item 6.
34

3

Index


PART I.
FINANCIAL INFORMATION

Item 1.
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

PHOTRONICS, INC.
Condensed Consolidated Balance Sheets
(in thousands, except per share amounts)
(unaudited)

 
May 3,
2020
   
October 31,
2019
 
ASSETS
           
Current assets:
           
Cash and cash equivalents
 
$
237,790
   
$
206,530
 
Accounts receivable, net of allowance of $1,282 in 2020 and $1,334 in 2019
   
135,035
     
134,454
 
Inventories
   
56,968
     
48,155
 
Other current assets
   
42,478
     
38,388
 
                 
Total current assets
   
472,271
     
427,527
 
                 
Property, plant and equipment, net
   
604,545
     
632,441
 
Intangible assets, net
   
5,690
     
7,870
 
Deferred income taxes
   
19,801
     
20,779
 
Other assets
   
31,581
     
30,048
 
Total assets
 
$
1,133,888
   
$
1,118,665
 
                 
LIABILITIES AND EQUITY
               
Current liabilities:
               
Short-term debt
 
$
9,858
   
$
8,731
 
Current portion of long-term debt
   
7,813
     
2,142
 
Accounts payable
   
76,293
     
91,379
 
Accrued liabilities
   
59,408
     
49,702
 
Total current liabilities
   
153,372
     
151,954
 
                 
Long-term debt
   
35,783
     
41,887
 
Other liabilities
   
23,075
     
13,732
 
Total liabilities
   
212,230
     
207,573
 
                 
Commitments and contingencies
   
     
 
                 
Equity:
               
Preferred stock, $0.01 par value, 2,000 shares authorized, none issued and outstanding
   
-
     
-
 
Common stock, $0.01 par value, 150,000 shares authorized, 66,215 shares issued and 64,751 outstanding at May 3, 2020 and 65,595 shares issued and outstanding at October 31, 2019
   
662
     
656
 
Additional paid-in capital
   
530,117
     
524,319
 
Retained earnings
   
270,506
     
253,922
 
Treasury stock, 1,464 shares at May 3, 2020
   
(16,894
)
   
-
 
Accumulated other comprehensive loss
   
(15,200
)
   
(9,005
)
Total Photronics, Inc. shareholders’ equity
   
769,191
     
769,892
 
Noncontrolling interests
   
152,467
     
141,200
 
Total equity
   
921,658
     
911,092
 
Total liabilities and equity
 
$
1,133,888
   
$
1,118,665
 

See accompanying notes to condensed consolidated financial statements.

4

Index

PHOTRONICS, INC.
Condensed Consolidated Statements of Income
(in thousands, except per share amounts)
(unaudited)

 
Three Months Ended
   
Six Months Ended
 
   
May 3,
2020
   
April 28,
2019
   
May 3,
2020
   
April 28,
2019
 
                         
Revenue
 
$
142,774
   
$
131,580
   
$
302,510
   
$
256,291
 
                                 
Cost of goods sold
   
112,341
     
105,570
     
237,475
     
204,179
 
                                 
Gross profit
   
30,433
     
26,010
     
65,035
     
52,112
 
                                 
Operating expenses:
                               
                                 
Selling, general and administrative
   
13,267
     
13,269
     
27,486
     
27,061
 
                                 
Research and development
   
4,462
     
3,542
     
8,541
     
7,805
 
                                 
Total operating expenses
   
17,729
     
16,811
     
36,027
     
34,866
 
                                 
Operating income
   
12,704
     
9,199
     
29,008
     
17,246
 
                                 
Other income (expense):
                               
Foreign currency transaction (losses) gains, net
   
(1,433
)
   
3,961
     
3,304
     
5,052
 
Interest expense, net
   
775
     
(355
)
   
(1,023
)
   
(886
)
Interest income and other income (expense), net
   
(293
)
   
325
     
464
     
873
 
                                 
Income before income taxes
   
11,753
     
13,130
     
31,753
     
22,285
 
                                 
Income tax provision
   
3,781
     
3,278
     
12,853
     
4,665
 
                                 
Net income
   
7,972
     
9,852
     
18,900
     
17,620
 
                                 
Net income attributable to noncontrolling interests
   
1,688
     
1,373
     
2,316
     
3,874
 
                                 
Net income attributable to Photronics, Inc. shareholders
 
$
6,284
   
$
8,479
   
$
16,584
   
$
13,746
 
                                 
Earnings per share:
                               
                                 
Basic
 
$
0.10
   
$
0.13
   
$
0.25
   
$
0.21
 
                                 
Diluted
 
$
0.10
   
$
0.13
   
$
0.25
   
$
0.20
 
                                 
Weighted-average number of common shares outstanding:
                               
                                 
Basic
   
64,937
     
66,261
     
65,246
     
66,422
 
                                 
Diluted
   
65,417
     
70,597
     
65,933
     
71,593
 

See accompanying notes to condensed consolidated financial statements.

5

Index

PHOTRONICS, INC.
Condensed Consolidated Statements of Comprehensive Income
(in thousands)
(unaudited)

 
Three Months Ended
   
Six Months Ended
 
   
May 3,
2020
   
April 28,
2019
   
May 3,
2020
   
April 28,
2019
 
                         
Net income
 
$
7,972
   
$
9,852
   
$
18,900
   
$
17,620
 
                                 
Other comprehensive income (loss), net of tax of $0:
                               
                                 
Foreign currency translation adjustments
   
(2,405
)
   
(7,054
)
   
(3,970
)
   
(482
)
                                 
Other
   
1
     
25
     
19
     
44
 
                                 
Net other comprehensive loss
   
(2,404
)
   
(7,029
)
   
(3,951
)
   
(438
)
                                 
Comprehensive income
   
5,568
     
2,823
     
14,949
     
17,182
 
                                 
Less: comprehensive income attributable to noncontrolling interests
   
2,742
     
1,515
     
4,560
     
5,298
 
                                 
Comprehensive income attributable to Photronics, Inc. shareholders
 
$
2,826
   
$
1,308
   
$
10,389
   
$
11,884
 

See accompanying notes to condensed consolidated financial statements.

6

Index

PHOTRONICS, INC.
Condensed Consolidated Statements of Equity
(in thousands)
(unaudited)

 
Three Months Ended May 3, 2020
 
   
Photronics, Inc. Shareholders
             
         
Additional
Paid-in
Capital
   
Retained
Earnings
   
Treasury
Stock
   
Accumulated
Other
Comprehensive
Loss
   
Non-
controlling
Interests
   
Total
Equity
 
     
 
Common Stock
 
   
Shares
   
Amount
 
                                                 
Balance at February 3, 2020
   
66,144
   
$
661
   
$
528,535
   
$
264,222
   
$
(11,000
)
 
$
(11,742
)
 
$
142,125
   
$
912,801
 
                                                                 
Net income
   
-
     
-
     
-
     
6,284
     
-
     
-
     
1,688
     
7,972
 
Other comprehensive (loss) income
   
-
     
-
     
-
     
-
     
-
     
(3,458
)
   
1,054
     
(2,404
)
Sale of common stock through employee stock option and purchase plans
   
45
     
1
     
363
     
-
     
-
     
-
     
-
     
364
 
Restricted stock awards vesting and expense
   
26
     
-
     
1,071
     
-
     
-
     
-
     
-
     
1,071
 
Share-based compensation expense
   
-
     
-
     
148
     
-
     
-
     
-
     
-
     
148
 
Purchase of treasury stock
   
-
     
-
     
-
     
-
     
(5,894
)
   
-
     
-
     
(5,894
)
Contribution from noncontrolling interest
   
-
     
-
     
-
     
-
     
-
     
-
     
7,600
     
7,600
 
                                                                 
Balance at May 3, 2020
   
66,215
   
$
662
   
$
530,117
   
$
270,506
   
$
(16,894
)
 
$
(15,200
)
 
$
152,467
   
$
921,658
 

 
Three Months Ended April 28, 2019
 
   
Photronics, Inc. Shareholders
             
   
Common Stock
   
Additional
Paid-in
   
Retained
   
Treasury
   
Accumulated
Other
Comprehensive
   
Non-
controlling
   
Total
 
   
Shares
   
Amount
   
Capital
   
Earnings
   
Stock
   
Income (Loss)
   
Interests
   
Equity
 
                                                 
Balance at January 28, 2019
   
69,917
   
$
699
   
$
557,188
   
$
236,665
   
$
(33,807
)
 
$
343
   
$
152,082
   
$
913,170
 
                                                                 
Net income
   
-
     
-
     
-
     
8,479
     
-
     
-
     
1,373
     
9,852
 
Other comprehensive (loss) income
   
-
     
-
     
-
     
-
     
-
     
(7,171
)
   
142
     
(7,029
)
Sale of common stock through employee stock option and purchase plans
   
41
     
1
     
271
     
-
     
-
     
-
     
-
     
272
 
Restricted stock awards vesting and expense
   
26
     
-
     
650
     
-
     
-
     
-
     
-
     
650
 
Share-based compensation expense
   
-
     
-
     
250
     
-
     
-
     
-
     
-
     
250
 
Subsidiary dividend payable
   
-
     
-
     
-
     
-
     
-
     
-
     
(18,837
)
   
(18,837
)
                                                                 
Balance at April 28, 2019
   
69,984
   
$
700
   
$
558,359
   
$
245,144
   
$
(33,807
)
 
$
(6,828
)
 
$
134,760
   
$
898,328
 

See accompanying notes to condensed consolidated financial statements.
7

Index
PHOTRONICS, INC.
Condensed Consolidated Statements of Equity
(in thousands)
(unaudited)

 
Six Months Ended May 3, 2020
 
   
Photronics, Inc. Shareholders
             
         
Additional
Paid-in
Capital
   
Retained
Earnings
   
Treasury
Stock
   
Accumulated
Other
Comprehensive
Loss
   
Non-
controlling
Interests
   
Total
Equity
 
     
 
Common Stock
 
   
Shares
   
Amount
 
                                                 
Balance at November 1, 2019
   
65,595
   
$
656
   
$
524,319
   
$
253,922
   
$
-
   
$
(9,005
)
 
$
141,200
   
$
911,092
 
                                                                 
Net income
   
-
     
-
     
-
     
16,584
     
-
     
-
     
2,316
     
18,900
 
Other comprehensive (loss) income
   
-
     
-
     
-
     
-
     
-
     
(6,195
)
   
2,244
     
(3,951
)
Sale of common stock through employee stock option and purchase plans
   
403
     
4
     
3,217
     
-
     
-
     
-
     
-
     
3,221
 
Restricted stock awards vesting and expense
   
217
     
2
     
1,827
     
-
     
-
     
-
     
-
     
1,829
 
Share-based compensation expense
   
-
     
-
     
499
     
-
     
-
     
-
     
-
     
499
 
Purchase of treasury stock
   
-
     
-
     
-
     
-
     
(16,894
)
   
-
     
-
     
(16,894
)
Contribution from noncontrolling interest
   
-
     
-
     
-
     
-
     
-
     
-
     
7,600
     
7,600
 
Repurchase of common stock of subsidiary
   
-
     
-
     
255
     
-
     
-
     
-
     
(893
)
   
(638
)
                                                                 
Balance at May 3, 2020
   
66,215
   
$
662
   
$
530,117
   
$
270,506
   
$
(16,894
)
 
$
(15,200
)
 
$
152,467
   
$
921,658
 

 
Six Months Ended April 28, 2019
 
   
Photronics, Inc. Shareholders
             
   
Common Stock
   
Additional
Paid-in
   
Retained
   
Treasury
   
Accumulated
Other
Comprehensive
   
Non-
controlling
   
Total
 
   
Shares
   
Amount
   
Capital
   
Earnings
   
Stock
   
Loss
   
Interests
   
Equity
 
                                                 
Balance at November 1, 2018
   
69,700
   
$
697
   
$
555,606
   
$
231,445
   
$
(23,111
)
 
$
(4,966
)
 
$
144,898
   
$
904,569
 
                                                                 
Adoption of ASU 2014-09
   
-
     
-
     
-
     
1,083
     
-
     
-
     
121
     
1,204
 
Adoption of ASU 2016-16
   
-
     
-
     
-
     
(1,130
)
   
-
     
-
     
(3
)
   
(1,133
)
Net income
   
-
     
-
     
-
     
13,746
     
-
     
-
     
3,874
     
17,620
 
Other comprehensive (loss) income
   
-
     
-
     
-
     
-
     
-
     
(1,862
)
   
1,424
     
(438
)
Sale of common stock through employee stock option and purchase plans
   
136
     
1
     
792
     
-
     
-
     
-
     
-
     
793
 
Restricted stock awards vesting and expense
   
148
     
2
     
1,217
     
-
     
-
     
-
     
-
     
1,219
 
Share-based compensation expense
   
-
     
-
     
744
     
-
     
-
     
-
     
-
     
744
 
Contribution from noncontrolling interest
   
-
     
-
     
-
     
-
     
-
     
-
     
29,394
     
29,394
 
Dividends to noncontrolling interests
   
-
     
-
     
-
     
-
     
-
     
-
     
(26,102
)
   
(26,102
)
Subsidiary dividend payable
   
-
     
-
     
-
     
-
     
-
     
-
     
(18,837
)
   
(18,837
)
Repurchase of common stock of subsidiary
   
-
     
-
     
-
     
-
     
-
     
-
     
(9
)
   
(9
)
Purchase of treasury stock
   
-
     
-
     
-
     
-
     
(10,696
)
   
-
     
-
     
(10,696
)
                                                                 
Balance at April 28, 2019
   
69,984
   
$
700
   
$
558,359
   
$
245,144
   
$
(33,807
)
 
$
(6,828
)
 
$
134,760
   
$
898,328
 
8

Index


PHOTRONICS, INC.
Condensed Consolidated Statements of Cash Flows
(in thousands)
(unaudited)

 
Six Months Ended
 
   
May 3,
2020
   
April 28,
2019
 
             
             
Cash flows from operating activities:
           
Net income
 
$
18,900
   
$
17,620
 
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
   
47,896
     
38,515
 
Share-based compensation
   
2,576
     
1,962
 
Changes in assets and liabilities:
               
Accounts receivable
   
(13
)
   
(2,295
)
Inventories
   
(8,989
)
   
(9,447
)
Other current assets
   
(6,887
)
   
(6,114
)
Accounts payable, accrued liabilities, and other
   
7,840
     
(42,528
)
                 
Net cash provided by (used in) operating activities
   
61,323
     
(2,287
)
                 
Cash flows from investing activities:
               
Purchases of property, plant and equipment
   
(30,127
)
   
(140,436
)
Government incentives
   
5,260
     
5,698
 
Other
   
(139
)
   
(23
)
                 
Net cash used in investing activities
   
(25,006
)
   
(134,761
)
                 
Cash flows from financing activities:
               
Proceeds from debt
   
1,140
     
39,633
 
Contribution from noncontrolling interest
   
7,600
     
29,394
 
Purchase of treasury stock
   
(16,894
)
   
(10,696
)
Repayments of long-term debt
   
(389
)
   
(61,220
)
Proceeds from share-based arrangements
   
3,423
     
1,033
 
Dividends paid to noncontrolling interests
   
-
     
(26,102
)
Other
   
(251
)
   
(45
)
                 
Net cash used in financing activities
   
(5,371
)
   
(28,003
)
                 
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
   
475
     
2,843
 
                 
Net increase (decrease) in cash, cash equivalents, and restricted cash
   
31,421
     
(162,208
)
Cash, cash equivalents, and restricted cash at beginning of period
   
209,291
     
331,989
 
                 
Cash, cash equivalents, and restricted cash at end of period
 
$
240,712
   
$
169,781
 
                 
Supplemental disclosure information:
               
                 
Accrual for property, plant and equipment purchased during the period
 
$
2,891
   
$
17,454
 
Accrual for property, plant and equipment purchased with funds receivable from government incentives
 
$
-
   
$
13,402
 
Subsidiary dividend payable
 
$
-
   
$
18,837
 

See accompanying notes to condensed consolidated financial statements.
9

Index

PHOTRONICS, INC.
Notes to Condensed Consolidated Financial Statements
(unaudited)
(in thousands, except share amounts and per share data)

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION


Photronics, Inc. (“Photronics”, “the Company”, “we”, “our”, or “us”) is one of the world's leading manufacturers of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of semiconductors and flat-panel displays (“FPDs”), and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during the fabrication of integrated circuits (“ICs” or “semiconductors”), a variety of FPDs and, to a lesser extent, other types of electrical and optical components. We currently have eleven manufacturing facilities, which are located in Taiwan (3), Korea, the United States (3), Europe (2), and two recently constructed facilities in China. Our FPD facility in Hefei, China, commenced production in the second quarter of fiscal 2019 and our IC facility in Xiamen, China, commenced production in the third quarter of fiscal 2019.


The accompanying unaudited condensed consolidated financial statements (“the financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of management, adjustments, all of which are of a normal recurring nature, considered necessary for a fair presentation have been included. The financial statements include the accounts of Photronics, its wholly owned subsidiaries, and the majority-owned subsidiaries which it controls. All intercompany balances and transactions have been eliminated in consolidation.


The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect amounts reported in them. Estimates are based on historical experience and on various assumptions that are believed to be reasonable under the circumstances. Our estimates are based on the facts and circumstances available at the time they are made. Actual results we report may differ from such estimates. We review these estimates periodically and reflect any effects of revisions in the period in which they are determined.


Certain reclassifications of prior period amounts have been made to conform to the current period presentation. These reclassifications included separating, as its own line item, Foreign currency transaction (losses) gains, net, from Interest income and other income (expense), net, on the condensed consolidated statements of income, and separating Share-based compensation from Accounts payable, accrued liabilities, and other, in the condensed consolidated statements of cash flows.


Our business is typically impacted during the first, and sometimes the second, quarters of our fiscal year by the North American, European, and Asian holiday periods, as some customers reduce their development and buying activities during those periods. Operating results for the interim period are not necessarily indicative of the results that may be expected for the fiscal year ending October 31, 2020. For further information, refer to the consolidated financial statements, and notes thereto, included in our Annual Report on Form 10-K for the year ended October 31, 2019.

NOTE 2 - INVENTORIES


Inventories are stated at the lower of cost, determined under the first-in, first-out ("FIFO") method, or net realizable value. Presented below are the components of inventory at the balance sheet dates:

 
May 3,
2020
   
October 31,
2019
 
             
Raw materials
 
$
55,110
   
$
46,027
 
Work in process
   
1,818
     
2,122
 
Finished goods
   
40
     
6
 
                 
   
$
56,968
   
$
48,155
 


10

Index
NOTE 3 - PROPERTY, PLANT AND EQUIPMENT


Property, plant and equipment consists of the following:

 
May 3,
2020
   
October 31,
2019
 
             
Land
 
$
11,916
   
$
12,085
 
Buildings and improvements
   
172,689
     
172,340
 
Machinery and equipment
   
1,746,552
     
1,748,483
 
Leasehold improvements
   
20,344
     
19,921
 
Furniture, fixtures and office equipment
   
14,501
     
14,404
 
Construction in progress
   
30,257
     
28,135
 
                 
     
1,996,259
     
1,995,368
 
Accumulated depreciation and amortization
   
(1,391,714
)
   
(1,362,927
)
                 
   
$
604,545
   
$
632,441
 


Depreciation and amortization expense for property, plant and equipment was $22.1 million and $45.6 million for the three and six-month periods ended May 3, 2020 respectively, and $18.6 million and $36.2 million for the three and six-month periods ended April 28, 2019, respectively.


NOTE 4 - PDMCX JOINT VENTURE


In January 2018, Photronics, through its wholly owned Singapore subsidiary (hereinafter, within this Note “we”, “Photronics”, or “our”), and Dai Nippon Printing Co., Ltd., through its wholly owned subsidiary “DNP Asia Pacific PTE, Ltd.” (hereinafter, within this Note, “DNP”) entered into a joint venture under which DNP obtained a 49.99% interest in our IC business in Xiamen, China. The joint venture, known as “Xiamen American Japan Photronics Mask Co., Ltd.” (hereinafter, “PDMCX”), was established to develop and manufacture photomasks for leading edge and advanced generation semiconductors. We entered into this joint venture to enable us to compete more effectively for the merchant photomask business in China, and to benefit from the additional resources and investment that DNP provides to enable us to offer advanced-process technology to our customers. No gain or loss was recorded upon the formation of this joint venture.


The total investment per the PDMCX operating agreement (“the Agreement”) is $160 million. As of May 3, 2020, Photronics and DNP had each contributed cash of approximately $55 million, and PDMCX obtained local financing of approximately $35 million. The remaining $15 million investment was funded, in May 2020, with  additional cash contributions from Photronics and DNP. As discussed in Note 5, liens were granted to the local financing entity on assets with a total carrying value of $94.1 million, as collateral for the loans.


Under the Agreement, DNP is afforded, under certain circumstances, the right to put its interest in PDMCX to Photronics. These circumstances include disputes regarding the strategic direction of PDMCX that may arise after the initial two-year term of the Agreement and cannot be resolved between the two parties. As of the date of issuance of these financial statements, DNP had not indicated its intention to exercise this right. In addition, both Photronics and DNP have the option to purchase, or put, their interest from, or to, the other party, should their ownership interest fall below twenty percent for a period of more than six consecutive months. Under all such circumstances, the sales of ownership interests would be at the exiting party’s ownership percentage of the joint venture’s net book value, with closing to take place within three business days of obtaining required approvals and clearance.


We recorded net losses from the operations of PDMCX of $0.4 million, and $4.1 million during the three and six-month periods ended May 3, 2020, respectively, and losses of $0.6 million and $1.9 million during the three and six-month periods ended April 28, 2019, respectively. General creditors of PDMCX do not have recourse to the assets of Photronics (other than the net assets of PDMCX), and our maximum exposure to loss from PDMCX at May 3, 2020, was $43.0 million.

11

Index

As required by the guidance in Topic 810 - “Consolidation” of the Accounting Standards Codification (“ASC”), we evaluated our involvement in PDMCX for the purpose of determining whether we should consolidate its results in our financial statements. The initial step of our evaluation was to determine whether PDMCX was a variable interest entity (“VIE”). Due to its lack of sufficient equity at risk to finance its activities without additional subordinated financial support, we determined that it was a VIE. Having made this determination, we then assessed whether we were the primary beneficiary of the VIE, and concluded that we were the primary beneficiary during the current and prior year reporting periods; thus, as required, the PDMCX financial results have been consolidated with those of Photronics. Our conclusion was based on the facts that we held a controlling financial interest in PDMCX (which resulted from our having the power to direct the activities that most significantly impacted its economic performance) and had the obligation to absorb losses and the right to receive benefits that could potentially be significant to PDMCX. Our conclusions that we had the power to direct the activities that most significantly affected the economic performance of PDMCX during the current and prior year reporting periods was based on our right to appoint the majority of its board of directors, which has, among others, the powers to manage the business (through its rights to appoint and evaluate PDMCX's management), incur indebtedness, enter into agreements and commitments, and acquire and dispose of PDMCX’s assets. In addition, as a result of the 50.01% variable interest we held during the current and prior-year periods, we had the obligation to absorb losses, and the right to receive benefits, that could potentially be significant to PDMCX.


The carrying amounts of PDMCX assets and liabilities included in our condensed consolidated balance sheets are presented in the following table, together with our exposure to loss related to these assets and liabilities.

 
May 3, 2020
   
October 31, 2019
 
Classification
 
Carrying
Amount
   
Photronics
Interest
   
Carrying
Amount
   
Photronics
Interest
 
                         
Current assets
 
$
45,646
   
$
22,828
   
$
24,142
   
$
12,074
 
Non-current assets
   
104,972
     
52,496
     
114,015
     
57,019
 
                                 
Total assets
   
150,618
     
75,324
     
138,157
     
69,093
 
                                 
Current liabilities
   
28,785
     
14,395
     
16,889
     
8,446
 
Non-current liabilities
   
35,831
     
17,919
     
42,094
     
21,051
 
                                 
Total liabilities
   
64,616
     
32,314
     
58,983
     
29,497
 
                                 
Net assets
 
$
86,002
   
$
43,010
   
$
79,174
   
$
39,596
 

NOTE 5 – LONG-TERM DEBT


Long-term debt consists of the following:

 
May 3,
2020
   
October 31,
2019
 
             
             
Project Loans
 
$
34,452
   
$
34,490
 
Working Capital Loans (value added tax component)
   
9,144
     
9,539
 
                 
     
43,596
     
44,029
 
Current portion of long-term debt
   
(7,813
)
   
(2,142
)
                 
 Long-term debt
 
$
35,783
   
$
41,887
 

12

Index

At May 3, 2020, maturities of our long-term debt over the next five fiscal years and thereafter were as follows:

2020 (remainder of)
 
$
1,755
 
2021
   
8,294
 
2022
   
12,417
 
2023
   
3,437
 
2024
   
6,582
 
Thereafter
   
11,111
 
 
 
$
43,596
 


As of May 3, 2020 and October 31, 2019, the weighted-average interest rates of our short-term debt were 3.51% and 3.84%, respectively.

Project Loans


In November 2018, PDMCX was approved for credit of the equivalent of $50 million, subject to certain limitations related to PDMCX registered capital at the time of the initial approval, pursuant to which PDMCX has and will enter into separate loan agreements (“the Project Loans”) for intermittent borrowings. The Project Loans, which are denominated in Chinese renminbi (RMB), are being used to finance certain capital expenditures in China. PDMCX granted liens on its interest in land, building, and certain equipment, which had a combined carrying value of $94.1 million as of May 3, 2020, as collateral for the Project Loans. As of May 3, 2020, PDMCX had borrowed 243.4 million RMB ($34.5 million) against this approval. Payments on these borrowings are due semi-annually through December 2025; the initial payment is scheduled for June 2020. The table below presents, in U.S. dollars, the timing of future payments against the borrowings.

 
Fiscal Year
 
   
2020
   
2021
   
2022
   
2023
   
2024
   
2025
   
2026
 
                                           
Principal payments
 
$
1,274
   
$
6,369
   
$
5,679
   
$
3,437
   
$
6,582
   
$
6,299
   
$
4,812
 


The interest rates on the Project Loans are based on the benchmark lending rate of the People’s Bank of China (4.9% at May 3, 2020). Interest incurred on the loans will be reimbursed through incentives provided by the Xiamen Torch Hi-Tech Industrial Development Zone, which provide for such reimbursements up to a prescribed limit.


Working Capital Loans


In November 2018, PDMCX received approval for unsecured credit of the equivalent of $25.0 million, pursuant to which PDMCX may enter into separate loan agreements. Under this credit agreement (the “Working Capital Loans”), PDMCX can borrow up to 140.0 million RMB to pay value-added taxes (“VAT”), and up to 60.0 million RMB to fund operations; combined total borrowings are limited to the equivalent of $25.0 million. As of May 3, 2020, PDMCX had 64.6 million RMB ($9.1 million) outstanding against the approval to pay VAT. Payments on these borrowings are due semiannually, in increasing amounts, through January 2022. The table below presents, in U.S. dollars, the timing of future payments against these borrowings.

 
Fiscal Year
 
   
2020
   
2021
   
2022
 
                   
Principal payments
 
$
481
   
$
1,925
   
$
6,738
 


As of May 3, 2020, PDMCX had borrowed, in several transactions to fund operations, 44.8 million RMB ($6.3 million) against the approval, all of which was outstanding as of that date repayments are due one year from the borrowing dates.


The interest rates on borrowings to fund operations are approximately 4.37 to 4.60%, and interest rates on borrowings to pay VAT are approximately 4.53 to 4.73%; both rates are based on the RMB Loan Prime Rate of the National Interbank Funding Center, plus spreads that range from 25.75 to 67.75 basis points. Interest incurred on the loans will be reimbursed through incentives provided by the Xiamen Torch Hi-Tech Industrial Development Zone, which provide for such reimbursements up to a prescribed limit.

13

Index
Equipment Loan


Effective July 2019, the Company entered into a Master Lease Agreement (“MLA”) which enables us to request advance payments or other funds to finance equipment to be leased or purchased in the U.S. In connection with this MLA, we were approved for financing of $35 million for the purchase of a high-end lithography tool. In the fourth quarter of fiscal 2019, the financing entity, upon our request, made an advance payment of $3.5 million to the equipment vendor on our behalf. Interest on this borrowing is payable monthly at thirty-day LIBOR plus 1% (1.79% at May 3, 2020), and will continue to accrue until the borrowing is repaid or, as allowed under the MLA, we enter into a lease for the equipment. We intend to enter into a lease agreement for the related equipment in fiscal year 2020; as such, we have classified this borrowing as current debt. All borrowings under the MLA are secured by the equipment to be leased or purchased.

Credit Agreement


In September 2018, we entered into a five-year amended and restated credit agreement (the “Credit Agreement”), which has a $50 million borrowing limit, with an expansion capacity to $100 million. The Credit Agreement is secured by substantially all of our assets located in the United States and common stock we own in certain foreign subsidiaries. The Credit Agreement includes minimum interest coverage ratio, total leverage ratio, and minimum unrestricted cash balance covenants (all of which we were in compliance with at May 3, 2020), and limits the amount of cash dividends, distributions, and redemptions we can pay on our common stock to an aggregate annual amount of $50 million. We had no outstanding borrowings against the Credit Agreement at May 3, 2020, and $50 million was available for borrowing. The interest rate on the Credit Agreement (1.37% at May 3, 2020) is based on our total leverage ratio at LIBOR plus a spread, as defined in the Credit Agreement.

NOTE 6 – REVENUE


We recognize revenue when, or as, control of a good or service transfers to a customer, in an amount that reflects the consideration to which we expect to be entitled in exchange for transferring those goods or services. We account for an arrangement as a revenue contract when each party has approved and is committed to perform under the contract, the rights of the contracting parties regarding the goods or services to be transferred and the payment terms are identifiable, the arrangement has commercial substance, and collection of consideration is probable. Substantially all of our revenue comes from the sales of photomasks. We typically contract with our customers to sell sets of photomasks, which are comprised of multiple layers, the predominance of which we invoice as they ship to customers. As the photomasks are manufactured to customer specifications, they have no alternative use to us and, as our contracts generally provide us with the right to payment for work completed to date, we recognize revenue as we perform, or “over time,” on most of our contracts. We measure our performance to date using an input method, which is based on our estimated costs to complete the various manufacturing phases of a photomask. At the end of a reporting period, there will be a number of uncompleted revenue contracts on which we have performed; for any such contracts under which we are entitled to be compensated for our costs incurred plus a reasonable profit, we recognize revenue and a corresponding contract asset for such performance. We account for shipping and handling activities that we perform after a customer obtains control of a good as being activities to fulfill our promise to transfer the good to the customer, rather than as promised services, or performance obligations, under the contract.


As stated above, photomasks are manufactured to customer specifications in accordance with their proprietary designs; thus, they are individually unique. Due to their uniqueness and other factors, their transaction prices are individually established through negotiations with customers; consequently, our photomasks do not have standard or “list” prices. The transaction prices of the vast majority of our revenue contracts include only fixed amounts of consideration. In certain instances, such as when we offer a customer an early payment discount, an estimate of variable consideration would be included in the transaction price, but only to the extent that a significant reversal of revenue would not occur when the uncertainty related to the variability is resolved.

Contract Assets, Contract Liabilities, and Accounts Receivable


We recognize a contract asset when our performance under a contract precedes our receipt of consideration from a customer, or before payment is due, and our receipt of consideration is conditional upon factors other than the passage of time. Contract assets reflect our transfer of control to customers of photomasks that are in process or completed but not yet shipped. A receivable is recognized when we have an unconditional right to payment for our performance, which generally occurs when we ship the photomasks. Our contract assets primarily consist of a significant amount of our in-process production orders and fully manufactured photomasks which have not yet shipped, for which we have an enforceable right to collect consideration (including a reasonable profit) in the event the in-process orders are cancelled by customers. On an individual contract basis, we net contract assets with contract liabilities (deferred revenue) for financial reporting purposes. Our contract assets and liabilities are typically classified as current, as our production cycle and our lead times are both under one year. Contract assets of $6.5 million are included in “Other” current assets, and contract liabilities of $10.7 and $5.0 million are included in Accrued Liabilities and Other Liabilities, respectively, in our May 3, 2020 condensed consolidated balance sheet. Our October 31, 2019 condensed consolidated balance sheet includes contract assets of $7.6 million, included in “Other” current assets, and contract liabilities of $11.5 million, included in Accrued liabilities. We did not impair any contract assets during the six-month periods ended May 3, 2020 or April 28, 2019. We recognized $0.9 million and $1.8 million of revenue from the settlement of contract liabilities that existed at the beginning of the three and six-month periods ended May 3, 2020, and recognized $0.5 million and $1.2 million of revenue in the respective prior year periods, that related to the settlement of contract liabilities that existed at the beginning of those periods.

14

Index

We generally record our accounts receivable at their billed amounts. All outstanding past due customer invoices are reviewed for collectibility during, and at the end of, every reporting period. To the extent we believe a loss on the collection of a customer invoice is probable, we record the loss and credit the allowance for doubtful accounts. In the event that an amount is determined to be uncollectible, we charge the allowance for doubtful accounts and derecognize the related receivable. Credit losses incurred on our accounts receivable during the three and six-month periods ended May 3, 2020, were immaterial, and we did not incur any credit losses on our accounts receivable during the three and six-month periods ended April 28, 2019.


Our invoice terms generally range from net thirty to ninety days, depending on both the geographic market in which the transaction occurs and our payment agreements with specific customers. In the event that our evaluation of a customer’s business prospects and financial condition indicate that the customer presents a collectibility risk, we modify terms of sale, which may require payment in advance of performance. We have elected the practical expedient allowed under ASC Topic 606 “Revenue from Contracts with Customers” (“Topic 606”) that permits us not to adjust a contract’s promised amount of consideration to reflect a financing component when the period between when we transfer control of goods or services to customers and when we are paid is one year or less.


In instances when we are paid in advance of our performance, we record a contract liability and, as allowed under the practical expedient in Topic 606, recognize interest expense only if the period between when we receive payment from the customer and the date when we expect to be entitled to the payment is greater than one year. Historically, advance payments we’ve received from customers have generally not preceded the completion of our performance obligations by more than one year.

Disaggregation of Revenue


The following tables present our revenue for the three and six-month periods ended May 3, 2020 and April 28, 2019, disaggregated by product type, geographic origin, and timing of recognition. At the beginning of fiscal year 2020, we changed the threshold for the definition of high-end FPD, from G8 and above and active matrix organic light-emitting diode (AMOLED) display screens, to G10.5 and above, AMOLED, and low-temperature polysilicon display screens (LTPS), to reflect the overall advancement of technology in the FPD industry. Our definition of high-end IC products remains as 28 nanometer or smaller. The revenue by product type for the three and six-month periods ended April 28, 2019, presented below has been reclassified to conform to the current period presentation.

 
Three Months Ended
   
Six Months Ended
 
   
May 3, 2020
   
April 28, 2019
   
May 3, 2020
   
April 28, 2019
 
                         
Revenue by Product Type
                       
 IC
                       
High-end
 
$
38,267
   
$
38,429
   
$
79,308
   
$
72,995
 
Mainstream
   
58,579
     
60,158
     
124,516
     
120,471
 
Total IC
 
$
96,846
   
$
98,587
   
$
203,824
   
$
193,466
 
                                 
FPD
                               
High-end
 
$
31,809
   
$
22,051
   
$
71,579
   
$
37,401
 
Mainstream
   
14,119
     
10,942
     
27,107
     
25,424
 
Total FPD
 
$
45,928
   
$
32,993
   
$
98,686
   
$
62,825
 
   
$
142,774
   
$
131,580
   
$
302,510
   
$
256,291
 
15

Index

 
Three Months Ended
   
Six Months Ended
 
   
May 3, 2020
   
April 28, 2019
   
May 3, 2020
   
April 28, 2019
 
                         
Revenue by Geographic Origin
                       
Taiwan
 
$
55,513
   
$
56,469
   
$
121,626
   
$
114,209
 
Korea
   
36,261
     
38,038
     
76,997
     
73,275
 
United States
   
24,857
     
26,742
     
49,925
     
49,215
 
China
   
17,486
     
1,467
     
37,386
     
1,730
 
Europe
   
8,331
     
8,435
     
15,874
     
16,788
 
Other
   
326
     
429
     
702
     
1,074
 
   
$
142,774
   
$
131,580
   
$
302,510
   
$
256,291
 
                                 
Revenue by Timing of Recognition
                               
Over time
 
$
126,071
   
$
123,853
   
$
263,905
   
$
244,699
 
At a point in time
   
16,703
     
7,727
     
38,605
     
11,592
 
   
$
142,774
   
$
131,580
   
$
302,510
   
$
256,291
 

Contract Costs


We pay commissions to third-party sales agents for certain sales that they obtain for us. However, the bases of the commissions are the transaction prices of the sales, which are completed in less than one year; thus, no relationship is established with a customer that will result in future business. Therefore, we would not recognize any portion of these sales commissions as costs of obtaining a contract, nor do we currently foresee other circumstances under which we would recognize such assets.

Remaining Performance Obligations


As we are typically required to fulfill customer orders within a short time period, our backlog of orders is generally not in excess of one to two weeks for IC photomasks and two to three weeks for FPD photomasks. As allowed under Topic 606, we have elected not to disclose our remaining performance obligations, which represent the costs associated with the completion of the manufacturing process of in-process photomasks related to contracts that have an original duration of one year or less.

Sales and Similar Taxes


We report our revenue net of any sales or similar taxes we collect on behalf of governmental entities.

Product Warranty


Our photomasks are sold under warranties that generally range from one to twenty-four months. We warrant that our photomasks conform to customer specifications, and will typically repair, replace, or issue a refund for, at our option, any photomasks that fail to do so. The warranties do not represent separate performance obligations in our revenue contracts. Historically, customer claims under warranty have been immaterial.
NOTE 7 – LEASES


We adopted Accounting Standards Update (“ASU”) 2016-02 and all subsequent amendments, collectively codified in ASC Topic 842 “Leases” (“Topic 842”), on November 1, 2019. The guidance requires modified retrospective adoption, either at the beginning of the earliest period presented or at the beginning of the period of adoption. We elected to apply the guidance at the beginning of the period of adoption and recorded, as of November 1, 2019, right-of-use (ROU) leased assets of $6.5 million. In conjunction with this, we recorded lease liabilities, which had been discounted at our incremental borrowing rates, of $6.5 million.


The guidance allows a number of elections and practical expedients, of which we elected the following:

-
Election not to recognize short-term leases on the balance sheet.
-
Practical expedient to not separate lease and non-lease components in a contract.
-
Practical expedient “package” for transitioning to the new guidance:
-
Not reassessing whether any expired or existing contracts are, or contain, leases.
-
Not reassessing lease classification for any existing or expired leases.
-
Not reassessing initial direct costs for any existing leases.

16

Index

Our involvement in lease arrangements has typically been as a lessee. We determine if an agreement is or contains a lease on the date of the lease agreement or commitment, if earlier. Our evaluation considers whether the arrangement includes an identified asset and whether it affords us the right to control the asset. Our having the right to control the identified asset is determined by whether we are entitled to substantially all of its economic benefits and can direct its use.


We recognize leases on our consolidated balance sheet when a lessor makes an asset underlying a lease having a term in excess of twelve months available for our use. The present value of lease payments over the term of the lease, which is determined using our incremental borrowing rate for collateralized loans at the commencement date of the lease, provides the basis for the initial measurement of ROU assets and their related lease liabilities. Variable lease payments, other than those that are dependent on an index or on a rate, are not included in the measurement of ROU assets and their related lease liabilities. Lease terms will include extension periods if the lease agreement includes an option to extend the lease that we are reasonably certain to exercise.


ROU assets underlying our leases include the land and facilities of some of our operating facilities, other real property, and machinery and equipment. As of May 3, 2020, we had ROU assets under operating leases of $6.5 million, included in “Other Assets”, and $1.8 and $4.1 million of lease liabilities, included in Accrued liabilities and Other liabilities, respectively. The following tables present lease payments under non-cancellable leases as of May 3, 2020.

 
 
Fiscal Year
                     
 
 
2020
   
2021
   
2022
   
2023
   
2024
   
Thereafter
   
Total Lease
Payments
   
Imputed
Interest*
   
Total
 
Lease payments
 
$
996
   
$
1,802
   
$
1,686
   
$
787
   
$
444
   
$
391
   
$
6,106
   
$
(255
)
 
$
5,851
 


*Imputed interest represents difference between undiscounted cash flows and discounted cash flows.



The following table presents lease costs for the three and six-month periods ended May 3, 2020.

 
Three Months Ended
   
Six Months Ended
 
   
May 3, 2020
   
May 3, 2020
 
             
Operating lease costs
 
$
633
   
$
1,797
 
Short-tern lease costs
 
$
102
   
$
212
 
Variable lease costs
 
$
129
   
$
129
 


Presented below is other information related to our operating leases.

Supplemental cash flows information:
           
   
Three Months Ended
   
Six Months Ended
 
   
May 3, 2020
   
May 3, 2020
 
             
Operating cash flows used for operating leases
 
$
502
   
$
2,387
 
ROU assets obtained in exchange for lease obligations
 
$
58
   
$
340
 

 
 
As of
 
 
 
May 3, 2020
 
 
     
Weighted-average remaining lease term
 
3.7 years
 
Weighted-average discount rate
   
2.41
%

17

Index

Rent expense, as calculated under guidance in effect prior to our adoption of the new leases guidance, was $3.0 million in fiscal year 2019. At October 31, 2019, future minimum lease payments under non-cancelable operating leases with initial terms in excess of one year were as presented in the table below. The amounts are undiscounted and were calculated in accordance with guidance in effect prior to our adoption of the new leases guidance.

2020
 
$
1,885
 
2021
   
1,613
 
2022
   
1,535
 
2023
   
742
 
2024
   
424
 
Thereafter
   
377
 
   
$
6,576
 

NOTE 8 - SHARE-BASED COMPENSATION


In March 2016, shareholders approved a new equity incentive compensation plan (the “Plan”), under which incentive stock options, non-qualified stock options, stock grants, stock-based awards, restricted stock, restricted stock units, stock appreciation rights, performance units, performance stock, and other stock or cash awards may be granted. Shares to be issued under the Plan may be authorized and unissued shares, issued shares that have been reacquired by us (in the open-market or in private transactions) and are being held in the treasury, or a combination thereof. The maximum number of shares of common stock approved that may be issued under the Plan is four million shares. Awards may be granted to officers, employees, directors, consultants, advisors, and independent contractors of Photronics or its subsidiaries. In the event of a change in control (as defined in the Plan), the vesting of awards may be accelerated. The Plan, aspects of which are more fully described below, prohibits further awards from being issued under prior plans. Total share-based compensation costs for the three and six-month periods ended May 3, 2020, were $1.2 million and $2.6 million, respectively, and $0.9 million and $2.0 million for the three and six-month periods ended April 28, 2019, respectively. No share-based compensation cost was capitalized as part of an asset and no related income tax benefits were recorded during the periods presented.

Restricted Stock


We periodically grant restricted stock awards, the restrictions on which typically lapse over a service period of one-to-four years. The fair value of the awards is determined on the date of grant, based on the closing price of our common stock. There were 5,000 restricted stock awards granted during the three-month period ended May 3, 2020, with a grant-date fair value of $9.90 per share, and there were 527,000 restricted stock awards granted during the six-month period ended May 3, 2020, with a grant-date fair value of $15.21 per share. There were 435,000 restricted stock awards granted during the six-month period ended April 28, 2019, with a weighted-average grant-date fair value of $9.80 per share. As of May 3, 2020, the total compensation cost not yet recognized related to unvested restricted stock awards was approximately $8.9 million. That cost is expected to be recognized over a weighted-average amortization period of 3.1 years. As of May 3, 2020, there were 854,866 shares of restricted stock outstanding.

Stock Options


Option awards generally vest in one-to-four years, and have a ten-year contractual term. All incentive and non-qualified stock option grants have an exercise price no less than the market value of the underlying common stock on the date of grant. The grant date fair values of options are based on closing prices of our common stock on the dates of grant and are calculated using the Black-Scholes option pricing model. Expected volatility is based on the historical volatility of our common stock. We use historical option exercise behavior and employee termination data to estimate expected term, which represents the period of time that options are expected to remain outstanding. The risk-free rate of return for the estimated term of the option is based on the U.S. Treasury yield curve in effect at the date of grant.


There were no share options granted during the six-month period ended May 3, 2020, or the three-month period ended April 28, 2019. There were 132,000 share options granted during the six-month period ended April 28, 2019, with a weighted-average grant-date fair value of $3.31 per share. The Company received cash from option exercises of $0.4 million and $3.2 million for the three and six-month periods ended May 3, 2020, respectively, and $0.3 million and $0.8 million for the three and six-month periods ended April 28, 2019, respectively. As of May 3, 2020, the total unrecognized compensation cost related to unvested option awards was approximately $0.6 million. That cost is expected to be recognized over a weighted-average amortization period of 2.0 years.

18

Index

The weighted-average inputs and risk-free rate of return ranges used to calculate the grant-date fair value of options issued during the six-month period ended April 28, 2019, are presented in the following table.

 
Six Months Ended
 
   
April 28, 2019
 
       
Volatility
   
33.1
%
         
Risk free rate of return
   
2.5-2.9
%
         
Dividend yield
   
0.0
%
         
Expected term
 
5.1 years
 


Information on outstanding and exercisable option awards as of May 3, 2020, is presented below.

Options
 
Shares
   
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life
 
Aggregate
Intrinsic
Value
 
                     
Outstanding at May 3, 2020
   
1,723,652
   
$
9.16
 
5.1 years
 
$
4,000
 
                           
Exercisable at May 3, 2020
   
1,433,324
   
$
9.07
 
4.6 years
 
$
3,494
 

NOTE 9 - INCOME TAXES


We calculate our provision for income taxes at the end of each interim reporting period on the basis of an estimated annual effective tax rate adjusted for tax items that are discrete to each period.


The effective tax rate of 32.2% exceeds the U.S. statutory rate of 21.0% in the three-month period ended May 3, 2020, primarily due to the non-recognition of the tax benefit of losses that, in certain jurisdictions, have been offset by valuation allowances, which were partially offset by the benefit of tax holidays and investment credits in certain foreign jurisdictions.


The effective tax rate of 40.5% exceeds the U.S. statutory rate of 21.0% in the six-month period ended May 3, 2020, primarily due to the non-recognition of the tax benefit of losses that, in certain jurisdictions, have been offset by valuation allowances, and the establishment of a valuation allowance for a loss carryforward in a non-U.S. jurisdiction, which were partially offset by the benefits of tax holidays and investment credits in certain foreign jurisdictions.


Valuation allowances, in jurisdictions with historic losses, eliminate the current tax benefit of losses in these jurisdictions where, based on the weight of information available to us, we determined that it is more likely than not that the tax benefits will not be realized. In the three-month period ended February 2,2020, as a result of the reassessment of the aforementioned available information, we established a valuation allowance of $2.1 million against a non-U.S. based loss-carryforward deferred tax asset that is not more likely than not to be realized.


Unrecognized tax benefits related to uncertain tax positions were $1.8 million at May 3, 2020, and $1.9 million at October 31, 2019, substantially all of which, if recognized, would favorably impact the Company’s effective tax rate. Accrued interest and penalties related to unrecognized tax benefits was $0.2 million at May 3, 2020 and October 31, 2019. Although the timing of the expirations of statutes of limitations may be uncertain, as they can be dependent upon the settlement of tax audits, the Company believes that the amount of uncertain tax positions (including interest and penalties, and net of tax benefits) that may be resolved over the next twelve months is immaterial. Resolution of these uncertain tax positions may result from either or both the lapses of statutes of limitations and tax settlements. The Company is no longer subject to tax authority examinations in the U.S. and major foreign or state jurisdictions for years prior to fiscal year 2015.


We were granted a five-year tax holiday in Taiwan that expired on December 31, 2019. This tax holiday reduced foreign taxes by $0.1 million in the six-month period ended May 3, 2020, by $0.3 million and $1.1 million in the three and six-month periods ended April 28, 2019, respectively, with immaterial per share impacts in the six-month period ended May 3, 2020, and the three-month period ended April 28, 2019, and a one cent per share effect in the six-month period ended April 28, 2019.

19

Index

The effective tax rate of 25.0% differs from the U.S. statutory rate of 21.0% in the three-month period ended April 28, 2019, primarily due to the elimination of tax benefits in jurisdictions, including the U.S., in which it is not more likely than not that the benefit will be realized; the effects of these eliminations were partially offset by the benefits of tax holidays and investment credits in certain foreign jurisdictions.


The effective tax rate of 20.9% differs from the U.S. statutory rate of 21.0% in the six-month period ended April 28, 2019, primarily due to the elimination of the tax benefits in jurisdictions, including the U.S., in which it is not more likely than not that the benefit will be realized; the effects of these eliminations were partially offset by the benefits of the settlement of a tax audit, as well as a tax holiday and investment credits in certain foreign jurisdictions.


NOTE 10 - EARNINGS PER SHARE


The calculation of basic and diluted earnings per share is presented below.

 
Three Months Ended
   
Six Months Ended
 
   
May 3,
2020
   
April 28,
2019
   
May 3,
2020
   
April 28
2019
 
                         
Net income attributable to Photronics, Inc. shareholders
 
$
6,284
   
$
8,479
   
$
16,584
   
$
13,746
 
                                 
Effect of dilutive securities:
                               
Interest expense on convertible notes, net of tax
   
-
     
349
     
-
     
845
 
                                 
Earnings used for diluted earnings per share
 
$
6,284
   
$
8,828
   
$
16,584
   
$
14,591
 
                                 
Weighted-average common shares computations:
                               
Weighted-average common shares used for basic earnings per share
   
64,937
     
66,261
     
65,246
     
66,422
 
Effect of dilutive securities:
                               
Share-based payment awards
   
480
     
438
     
687
     
451
 
Convertible notes
   
-
     
3,898
     
-
     
4,720
 
                                 
Potentially dilutive common shares
   
480
     
4,336
     
687
     
5,171
 
                                 
Weighted-average common shares used for diluted earnings per share
   
65,417
     
70,597
     
65,933
     
71,593
 
                                 
                                 
Basic earnings per share
 
$
0.10
   
$
0.13
   
$
0.25
   
$
0.21
 
Diluted earnings per share
 
$
0.10
   
$
0.13
   
$
0.25
   
$
0.20
 


The table below shows the outstanding weighted-average share-based payment awards that were excluded from the calculation of diluted earnings per share because their exercise price exceeded the average market value of the common shares for the period or, under application of the treasury stock method, they were otherwise determined to be antidilutive.

 
Three Months Ended
   
Six Months Ended
 
   
May 3,
2020
   
April 28,
2019
   
May 3,
2020
   
April 28,
2019
 
                         
Share-based payment awards
   
1,009
     
1,204
     
591
     
1,134
 
                                 
Total potentially dilutive shares excluded
   
1,009
     
1,204
     
591
     
1,134
 


20

Index
NOTE 11 - CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME BY COMPONENT


The following tables set forth the changes in our accumulated other comprehensive income by component (net of tax of $0) for the three and six-month periods ended May 3, 2020 and April 28, 2019.

 
Three Months Ended May 3, 2020
 
   
Foreign Currency
Translation
Adjustments
   
Other
   
Total
 
                   
Balance at February 3, 2020
 
$
(11,076
)
 
$
(666
)
 
$
(11,742
)
Other comprehensive (loss) income
   
(2,405
)
   
1
     
(2,404
)
Less: other comprehensive income attributable to noncontrolling interests
   
1,054
     
-
     
1,054
 
                         
Balance at May 3, 2020
 
$
(14,535
)
 
$
(665
)
 
$
(15,200
)

 
Three Months Ended April 28, 2019
 
   
Foreign Currency
Translation
Adjustments
   
Other
   
Total
 
                   
                   
Balance at January 28, 2019
 
$
971
   
$
(628
)
 
$
343
 
Other comprehensive (loss) income
   
(7,054
)
   
25
     
(7,029
)
Less: other comprehensive income attributable to noncontrolling interests
   
129
     
13
     
142
 
                         
Balance at April 28, 2019
 
$
(6,212
)
 
$
(616
)
 
$
(6,828
)

 
Six Months Ended May 3, 2020
 
   
Foreign Currency
Translation
Adjustments
   
Other
   
Total
 
                   
Balance at November 1, 2019
 
$
(8,331
)
 
$
(674
)
 
$
(9,005
)
Other comprehensive (loss) income
   
(3,970
)
   
19
     
(3,951
)
Less: other comprehensive income attributable to noncontrolling interests
   
2,234
     
10
     
2,244
 
                         
Balance at May 3, 2020
 
$
(14,535
)
 
$
(665
)
 
$
(15,200
)
21

Index

 
Six Months Ended April 28, 2019
 
   
Foreign Currency
Translation
Adjustments
   
Other
   
Total
 
                   
Balance at November 1, 2018
 
$
(4,328
)
 
$
(638
)
 
$
(4,966
)
Other comprehensive (loss) income
   
(482
)
   
44
     
(438
)
Less: other comprehensive income attributable to noncontrolling interests
   
1,402
     
22
     
1,424
 
                         
Balance at April 28, 2019
 
$
(6,212
)
 
$
(616
)
 
$
(6,828
)

NOTE 12 - FAIR VALUE MEASUREMENTS


The accounting framework for determining fair value includes a hierarchy for ranking the quality and reliability of the information used to measure fair value, which enables the reader of the financial statements to assess the inputs used to develop those measurements. The fair value hierarchy consists of three tiers as follows: Level 1, defined as quoted market prices (unadjusted) in active markets for identical securities; Level 2, defined as inputs other than Level 1 that are observable, either directly or indirectly; and Level 3, defined as unobservable inputs that are not corroborated by market data.


The fair values of our cash and cash equivalents (Level 1 measurements), accounts receivable, accounts payable, and certain other current assets and current liabilities (Level 2 measurements) approximate their carrying values due to their short-term maturities. The fair values of our variable rate debt instruments are a Level 2 measurement and approximates their carrying values due to the variable nature of the underlying interest rates. We did not have any assets or liabilities measured at fair value, on a recurring or a nonrecurring basis, at May 3, 2020 or October 31, 2019.

NOTE 13 – SHARE REPURCHASE PROGRAMS


In August 2019, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b5-1 of the Securities Act of 1933 (as amended). The company commenced repurchasing shares under this authorization on September 25, 2019. All of the 0.9 million shares repurchased under this authorization prior to November 1, 2019, were retired in fiscal 2019; the repurchase program was terminated on March 20, 2020. The table below presents information on this repurchase program.

 
Three Months Ended May 3, 2020
   
Six Months Ended May 3, 2020
   
From Inception Date of
September 25, 2019
 
                   
Number of shares repurchased
   
549
     
1,464
     
2,460
 
                         
Cost of shares repurchased
 
$
5,894
   
$
16,894
   
$
27,894
 
                         
Average price paid per share
 
$
10.75
   
$
11.54
   
$
11.34
 


In October 2018, the Company’s board of directors authorized the repurchase of up to $25 million of its common stock, to have been executed in open-market transactions or in accordance with a repurchase plan under Rule 10b5-1 of the Securities Act of 1933 (as amended). The share repurchase program commenced on October 22, 2018, and was terminated on February 1, 2019. All of the shares repurchased under this program were retired in fiscal 2019. The table below presents information on this repurchase program.
22

Index

 
Three Months Ended
January 27, 2019
   
From Inception Date of
October 22, 2018
 
             
Number of shares repurchased
   
1,137
     
1,467
 
                 
Cost of shares repurchased
 
$
10,694
   
$
13,807
 
                 
Average price paid per share
 
$
9.40
   
$
9.41
 

NOTE 14 - COMMITMENTS AND CONTINGENCIES


As of May 3, 2020, the Company had commitments outstanding for capital expenditures of approximately $138 million, primarily for the purchase of high-end IC equipment. See Note 7 for information on our operating lease commitments.


The Company’s wholly owned subsidiary in South Korea has been involved in litigation regarding a 2016 informational tax filing for its non-South Korean bank accounts that was not timely made under a then recently issued presidential decree. A fine (based solely on the amount in such accounts) in the amount of $2.2 million was assessed against our subsidiary. Our subsidiary appealed the fine on the grounds that it was not required to make the tax filing, and such appeal was pursued up to the Supreme Court in South Korea. Under South Korean law, the tax authorities were entitled to pursue the matter in both civil and criminal courts simultaneously, with the proviso that any criminal fine imposed would act to dismiss any civil fine. The prosecutor recommended a fine of $0.03 million. The civil matter has subsequently been dismissed. Photronics was notified on March 12, 2020, that the Supreme Court rendered a decision against our subsidiary on the issue of whether our subsidiary was required to make the tax filing and remanded the case to the appellate court for determination of the fine. We are awaiting a trial date from the appellate court. Prior to the Supreme Court decision, the possibility of a fine had been deemed remote, as our initial assessment based on advice of local counsel and the subsequent judgments in the lower courts were all in our favor. Our estimate of the possible range of loss is $0.03 million to $2.2 million with the most likely amount being $0.03 million (based on the prosecutor’s recommendation). Accordingly, during the three-month period ended May 3, 2020, we accrued a contingent loss of $0.03 million with a charge to Selling, general and administrative expense in the consolidated statements of income. It is reasonably possible that the estimated loss will change in the near term. Our exposure to loss in excess of amounts accrued is $2.17 million. The imposition of the fine will not have a material impact on our financial position or financial performance.


We are subject to various other claims that arise in the ordinary course of business. We believe that our potential liability under such claims, individually or in the aggregate, will not have a material effect on the consolidated financial statements.

NOTE 15 - RECENT ACCOUNTING PRONOUNCEMENTS

Accounting Standards Updates Adopted


We adopted ASU 2016-02 and all subsequent amendments, collectively codified in ASC Topic 842 “Leases” (“Topic 842”), on November 1, 2019. The guidance requires modified retrospective adoption, either at the beginning of the earliest period presented or at the beginning of the period of adoption. We elected to apply the guidance at the beginning of the period of adoption and recorded, as of November 1, 2019, right-of-use (ROU) leased assets of $6.5 million. In conjunction with this, we recorded lease liabilities, which had been discounted at our incremental borrowing rates, of $6.5 million. Our adoption of Topic 842 did not affect our cash flows or our ability to comply with covenants under our credit agreement. Please see Note 7 for our leases disclosure.

Accounting Standards Updates to be Adopted


In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”, which provides optional expedients and exceptions to applying the guidance on contract modifications, hedge accounting, and other transactions, to simplify the accounting for transitioning from the London Interbank Offered Rate, and other interbank offered rates expected to be discontinued, to alternative reference rates. The guidance in this Update was effective upon its issuance; if elected, it is to be applied prospectively through December 31, 2022. We are currently evaluating the effect the potential adoption of this ASU will have on our consolidated financial statements.


In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses”, the main objective of which is to provide more useful information about expected credit losses on financial instruments and other commitments of an entity to extend credit. In support of this objective, the ASU replaces the incurred loss impairment methodology, found in current GAAP, with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. This ASU requires a cumulative-effect adjustment as of the beginning of the first reporting period in which the guidance is adopted. ASU 2016-13 is effective for Photronics in its first quarter of fiscal year 2021, with early adoption permitted beginning in the first quarter of fiscal year 2019. We have not early adopted and are currently evaluating the effect that this ASU will have on our consolidated financial statements.

23

Index

Item 2.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

Management's discussion and analysis ("MD&A") of the Company's financial condition, results of operations and outlook should be read in conjunction with its condensed consolidated financial statements and related notes. Various segments of this MD&A contain forward-looking statements, all of which are presented based on current expectations, which may be adversely affected by uncertainties and risk factors (presented throughout this filing and in the Company's Annual Report on Form 10-K for the fiscal 2019 year), that may cause actual results to materially differ from these expectations.

We sell substantially all of our photomasks to semiconductor designers and manufacturers, and manufacturers of FPDs. Photomask technology is also being applied to the fabrication of other higher-performance electronic products such as photonics, microelectronic mechanical systems and certain nanotechnology applications. Our selling cycle is tightly interwoven with the development and release of new semiconductor and FPD designs and applications, particularly as they relate to the semiconductor industry's migration to more advanced product innovation, design methodologies, and fabrication processes. We believe that the demand for photomasks primarily depends on design activity rather than sales volumes from products manufactured using photomask technologies. Consequently, an increase in semiconductor or FPD sales does not necessarily result in a corresponding increase in photomask sales. However, the reduced use of customized ICs, reductions in design complexity, other changes in the technology or methods of manufacturing or designing semiconductors, or a slowdown in the introduction of new semiconductor or FPD designs could reduce demand for photomasks ‒ even if the demand for semiconductors and FPDs increases. Advances in semiconductor, FPD, and photomask design and semiconductor and FPD production methods that shift the burden of achieving device performance away from lithography could also reduce the demand for photomasks. Historically, the microelectronic industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These downturns have been characterized by, among other things, diminished product demand, excess production capacity, and accelerated erosion of selling prices, with a concomitant effect on revenue and profitability.

We are typically required to fulfill customer orders within a short period of time after receipt of an order, sometimes within twenty-four hours. This results in a minimal level of backlog orders, typically one to two weeks of backlog for IC photomasks and two to three weeks of backlog for FPD photomasks.

The global semiconductor and FPD industries are driven by end markets which have been closely tied to consumer-driven applications of high-performance devices, including, but not limited to, mobile display devices, mobile communications, and computing solutions. While we cannot predict the timing of the industry's transition to volume production of next-generation technology nodes, or the timing of up and down cycles with precise accuracy, we believe that such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition, and operating results as they occur. We believe our ability to remain successful in these environments is dependent upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.

Recent Developments

In the first quarter of fiscal 2020, we acquired the remaining 0.2% of noncontrolling interests in Photronics Cheonan, Ltd. (formerly PK, Ltd.), our South Korean subsidiary, for $0.6 million.

In the first quarter of fiscal 2020, we adopted ASU 2016-02 and all subsequent amendments, collectively codified in Accounting Standards Codification Topic 842 - “Leases” (“Topic 842”). This guidance requires modified retrospective adoption, either at the beginning of the earliest period presented or at the beginning of the period of adoption; we elected to apply the guidance at the beginning of the period of adoption, and recognized right-of-use leased assets of $6.5 million and corresponding lease liabilities which were discounted at our incremental borrowing rates, on our November 1, 2019 condensed consolidated balance sheet to reflect our adoption of the guidance. Our adoption of Topic 842 did not affect our cash flows or our ability to comply with covenants under our credit agreements.

In the fourth quarter of fiscal 2019, our board of directors declared a dividend of one preferred stock purchase right (a “Right”), payable on or about October 1, 2019, for each share of common stock, par value $0.01 per share, of the Company outstanding on September 30, 2019, to the stockholders of record on that date. In connection with the distribution of the Rights, we entered into a Section 382 Rights Agreement (the “Rights Agreement”), dated as of September 23, 2019, between the Company and Computershare Trust Company, N.A., a federally chartered trust company, as rights agent. The purpose of the Rights Agreement is to deter trading of our common stock that would result in a change in control (as defined in Internal Revenue Code Section 382), thereby preserving our future ability to use our historical federal net operating losses and other Tax Attributes (as defined in the Rights Agreement). Each Right entitles the registered holder to purchase from the Company one one-thousandth of a share of Series A Preferred Stock, par value $0.01 per share, at a price of $33.63, subject to adjustment. The Rights, which are described in the Company’s Current Report on Form 8-K filed on September 24, 2019, are in all respects subject to and governed by the provisions of the Rights Agreement. The Rights will expire at the earliest to occur of (i) the close of business on the day following the date on which our board of directors determines, in its sole discretion, that the Rights Agreement is no longer necessary for the preservation of material valuable tax attributes, or the tax attributes have been fully utilized and may no longer be carried forward or (ii) the close of business on September 22, 2022.

24

Index
In the fourth quarter of fiscal 2019, PDMC, the Company’s majority-owned IC subsidiary in Taiwan, paid a dividend of which 49.99%, or approximately $18.9 million, was paid to noncontrolling interests.

In the fourth quarter of fiscal 2019, upon our request, a financing entity made an advance payment of $3.5 million to an equipment vendor. We entered into a Master Lease Agreement (“MLA”) with this financing entity, which became effective in July 2019. The MLA enables us to request advance payments or other funds to finance equipment to be leased or purchased in the U.S. In connection with this MLA, we have been approved for financing of $35 million for the purchase of a high-end lithography tool. Interest on this borrowing is payable monthly at thirty-day LIBOR plus 1% (1.79% at May 3, 2020), and will continue to accrue until the borrowing is repaid or, as allowed under the MLA, we enter into a lease for the equipment. We intend to enter into a lease agreement for the related equipment in fiscal year 2020.

In the fourth quarter of fiscal 2019, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b5-1 of the Securities Act of 1933 (as amended). We repurchased 2.5 million shares, at a cost of $27.9 million (an average price of $11.34 per share), under this authorization. All shares repurchased during fiscal 2019 (0.9 million) were retired in fiscal 2019; the repurchase program was terminated on March 20 2020.

In the second quarter of fiscal 2019, we repaid, upon maturity, the entire $57.5 million principal amount of the convertible senior notes we issued in April 2016.

In the first quarter of fiscal 2019, PDMC paid a dividend, of which 49.99%, or approximately $26.1 million, was paid to noncontrolling interests.

In the first quarter of fiscal 2019, PDMCX was approved for credit of the equivalent of $50 million, subject to certain limitations related to PDMCX registered capital at the time of the initial approval, pursuant to which PDMCX has and will enter into separate loan agreements (“the Project Loans”) for intermittent borrowings. The Project Loans, which are denominated in Chinese renminbi (RMB), are being used to finance certain capital expenditures in China. PDMCX granted liens on its interest in land, building, and certain equipment as collateral for the Project Loans. As of May 3, 2020, PDMCX had borrowed 243.4 million RMB ($34.5 million) against this approval. Payments on these borrowings are due semi-annually through December 2025; the initial payment is scheduled for June 2020. See Note 5 of the condensed consolidated financial statements for additional information on these loans.

In the first quarter of fiscal 2019, PDMCX received approval for unsecured credit of the equivalent of $25.0 million, pursuant to which PDMCX may enter into separate loan agreements. Under this credit agreement, PDMCX can borrow up to 140.0 million RMB to pay value-added taxes (“VAT”) and up to 60.0 million RMB to fund operations; combined total borrowings are limited to the equivalent of $25.0 million. As of May 3, 2020, PDMCX had outstanding 44.8 million RMB ($6.3 million) to fund operations, with repayments due one year from the borrowing dates of the separate loan agreements. As of May 3, 2020, PDMCX had outstanding 64.6 million RMB ($9.1 million) borrowed to pay VAT. Payments on these borrowings are due semiannually, in increasing amounts, through January 2022. See Note 5 of the condensed consolidated financial statements for additional information on these loans.

 In the fourth quarter of fiscal 2018, the Company’s board of directors authorized the repurchase of up to $25 million of its common stock, to have been executed in open-market transactions or in accordance with a repurchase plan under Rule 10b5-1 of the Securities Act of 1933 (as amended). The share repurchase program commenced, under Rule 10b5-1, on October 22, 2018, and was terminated on February 1, 2019. We repurchased 1.5 million shares at a cost of $13.8 million (an average of $9.41 per share) under this authorization.

25

Index
Results of Operations
Three and Six-Months ended May 3, 2020

The following table presents selected operating information expressed as a percent of revenue.

 
Three Months Ended
   
Six Months Ended
 
   
May 3,
2020
   
February 2,
2020
   
April 28,
2019
   
May 3,
2020
   
April 28,
2019
 
Revenue
   
100.0
%
   
100.0
%
   
100.0
%
   
100.0
%
   
100.0
%
Cost of goods sold
   
78.7
     
78.3
     
80.2
     
78.5
     
79.7
 
                                         
Gross profit
   
21.3
     
21.7
     
19.8
     
21.5
     
20.3
 
Selling, general and administrative expenses
   
9.3
     
8.9
     
10.1
     
9.2
     
10.6
 
Research and development expenses
   
3.1
     
2.6
     
2.7
     
2.7
     
3.0
 
                                         
Operating income
   
8.9
     
10.2
     
7.0
     
9.6
     
6.7
 
Other income (expense), net
   
(0.7
)
   
2.3
     
3.0
     
0.9
     
2.0
 
                                         
Income before income taxes
   
8.2
     
12.5
     
10.0
     
10.5
     
8.7
 
Income tax provision
   
2.6
     
5.7
     
2.5
     
4.3
     
1.8
 
                                         
Net income
   
5.6
     
6.8
     
7.5
     
6.2
     
6.9
 
Net income attributable to noncontrolling interests
   
1.2
     
0.4
     
1.1 1.1
     
0.7
     
1.5
 
                                         
Net income attributable to Photronics, Inc. shareholders
   
4.4
%
   
6.4
%
   
6.4
%
   
5.5
%
   
5.4
%

Note: All tabular comparisons included in the following discussion, unless otherwise indicated, are for the three months ended May 3, 2020 (Q2 FY20), February 2, 2020 (Q1 FY20) and April 28, 2019 (Q2 FY19), and for the six months ended May 3, 2020 (YTD FY20) and April 28, 2019 (YTD FY19), in millions of dollars.

Revenue

Our quarterly revenues can be affected by the seasonal purchasing practices of our customers. As a result, demand for our products is typically reduced during the first, and sometimes the second, quarters of our fiscal year, by the North American, European, and Asian holiday periods, as some of our customers reduce their development and, consequently, their buying activities during those periods.

At the beginning of fiscal year 2020, we changed the threshold for the definition of high-end FPD, from G8 and above and active matrix organic light-emitting diode (AMOLED) display screens, to G10.5 and above, AMOLED, and low-temperature polysilicon display screens (LTPS), to reflect the overall advancement of technology in the FPD industry. Our definition of high-end IC products remains as 28 nanometer or smaller. The following analyses of quarterly changes in revenue by product type for the three-month periods ended February 2, 2020 and April 28, 2019, and the six-month period ended April 28, 2019, have been modified to reflect this change. High-end photomasks typically have higher selling prices (ASPs) than mainstream products.

26

Index
The following tables present changes in disaggregated revenue in Q2 FY20 and YTD FY20 from revenue in prior reporting periods. Columns may not total due to rounding.

Quarterly Changes in Revenue by Product Type

 
Q2 FY20 from Q1 FY20
   
Q2 FY20 from Q2 FY19
   
YTD FY20 from YTD FY19
 
   
Revenue in
Q2 FY20
   
Increase
(Decrease)
   
Percent
Change
   
Increase
(Decrease)
   
Percent
Change
   
Revenue in
YTD FY20
   
Increase
(Decrease)
   
Percent
Change
 
IC
                                               
High-end
 
$
38.3
   
$
(2.8
)
   
(6.8
)%
 
$
(0.2
)
   
(0.4
)%
 
$
79.3
   
$
6.3
     
8.6
%
Mainstream
   
58.6
     
(7.4
)
   
(11.2
)%
   
(1.6
)
   
(2.6
)%
   
124.5
     
4.0
     
3.4
%
                                                                 
Total IC
 
$
96.8
   
$
(10.1
)
   
(9.5
)%
 
$
(1.7
)
   
(1.8
)%
 
$
203.8
   
$
10.4
     
5.4
%
                                                                 
FPD
                                                               
High-end
 
$
31.8
   
$
(8.0
)
   
(20.0
)%
 
$
9.8
     
44.2
%
 
$
71.6
   
$
34.2
     
91.4
%
Mainstream
   
14.1
     
1.1
     
8.7
%
   
3.2
     
29.0
%
   
27.1
     
1.7
     
6.6
%
                                                                 
Total FPD
 
$
45.9
   
$
(6.8
)
   
(12.9
)%
 
$
12.9
     
39.2
%
 
$
98.7
   
$
35.9
     
57.1
%
                                                                 
Total Revenue
 
$
142.8
   
$
(17.0
)
   
(10.6
)%
 
$
11.2
     
8.5
%
 
$
302.5
   
$
46.2
     
18.0
%

Quarterly Changes in Revenue by Geographic Origin

 
Q2 FY20 from Q1 FY20
   
Q2 FY20 from Q2 FY19
         
YTD FY20 from YTD FY19
 
   
Revenue in
Q2 FY20
   
Increase
(Decrease)
   
Percent
Change
   
Increase
(Decrease)
   
Percent
Change
   
Revenue in
YTD FY20
   
Increase
(Decrease)
   
Percent
Change
 
Taiwan
 
$
55.5
   
$
(10.6
)
   
(16.0
)%
 
$
(1.0
)
   
(1.7
)%
 
$
121.6
   
$
7.4
     
6.5
%
Korea
   
36.3
     
(4.5
)
   
(11.0
)%
   
(1.8
)
   
(4.7
)%
   
77.0
     
3.7
     
5.1
%
United States
   
24.9
     
(0.2
)
   
(0.8
)%
   
(1.9
)
   
(7.0
)%
   
49.9
     
0.7
     
1.4
%
Europe
   
8.3
     
0.8
     
10.4
%
   
(0.1
)
   
(1.2
)%
   
15.9
     
(0.9
)
   
(5.4
)%
China
   
17.5
     
(2.4
)
   
(12.1
)%
   
16.0
     
1,091.8
%
   
37.4
     
35.7
     
2,060.9
%
Other
   
0.3
     
0.0
     
(13.2
)%
   
(0.1
)
   
(24.0
)%
   
0.7
     
(0.4
)
   
(34.7
)%
                                                                 
   
$
142.8
   
$
(17.0
)
   
(10.6
)%
 
$
11.2
     
8.5
%
 
$
302.5
   
$
46.2
     
18.0
%

Revenue decreased $17.0 million, or 10.6%, in Q2 FY20, compared with Q1 FY20, primarily due to push-outs of orders, first in China, due to the extended Lunar New Year period and concomitant reductions in manufacturing activity attributable to the coronavirus pandemic, and then in our other sites, as we encountered mobility restrictions due to the pandemic. The greatest impact of these restrictions was experienced in the mainstream IC and high-end FPD product lines. On a geographic basis, Asia revenue declined in varying degrees, the U.S. revenue was essentially flat, and Europe revenue increased $0.8 million or 10.4%. Most of our IC customers’ products have been deemed to be essential. However, with many of their design teams working remotely, design verification processes have been delayed, resulting in delays in their orders. Our three FPD facilities operated at capacity in Q2 FY20, but orders for G10.5+ products decreased from Q1 FY20, resulting in lower high-end and total FPD revenue in the current quarter.

Revenue increased 8.5% in Q2 FY20, compared with Q2 FY19, due to increased high-end and mainstream FPD revenues. The increases reflected both stronger global demand and our increased ability to meet it through the utilization of our China-based FPD factory. IC revenues declined moderately by 1.8%, as design releases were behind schedule due to delays in design verification processes. On a geographic basis, the increase in revenue was attributable to revenues in our two China-based facilities.

On a year-to-date basis, revenues increased $46.2 million, or 18.0%, from YTD FY19, resulting from growth in all product categories, led by high-end FPD, which grew $34.2 million, or 91.4%, from the prior year period. While this growth was led by increased revenues from G10.5+ products, there were also significant increases in revenues from both AMOLED and LTPS products. On a geographic basis, approximately 77% of the increase was attributable to revenues in our two China-based sites.

27

Index
Gross Margin

 
Three Months Ended
   
Six Months Ended
 
   
Q2 FY20
   
Q1 FY20
   
Percent
Change
   
Q2 FY19
   
Percent
Change
   
YTD FY20
   
YTD FY19
   
Percent
Change
 
                                                 
                                                 
Gross profit
 
$
30.4
   
$
34.6
     
(12.0
)%
 
$
26.0
     
17.0
%
 
$
65.0
   
$
52.1
     
24.8
%
Gross margin
   
21.3
%
   
21.7
%
           
19.8
%
           
21.5
%
   
20.3
%
       

Gross margin decreased by 0.4% in Q2 FY20, from Q1 FY20, primarily as a result of the previously discussed 10.6% decrease in revenue. Total cost of goods sold decreased 10.2%, with the primary drivers being: an 11.8% decrease in material costs, reflecting the decrease in revenue; a decrease in compensation and related costs of 10.3%; a decrease in overhead costs of 8.9%, as variable and discretionary expenses declined in most categories, with the most notable exception being tool maintenance, which increased $0.6 million, or 11.3%.

Gross margin increased by 1.5 percentage points in Q2 FY20, from Q2 FY19, primarily as a result of the 8.5% growth in revenue in the current year quarter. Material costs, as a percent of revenue, increased 1.0%, in contrast to labor costs, which decreased by 1.8 percentage points as a percent of revenue. Overhead costs increased 6.2%, with depreciation at our two China-based facilities, both of which began production in fiscal year 2019, the predominant cause. Net of depreciation at the China-based facilities, overhead costs decreased 1.0% from the prior year quarter.

Gross margin increased by 1.2% in YTD FY20, from YTD FY19, primarily as a result of the 18.0% increase in revenue. Material costs, as a percent of revenue, increased 1.1 percentage points, in contrast to labor costs, which fell 1.7%, as a percent of revenue. Overhead costs increased 16.8%, with depreciation at our two China-based facilities, which began production in FY19, accounting for approximately half of the increase. Other outside services and other equipment related costs were up 27.5% and 15.6%, respectively, contributing significantly to the overall increase in overhead costs.

As we operate in a high fixed cost environment, increases or decreases in our revenues and capacity utilization will generally positively or negatively impact our gross margin.

Selling, General and Administrative Expenses

Selling, general and administrative expenses decreased by $1.0 million, or 6.7%, to $13.3 million in Q2 FY20, from $14.2 million in Q1 FY20, primarily due to decreased compensation and related expenses. Selling, general and administrative expenses was unchanged from Q2 FY19, decreasing by 0.8 percentage points, as a percent of revenue. Selling, general and administrative expenses increased by $0.4 million, or 1.5%, to $27.5 million in YTD FY20, from $27.1 million in YTD FY19, primarily due to increased compensation and related expenses.

Research and Development Expenses

Research and development expenses consist of development efforts generally related to process technologies for high-end IC nodes and FPD applications.

Research and development expense increased $0.4 million, to $4.5 million, or 9.4%, in Q2 FY20, from Q1 FY20, primarily as a result of increased FPD development activities in China and IC development activities in the U.S. Research and development expense increased $ 0.9 million, or 26.0%, in Q2 FY20, from Q2 FY19, due to increased spending in the U.S. and the two China-based facilities. Research and development expense increased $ 0.7 million, or 9.4%, in YTD FY20, from YTD FY19, primarily due to increased development activities at the two China-based facilities, which were partially offset by reduced activities in the U.S.

28

Index
Other Income (Expense)

 
Three Months Ended
   
Six Months Ended
 
   
Q2 FY20
   
Q1 FY20
   
Q2 FY19
   
YTD FY20
   
YTD FY19
 
                               
                               
Foreign currency transaction (losses) gains, net
 
$
(1.4
)
 
$
4.7
   
$
4.0
   
$
3.3
   
$
5.1
 
Interest expense, net
   
0.8
     
(1.8
)
   
(0.4
)
   
(1.0
)
   
(0.9
)
Interest income and other income (expense), net
   
(0.3
)
   
0.8
     
0.3
     
0.5
     
0.9
 
                                         
Other income (expense), net
 
$
(1.0
)
 
$
3.7
   
$
3.9
   
$
2.8
   
$
5.0
 

Other income (expense), net decreased $4.7 million from income of $3.7 million in Q1 FY20 to a loss of $1.0 million in Q2 FY20, primarily due to an unfavorable change in foreign currency transaction results of $6.1 million, partially offset by the receipt of interest subsidies in Q2 F20. Other income (expense), net decreased by $4.9 million, from income of $3.9 million in Q2 FY19, to the loss of $1.0 million in Q2 FY20; this loss was primarily due to an unfavorable change in foreign currency transaction results of $5.4 million. Other income (expense), net decreased $2.2 million year-to-date primarily due to a decrease in foreign currency exchange gains of $1.8 million in YTD FY20, compared with the prior year period.

Income Tax Provision

 
Three Months Ended
   
Six Months Ended
 
   
Q2 FY20
   
Q1 FY20
   
Q2 FY19
   
YTD FY20
   
YTD FY19
 
                               
                               
Income tax provision
 
$
3.8
   
$
9.1
   
$
3.3
   
$
12.9
   
$
4.7
 
Effective income tax rate
   
32.2
%
   
45.4
%
   
25.0
%
   
40.5
%
   
20.9
%

The effective income tax rate is sensitive to the jurisdictional mix of earnings, due, in part, to the non-recognition of tax benefits on losses in jurisdictions with valuation allowances.

The effective income tax rate decreased in Q2 FY20, compared with Q1 FY20, primarily due to the establishment of a valuation allowance for a loss carryforward in a non-U.S. jurisdiction in Q1 FY20 and changes in the jurisdictional mix of earnings. The effective income tax rate increased in Q2 FY20, compared with Q2 FY19, due to changes in the jurisdictional mix of earnings and the expiration of a tax holiday in Taiwan in December 2019.

The effective income tax rate increased in YTD FY20, compared with YTD FY19, primarily due to the YTD FY20 establishment of a valuation allowance for a loss carryforward in a non-U.S. jurisdiction, which was partially offset by a non-repetitive, one-time audit settlement benefit in YTD FY19, as well as changes in the jurisdictional mix of earnings, the expiration of a tax holiday in Taiwan, and use of investment credits to reduce tax expense in 2019.

Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $1.7 million in Q2 FY20, which represented an increase of $1.1 million from Q1 FY20, as a decreased loss at our China-based IC facility exceeded decreased income at our Taiwan-based IC facility. Net income attributable to noncontrolling interests increased $0.3 million in Q2 FY20 from $1.4 million in Q2 FY19, as a result of increased income at our Taiwan-based IC facility, and a decreased loss at our China-based IC facility. On a year-to-date basis, net income attributable to noncontrolling interests decreased $1.6 million; the decrease was the result of an increased loss at the China-based facility, which was partially offset by increased income at the Taiwan-based facility. We hold 50.01% ownership interests in both of these facilities.

Liquidity and Capital Resources

We had cash and cash equivalents of $237.8 million at the end of Q2 FY20, compared with $206.5 million at the end of fiscal 2019. The net increase is primarily attributable to:

-
$61.3 million provided by operating activities;
-
$7.6 million contributed to our China-based IC facility by noncontrolling interests;
-
$5.3 million government incentives received in China;
-
$3.4 million received from exercises of employee stock options;
-
$1.1 million received from borrowings in China;
-
$30.1 million paid for property, plant, and equipment;
-
$16.9 million used to repurchase our common stock.

29

Index
Our working capital at the end of Q2 FY20 was $318.9 million, compared with $275.6 million at the end of fiscal 2019. The $43.3 million net increase is primarily attributable to the below increases (decreases) in working capital:

-
Increased cash and cash equivalents of $31.3 million;
-
Increased inventories of $8.8 million, acquired to protect against potential COVID 19 related supply chain disruptions;
-
Increased recoverable value added taxes of $6.2 million, related to our China-based facilities;
-
Decreased discretionary compensation accruals of $5.3 million;
-
Decreased accruals for capital expenditures of $4.6 million;
-
Increased current portion of long-term debt of $(6.8) million;
-
Increased value added taxes payable of $(6.3) million.

The net cash provided by operating activities of $61.3 million in YTD FY20 was a $63.6 million increase from $2.3 million used in YTD FY19. The net increase was primarily due to:

-
Increased net income of $1.3 million in YTD FY20;
-
Increased non-cash add backs to net income, including depreciation, share-based compensation and deferred income taxes of  $10.2 million in YTD FY20;
-
A comparative decrease in value added tax prepayments related to our China facilities of $25.1 million inQ1 FY20. These  prepayments are recoverable through future revenue transactions of the facilities;
-
A comparative decrease in the increase of prepaid income taxes of $2.8 million in YTD FY20;
-
Increased operating lease liabilities of $1.8 million, which resulted from our adoption of ASC 842 in Q1 FY20.

Net cash used in investing activities was $25.0 million in YTD FY20, a decrease of $109.8 million from the $134.8 million used in YTD FY19. The net decrease was primarily attributable to decreased capital expenditures of $110.3 million; this was the result of a reduction in payments to equip our China-based facilities, which were in the start-up phase in the first half of fiscal year 2019.

Net cash flows used in financing activities decreased to $5.4 million in YTD FY20 from $28.0 million used in YTD FY19. Significant components of the $22.6 million net decrease were:

-
$57.5 million used to repay (upon their maturity) our convertible senior notes in YTD FY19;
-
$26.1 million used to pay dividends to DNP (related to their 49.99% interest in our IC facility in Taiwan) in YTD FY19;
-
$(38.5) million less received from borrowings in China in YTD FY20 than in YTD FY19;
-
$(21.8) million less contributed by DNP to maintain their proportionate ownership interest in our IC joint venture in China  in YTD FY20 than in YTD FY19.

As of May 3, 2020 and October 31, 2019, our total cash and cash equivalents included $192.7 million and $147.2 million, respectively, held by our foreign subsidiaries. The majority of earnings of our foreign subsidiaries are considered to be indefinitely reinvested. Repatriation of these funds to the U.S. may subject them to U.S. state income taxes and local country withholding taxes in certain jurisdictions. Furthermore, our foreign subsidiaries continue to grow through the reinvestment of earnings in additional manufacturing capacity and capability, particularly in the high-end IC and FPD areas.

Our liquidity, as we operate in a high fixed cost environment, is highly dependent on our revenue, cash conversion cycle, and the timing of our capital expenditures (which can vary significantly from period to period). We believe that our cash on hand, cash generated from operations, and amounts available to borrow will be sufficient to meet our cash requirements for the next twelve months. However, depending on conditions in the semiconductor and FPD markets, our cash flows from operations and current holdings of cash may not be adequate to meet our current and long-term needs for capital expenditures, operations and debt repayments. Historically, in certain years, we have used external financing to fund these needs. Due to conditions in the credit markets and covenant restrictions on our existing debt, some financing instruments we have used in the past may not be available to us when required. Consequently, we cannot assure that additional sources of financing would be available to us on commercially favorable terms, should our long-term cash requirements exceed our existing cash and cash available under our credit agreements (which are discussed in Note 5 to the condensed consolidated financial statements).

30

Index
As of May 3, 2020, we had outstanding capital commitments of approximately $138 million. We intend to finance our capital expenditures with our working capital, contributions from our joint venture partners, borrowings under the MLA we entered into in fiscal 2019 (as discussed in Note 5 to the condensed consolidated financial statements), cash generated from operations and, if necessary, additional borrowings. Our remaining funding commitment for our IC facility in China, which commenced production in the third quarter of fiscal 2019, was approximately $8 million as of May 3, 2020; we fulfilled this commitment in May 2020.

Off-Balance Sheet Arrangements

As noted above, in January 2018, Photronics, through its wholly owned Singapore subsidiary, entered into the PDMCX joint venture with DNP, through its wholly owned subsidiary “DNP Asia Pacific PTE, Ltd.” under which DNP obtained a 49.99% interest in our IC business in Xiamen, China. The joint venture was established to develop and manufacture photomasks for leading edge and advanced generation semiconductors. Under the joint venture’s operating agreement, DNP is afforded, under certain circumstances, the right to put its interest in PDMCX to Photronics. These circumstances include disputes regarding the strategic direction of PDMCX that may arise after the initial two-year term of the Agreement that cannot be resolved between the two parties. As of the date of issuance of this report, DNP had not indicated its intention to exercise this right. In addition, both Photronics and DNP have the option to purchase, or put, their interest from, or to, the other party, should their ownership interest fall below 20% for a period of more than six consecutive months. Under all such circumstances, the sales of ownership interests would be at the exiting party’s ownership percentage of the joint venture’s net book value, with closing to take place within three business days of obtaining required approvals and clearance. Should DNP exercise an option to put their, or purchase our, interest in PDMCX we may, depending on the relationship of the fair and book value of PDMCX’s net assets, incur a loss. As of May 3, 2020, Photronics and DNP each had net investments in PDMCX of $43.0 million.

Business Outlook

While the near-term effects of the global coronavirus pandemic on our business cannot be predicted, we continue to believe that a majority of the growth in the IC and FPD markets will continue to come from the Asia region, predominantly in China. We expect to meet these demands both through the utilization of our new facilities in China, and by importing photomasks into China from our other facilities. We make continual assessments of our global manufacturing strategy and monitor our revenue and related cash flows from operations. These ongoing assessments could result in future facility closures, asset redeployments, impairments of intangible or long-lived assets, workforce reductions, or the addition of manufacturing facilities, all of which would be based on market conditions and customer requirements.

Our future results of operations and the other forward-looking statements contained in this filing involve a number of risks and uncertainties, some of which are discussed in Part1, Item 1A in our Annual Report on Form 10-K for the year ended October 31, 2019 and in Part 2, Item 1A in our Quarterly Report on Form 10-Q for the quarter ended February 2, 2020; a number of other unforeseen factors could cause actual results to differ materially from our expectations.

Effect of Recent Accounting Pronouncements

See “Item 1. Condensed Consolidated Financial Statements– Notes to Condensed Consolidated Financial Statements – Note 15 – Recent Accounting Pronouncements” for recent accounting pronouncements that may affect the Company’s financial reporting.

Item 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Foreign Currency Exchange Rate Risk

We conduct business in several major international currencies throughout our worldwide operations, and our financial performance may be affected by fluctuations in the exchange rates of these currencies. Changes in exchange rates can positively or negatively affect our reported revenue, operating income, assets, liabilities, and equity. The functional currencies of our Asian subsidiaries are the South Korean won, the New Taiwan dollar, the Chinese renminbi, and the Singapore dollar. The functional currencies of our European subsidiaries are the British pound and the euro. In addition, we engage in transactions in, and have exposures to, the Japanese yen.

We attempt to minimize our risk of foreign currency transaction losses by producing products in the same country in which the products are sold (thereby generating revenues and incurring expenses in the same currency), and by managing our working capital. However, in some instances, we sell products in a currency other than the functional currency of the country where it was produced, or purchase products in a currency that differs from the functional currency of the purchasing entity. In addition, to the extent practicable, we attempt to reduce our exposure to foreign currency exchange fluctuations by converting cash and cash equivalents into the functional currency of the subsidiary which holds the cash. We may also enter into derivative contracts to mitigate our exposure to foreign currency fluctuations when we have a significant purchase obligation, or a significant receivable denominated in a currency that differs from the functional currency of the transacting subsidiary. We do not enter into derivatives for speculative purposes. There can be no assurance that this approach will protect us from the need to recognize significant foreign currency transaction gains and losses, especially in the event of a significant adverse movement in the value of any foreign currency in which we conduct business against any of our functional currencies, including the U.S. dollar.

31

Index
Our primary net foreign currency exposures as of May 3, 2020, included the South Korean won, the Japanese yen, the New Taiwan dollar, the Chinese renminbi, the Singapore dollar, the British pound sterling, and the euro. As of that date, a 10% adverse movement in the value of currencies different than the functional currencies of our subsidiaries would have resulted in a net unrealized pre-tax loss of $33.1 million, which represents a decrease of $0.8 million from our exposure at February 2, 2020, and is equivalent to our exposure at October 31, 2019. Our most significant exposures at May 3, 2020, related to the Chinese renminbi and the South Korean won to the U.S. dollar, which were, respectively, $13.3 million and $11.8 million at that date. We do not believe that a 10% change in the exchange rates of non-US dollar currencies, other than the aforementioned currencies and the Japanese Yen, would have had a material effect on our May 3, 2020, condensed consolidated financial statements.

Interest Rate Risk

A 10% adverse movement in the interest rates on our variable rate borrowings would not have had a material effect on our May 3, 2020 condensed consolidated financial statements.

Item 4.
CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We have established and currently maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), designed to provide reasonable assurance that information required to be disclosed in reports filed under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to management, including our chief executive officer and chief financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Our management, under the supervision and with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting during the second fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II.
OTHER INFORMATION

Item 1.
LEGAL MATTERS

The Company’s wholly owned subsidiary in South Korea has been involved in litigation regarding a 2016 informational tax filing regarding its non-South Korean bank accounts that was not timely made under a then recently issued presidential decree. A fine (based solely on the amount in such accounts) in the amount of $2.2 million was assessed against our subsidiary. Our subsidiary appealed the fine on the grounds that it was not required to make the tax filing, and such appeal was pursued up to the Supreme Court in South Korea. Under South Korean law, the tax authorities were entitled to pursue the matter in both civil and criminal courts simultaneously, with the proviso that any criminal fine imposed would act to dismiss any civil fine. The prosecutor recommended a fine of $0.03 million. The civil matter has subsequently been dismissed. Photronics was notified on March 12, 2020, that the Supreme Court rendered a decision against our subsidiary on the issue of whether our subsidiary was required to make the tax filing and remanded the case to the appellate court for determination of the fine. We are awaiting a trial date from the appellate court. Prior to the Supreme Court decision, the possibility of a fine had been deemed remote, as our initial assessment based on advice of local counsel and the subsequent judgments in the lower courts were all in our favor. Our estimate of the possible range of loss is $0.03 million to $2.2 million with the most likely amount being $0.03 million (based on the prosecutor’s recommendation). Accordingly, during the three-month period ended May 3, 2020, we accrued a contingent loss of $0.03 million, with a charge to Selling, general and administrative expense in the consolidated statements of income. It is reasonably possible that the estimated loss will change in the near term. Our exposure to loss in excess of amounts accrued is $2.17 million. The imposition of the fine will not have a material impact on our financial position or financial performance.

32

Index
We are subject to various other claims that arise in the ordinary course of business. We believe that such claims, individually or in the aggregate, will not have a material effect on the consolidated financial statements.

Item 1A.
RISK FACTORS

Other than the below, there have been no other material changes to risks relating to our business as disclosed in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended October 31, 2019 and Part 2, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended February 2, 2020.

Our expansion into China entails substantial risks.

In the past year, we commenced operations at our two newly constructed manufacturing facilities in China. These investments are subject to substantial risks which may include, but are not limited to: the inability to protect our intellectual property rights under Chinese law, which may not offer as high a level of protection as U.S. law; unexpectedly long negotiation periods with Chinese suppliers and customers; quality issues related to materials sourced from local vendors; unexpectedly high labor costs due to a tight labor supply; and difficulty in repatriating funds and selling or transferring assets. Our investments in China also expose us to a significant additional foreign currency exchange risk, which we had not been subject to in recent years. In addition, while we do not see any imminent threat, as tensions have escalated between the U.S. and China, we believe there is an enhanced risk that our substantial investments in China may be subject to unforeseen restrictions, which may include expropriation of the investments by the Chinese government. These and other risks may result in our not realizing a return on, or losing some, or all, of our planned investments in China, which would have a material adverse effect on our financial condition and financial performance.

Our business could be adversely impacted by global or regional catastrophic events.

Our business could be adversely affected by terrorist acts, widespread outbreaks of infectious diseases (such as the COVID-19 pandemic), government responses such as shelter-in-place directives to limit the impact of infectious diseases, or the outbreak or escalation of wars, especially in the Asian markets in which we generate a significant portion of our sales and in Japan where we purchase raw materials and capital equipment. Such events in the geographic regions in which we do business, including escalations of political tensions and military conflicts within the Korean Peninsula, or between the People’s Republic of China and the U.S. or the Republic of China (Taiwan), could have material adverse impacts on our revenue, cost and availability of raw materials, results of operations, cash flows, and financial condition.

Our products and technology could be subject to U.S. export control laws and the export control laws of the foreign jurisdictions where we operate

We are subject to various laws relating to the export of products we manufacture and the technology related thereto, and our failure to comply with these laws could subject us to substantial fines, penalties and even injunctions, the imposition of which could have a material adverse effect on the success of our business.
 
We are subject to the export control laws of the United States and the export control laws of the foreign jurisdictions where we operate. On April 28, 2020, the Trump administration significantly expanded the reach of U.S. export controls over certain products and certain countries. The U.S. Department of Commerce has, among other things:  expanded license requirements to China, Russia and Venezuela; broadened the list of products covered by these expanded license requirements; expanded the definition of “military end use”; created a new “reason for control”; created a new review policy for certain items to certain countries; added substantial electronic export information filing requirements; eliminated the license exception for civil end use for certain countries, including China, Russia and Venezuela; and proposed to remove those same countries from the list of those eligible for additional re-exports license exceptions. The final rules relating to most of these changes are effective June 29, 2020, and comments to the proposed rule on re-exports are due on the same day. Application of these laws may adversely affect our business in various ways, including by regulating the export of our products, equipment, services, and technology from the United States and abroad, increasing the time necessary to obtain required authorizations, and the possibility of monetary fines and other penalties for non-compliance.

Item 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

In August 2019, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b5-1 of the Securities Act of 1933 (as amended). The authorization did not obligate us to repurchase any dollar amount or number of shares of common stock, and the repurchase program could have been suspended or discontinued at any time. The following table presents information on our common stock repurchase activity for the second fiscal quarter of 2020.

 
Total Number of
Shares Purchased
(in millions)
   
Average Price
Paid
Per share
   
Total Number of Shares
Purchased as Part of
Publicly Announced
Program (in millions)
   
Dollar Value of
Shares That May
Yet Be Purchased
(in millions)
 
                         
Period
                       
February 3, 2020 – March 1, 2020
   
0.1
   
$
12.37
     
0.1
   
$
77.0
 
March 2, 2020 – March 29, 2020
   
0.5
   
$
10.48
     
0.5
   
$
0.0
*
Total
   
0.6
   
$
10.75
     
0.6
         

* The share repurchase program was terminated on March 20, 2020.


33

Index
Item 6.
EXHIBITS


 
 
 
 
Incorporated by Reference
 
Exhibit
Number
 
 
Description
 
Form
File
Number
Exhibit
Filing
 Date
Filed or
Furnished
Herewith
 
Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a)
of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002.
 
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a)
of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002.
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
 
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
101.INS
 
XBRL Instance Document
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
101.SCH
 
XBRL Taxonomy Extension Schema Document
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
 
 
 
 
 
X
 
 
 
 
 
 
 
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
 
 
 
X

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
Photronics, Inc.
 
 
 
(Registrant)
 
 
 
 
 
 
By:
/s/ JOHN P. JORDAN
 
By:
/s/ ERIC RIVERA
 
 
JOHN P. JORDAN
 
 
ERIC RIVERA
 
 
Senior Vice President,
 
 
Vice President,
 
 
Chief Financial Officer
 
 
Corporate Controller 
 
 
(Principal Financial Officer)
 
 
(Principal Accounting Officer) 
 
 
 
 
 
 
Date:  June 12, 2020
 
Date:  June 12, 2020


34

EXHIBIT 31.1

I, Peter S. Kirlin, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Photronics, Inc.

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and


b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 
/s/ PETER S. KIRLIN



Peter S. Kirlin

Chief Executive Officer

June 12, 2020





EXHIBIT 31.2

I, John P. Jordan, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Photronics, Inc.

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):


a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and


b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 
/s/ JOHN P. JORDAN



John P. Jordan

Chief Financial Officer

June 12, 2020





EXHIBIT 32.1

Section 1350 Certification of the Chief Executive Officer

I, Peter S. Kirlin, Chief Executive Officer of Photronics, Inc. (the “Company”), certify, to my knowledge, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1)
The Quarterly Report on Form 10-Q of the Company for the quarter ended May 3, 2020 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

The foregoing certification is being furnished pursuant to 18 U.S.C. § 1350 and will not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.

/s/ PETER S. KIRLIN



Peter S. Kirlin

Chief Executive Officer

June 12, 2020
 




EXHIBIT 32.2

Section 1350 Certification of the Chief Financial Officer

I, John P. Jordan, Chief Financial Officer of Photronics, Inc. (the “Company”), certify, to my knowledge, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1)
The Quarterly Report on Form 10-Q of the Company for the quarter ended May 3, 2020 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

The foregoing certification is being furnished pursuant to 18 U.S.C. § 1350 and will not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.

/s/ JOHN P. JORDAN



John P. Jordan

Chief Financial Officer

June 12, 2020




v3.20.1
REVENUE, Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 03, 2020
Apr. 28, 2019
May 03, 2020
Apr. 28, 2019
Disaggregation of Revenue [Abstract]        
Revenue $ 142,774 $ 131,580 $ 302,510 $ 256,291
Over Time [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 126,071 123,853 263,905 244,699
At a Point in Time [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 16,703 7,727 38,605 11,592
Taiwan [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 55,513 56,469 121,626 114,209
Korea [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 36,261 38,038 76,997 73,275
United States [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 24,857 26,742 49,925 49,215
China [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 17,486 1,467 37,386 1,730
Europe [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 8,331 8,435 15,874 16,788
Other [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 326 429 702 1,074
IC [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 96,846 98,587 203,824 193,466
High-end [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 38,267 38,429 79,308 72,995
Mainstream [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 58,579 60,158 124,516 120,471
FPD [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 45,928 32,993 98,686 62,825
High-end [Member]        
Disaggregation of Revenue [Abstract]        
Revenue 31,809 22,051 71,579 37,401
Mainstream [Member]        
Disaggregation of Revenue [Abstract]        
Revenue $ 14,119 $ 10,942 $ 27,107 $ 25,424
v3.20.1
PDMCX JOINT VENTURE, VIE (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
May 31, 2020
May 03, 2020
Apr. 28, 2019
May 03, 2020
Apr. 28, 2019
Oct. 31, 2019
Variable Interest Entity [Abstract]            
Consolidation liabilities   $ 212,230   $ 212,230   $ 207,573
Consolidated assets pledged   1,133,888   1,133,888   1,118,665
PDMCX [Member]            
Variable Interest Entity [Abstract]            
Gain (loss) on consolidation       0    
Total committed investment   160,000   160,000    
Consolidation liabilities   64,616   64,616   58,983
Consolidated assets pledged   150,618   $ 150,618   138,157
Initial term of agreement       2 years    
Period before put or purchase option can be exercised       6 months    
Operating (loss)   (400) $ (600) $ (4,100) $ (1,900)  
PDMCX [Member] | Minimum [Member]            
Variable Interest Entity [Abstract]            
Ownership percentage       20.00%    
PDMCX [Member] | Maximum [Member]            
Variable Interest Entity [Abstract]            
Number of business days for obtaining required approvals and clearance for exiting party       3 days    
PDMCX [Member] | Subsequent Event [Member]            
Variable Interest Entity [Abstract]            
Financial or other support, amount $ 15,000          
PDMCX [Member] | Local Financing [Member]            
Variable Interest Entity [Abstract]            
Consolidation liabilities   35,000   $ 35,000    
PDMCX [Member] | Local Financing [Member] | Asset Pledged as Collateral [Member]            
Variable Interest Entity [Abstract]            
Consolidated assets pledged   94,100   $ 94,100    
Photronics Interest [Member]            
Variable Interest Entity [Abstract]            
Ownership percentage       50.01%    
Financial or other support, amount       $ 55,000    
Consolidation liabilities   32,314   32,314   29,497
Consolidated assets pledged   75,324   75,324   $ 69,093
Maximum exposure to loss   $ 43,000   $ 43,000    
DNP [Member]            
Variable Interest Entity [Abstract]            
Ownership percentage       49.99%    
Financial or other support, amount       $ 55,000    
v3.20.1
SHARE REPURCHASE PROGRAMS (Tables)
6 Months Ended
May 03, 2020
SHARE REPURCHASE PROGRAMS [Abstract]  
Shares Repurchase Programs

In August 2019, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b5-1 of the Securities Act of 1933 (as amended). The company commenced repurchasing shares under this authorization on September 25, 2019. All of the 0.9 million shares repurchased under this authorization prior to November 1, 2019, were retired in fiscal 2019; the repurchase program was terminated on March 20, 2020. The table below presents information on this repurchase program.

 
Three Months Ended May 3, 2020
   
Six Months Ended May 3, 2020
   
From Inception Date of
September 25, 2019
 
                   
Number of shares repurchased
   
549
     
1,464
     
2,460
 
                         
Cost of shares repurchased
 
$
5,894
   
$
16,894
   
$
27,894
 
                         
Average price paid per share
 
$
10.75
   
$
11.54
   
$
11.34
 


In October 2018, the Company’s board of directors authorized the repurchase of up to $25 million of its common stock, to have been executed in open-market transactions or in accordance with a repurchase plan under Rule 10b5-1 of the Securities Act of 1933 (as amended). The share repurchase program commenced on October 22, 2018, and was terminated on February 1, 2019. All of the shares repurchased under this program were retired in fiscal 2019. The table below presents information on this repurchase program.

 
Three Months Ended
January 27, 2019
   
From Inception Date of
October 22, 2018
 
             
Number of shares repurchased
   
1,137
     
1,467
 
                 
Cost of shares repurchased
 
$
10,694
   
$
13,807
 
                 
Average price paid per share
 
$
9.40
   
$
9.41
 
v3.20.1
FAIR VALUE MEASUREMENTS
6 Months Ended
May 03, 2020
FAIR VALUE MEASUREMENTS [Abstract]  
FAIR VALUE MEASUREMENTS
NOTE 12 - FAIR VALUE MEASUREMENTS


The accounting framework for determining fair value includes a hierarchy for ranking the quality and reliability of the information used to measure fair value, which enables the reader of the financial statements to assess the inputs used to develop those measurements. The fair value hierarchy consists of three tiers as follows: Level 1, defined as quoted market prices (unadjusted) in active markets for identical securities; Level 2, defined as inputs other than Level 1 that are observable, either directly or indirectly; and Level 3, defined as unobservable inputs that are not corroborated by market data.


The fair values of our cash and cash equivalents (Level 1 measurements), accounts receivable, accounts payable, and certain other current assets and current liabilities (Level 2 measurements) approximate their carrying values due to their short-term maturities. The fair values of our variable rate debt instruments are a Level 2 measurement and approximates their carrying values due to the variable nature of the underlying interest rates. We did not have any assets or liabilities measured at fair value, on a recurring or a nonrecurring basis, at May 3, 2020 or October 31, 2019.
v3.20.1
INVENTORIES (Policies)
6 Months Ended
May 03, 2020
INVENTORIES [Abstract]  
Inventories Inventories are stated at the lower of cost, determined under the first-in, first-out ("FIFO") method, or net realizable value.
v3.20.1
Condensed Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 03, 2020
Apr. 28, 2019
May 03, 2020
Apr. 28, 2019
Condensed Consolidated Statements of Comprehensive Income (unaudited) [Abstract]        
Other comprehensive income (loss), tax $ 0 $ 0 $ 0 $ 0
v3.20.1
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Thousands
May 03, 2020
Oct. 31, 2019
Current assets:    
Cash and cash equivalents $ 237,790 $ 206,530
Accounts receivable, net of allowance of $1,282 in 2020 and $1,334 in 2019 135,035 134,454
Inventories 56,968 48,155
Other current assets 42,478 38,388
Total current assets 472,271 427,527
Property, plant and equipment, net 604,545 632,441
Intangible assets, net 5,690 7,870
Deferred income taxes 19,801 20,779
Other assets 31,581 30,048
Total assets 1,133,888 1,118,665
Current liabilities:    
Short-term debt 9,858 8,731
Current portion of long-term debt 7,813 2,142
Accounts payable 76,293 91,379
Accrued liabilities 59,408 49,702
Total current liabilities 153,372 151,954
Long-term debt 35,783 41,887
Other liabilities 23,075 13,732
Total liabilities 212,230 207,573
Commitments and contingencies
Equity:    
Preferred stock, $0.01 par value, 2,000 shares authorized, none issued and outstanding 0 0
Common stock, $0.01 par value, 150,000 shares authorized, 66,215 shares issued and 64,751 outstanding at May 3, 2020 and 65,595 shares issued and outstanding at October 31, 2019 662 656
Additional paid-in capital 530,117 524,319
Retained earnings 270,506 253,922
Treasury stock, 1,464 shares at May 3, 2020 (16,894) 0
Accumulated other comprehensive loss (15,200) (9,005)
Total Photronics, Inc. shareholders' equity 769,191 769,892
Noncontrolling interests 152,467 141,200
Total equity 921,658 911,092
Total liabilities and equity $ 1,133,888 $ 1,118,665
v3.20.1
SHARE-BASED COMPENSATION (Policies)
6 Months Ended
May 03, 2020
Employee Stock Option [Member]  
Stock Options [Abstract]  
Share-Based Compensation

Option awards generally vest in one-to-four years, and have a ten-year contractual term. All incentive and non-qualified stock option grants have an exercise price no less than the market value of the underlying common stock on the date of grant. The grant date fair values of options are based on closing prices of our common stock on the dates of grant and are calculated using the Black-Scholes option pricing model. Expected volatility is based on the historical volatility of our common stock. We use historical option exercise behavior and employee termination data to estimate expected term, which represents the period of time that options are expected to remain outstanding. The risk-free rate of return for the estimated term of the option is based on the U.S. Treasury yield curve in effect at the date of grant.
v3.20.1
PDMCX JOINT VENTURE
6 Months Ended
May 03, 2020
PDMCX JOINT VENTURE [Abstract]  
PDMCX JOINT VENTURE
NOTE 4 - PDMCX JOINT VENTURE


In January 2018, Photronics, through its wholly owned Singapore subsidiary (hereinafter, within this Note “we”, “Photronics”, or “our”), and Dai Nippon Printing Co., Ltd., through its wholly owned subsidiary “DNP Asia Pacific PTE, Ltd.” (hereinafter, within this Note, “DNP”) entered into a joint venture under which DNP obtained a 49.99% interest in our IC business in Xiamen, China. The joint venture, known as “Xiamen American Japan Photronics Mask Co., Ltd.” (hereinafter, “PDMCX”), was established to develop and manufacture photomasks for leading edge and advanced generation semiconductors. We entered into this joint venture to enable us to compete more effectively for the merchant photomask business in China, and to benefit from the additional resources and investment that DNP provides to enable us to offer advanced-process technology to our customers. No gain or loss was recorded upon the formation of this joint venture.


The total investment per the PDMCX operating agreement (“the Agreement”) is $160 million. As of May 3, 2020, Photronics and DNP had each contributed cash of approximately $55 million, and PDMCX obtained local financing of approximately $35 million. The remaining $15 million investment was funded, in May 2020, with  additional cash contributions from Photronics and DNP. As discussed in Note 5, liens were granted to the local financing entity on assets with a total carrying value of $94.1 million, as collateral for the loans.


Under the Agreement, DNP is afforded, under certain circumstances, the right to put its interest in PDMCX to Photronics. These circumstances include disputes regarding the strategic direction of PDMCX that may arise after the initial two-year term of the Agreement and cannot be resolved between the two parties. As of the date of issuance of these financial statements, DNP had not indicated its intention to exercise this right. In addition, both Photronics and DNP have the option to purchase, or put, their interest from, or to, the other party, should their ownership interest fall below twenty percent for a period of more than six consecutive months. Under all such circumstances, the sales of ownership interests would be at the exiting party’s ownership percentage of the joint venture’s net book value, with closing to take place within three business days of obtaining required approvals and clearance.


We recorded net losses from the operations of PDMCX of $0.4 million, and $4.1 million during the three and six-month periods ended May 3, 2020, respectively, and losses of $0.6 million and $1.9 million during the three and six-month periods ended April 28, 2019, respectively. General creditors of PDMCX do not have recourse to the assets of Photronics (other than the net assets of PDMCX), and our maximum exposure to loss from PDMCX at May 3, 2020, was $43.0 million.


As required by the guidance in Topic 810 - “Consolidation” of the Accounting Standards Codification (“ASC”), we evaluated our involvement in PDMCX for the purpose of determining whether we should consolidate its results in our financial statements. The initial step of our evaluation was to determine whether PDMCX was a variable interest entity (“VIE”). Due to its lack of sufficient equity at risk to finance its activities without additional subordinated financial support, we determined that it was a VIE. Having made this determination, we then assessed whether we were the primary beneficiary of the VIE, and concluded that we were the primary beneficiary during the current and prior year reporting periods; thus, as required, the PDMCX financial results have been consolidated with those of Photronics. Our conclusion was based on the facts that we held a controlling financial interest in PDMCX (which resulted from our having the power to direct the activities that most significantly impacted its economic performance) and had the obligation to absorb losses and the right to receive benefits that could potentially be significant to PDMCX. Our conclusions that we had the power to direct the activities that most significantly affected the economic performance of PDMCX during the current and prior year reporting periods was based on our right to appoint the majority of its board of directors, which has, among others, the powers to manage the business (through its rights to appoint and evaluate PDMCX's management), incur indebtedness, enter into agreements and commitments, and acquire and dispose of PDMCX’s assets. In addition, as a result of the 50.01% variable interest we held during the current and prior-year periods, we had the obligation to absorb losses, and the right to receive benefits, that could potentially be significant to PDMCX.


The carrying amounts of PDMCX assets and liabilities included in our condensed consolidated balance sheets are presented in the following table, together with our exposure to loss related to these assets and liabilities.

 
May 3, 2020
   
October 31, 2019
 
Classification
 
Carrying
Amount
   
Photronics
Interest
   
Carrying
Amount
   
Photronics
Interest
 
                         
Current assets
 
$
45,646
   
$
22,828
   
$
24,142
   
$
12,074
 
Non-current assets
   
104,972
     
52,496
     
114,015
     
57,019
 
                                 
Total assets
   
150,618
     
75,324
     
138,157
     
69,093
 
                                 
Current liabilities
   
28,785
     
14,395
     
16,889
     
8,446
 
Non-current liabilities
   
35,831
     
17,919
     
42,094
     
21,051
 
                                 
Total liabilities
   
64,616
     
32,314
     
58,983
     
29,497
 
                                 
Net assets
 
$
86,002
   
$
43,010
   
$
79,174
   
$
39,596
 
v3.20.1
SHARE-BASED COMPENSATION
6 Months Ended
May 03, 2020
SHARE-BASED COMPENSATION [Abstract]  
SHARE-BASED COMPENSATION
NOTE 8 - SHARE-BASED COMPENSATION


In March 2016, shareholders approved a new equity incentive compensation plan (the “Plan”), under which incentive stock options, non-qualified stock options, stock grants, stock-based awards, restricted stock, restricted stock units, stock appreciation rights, performance units, performance stock, and other stock or cash awards may be granted. Shares to be issued under the Plan may be authorized and unissued shares, issued shares that have been reacquired by us (in the open-market or in private transactions) and are being held in the treasury, or a combination thereof. The maximum number of shares of common stock approved that may be issued under the Plan is four million shares. Awards may be granted to officers, employees, directors, consultants, advisors, and independent contractors of Photronics or its subsidiaries. In the event of a change in control (as defined in the Plan), the vesting of awards may be accelerated. The Plan, aspects of which are more fully described below, prohibits further awards from being issued under prior plans. Total share-based compensation costs for the three and six-month periods ended May 3, 2020, were $1.2 million and $2.6 million, respectively, and $0.9 million and $2.0 million for the three and six-month periods ended April 28, 2019, respectively. No share-based compensation cost was capitalized as part of an asset and no related income tax benefits were recorded during the periods presented.

Restricted Stock


We periodically grant restricted stock awards, the restrictions on which typically lapse over a service period of one-to-four years. The fair value of the awards is determined on the date of grant, based on the closing price of our common stock. There were 5,000 restricted stock awards granted during the three-month period ended May 3, 2020, with a grant-date fair value of $9.90 per share, and there were 527,000 restricted stock awards granted during the six-month period ended May 3, 2020, with a grant-date fair value of $15.21 per share. There were 435,000 restricted stock awards granted during the six-month period ended April 28, 2019, with a weighted-average grant-date fair value of $9.80 per share. As of May 3, 2020, the total compensation cost not yet recognized related to unvested restricted stock awards was approximately $8.9 million. That cost is expected to be recognized over a weighted-average amortization period of 3.1 years. As of May 3, 2020, there were 854,866 shares of restricted stock outstanding.

Stock Options


Option awards generally vest in one-to-four years, and have a ten-year contractual term. All incentive and non-qualified stock option grants have an exercise price no less than the market value of the underlying common stock on the date of grant. The grant date fair values of options are based on closing prices of our common stock on the dates of grant and are calculated using the Black-Scholes option pricing model. Expected volatility is based on the historical volatility of our common stock. We use historical option exercise behavior and employee termination data to estimate expected term, which represents the period of time that options are expected to remain outstanding. The risk-free rate of return for the estimated term of the option is based on the U.S. Treasury yield curve in effect at the date of grant.


There were no share options granted during the six-month period ended May 3, 2020, or the three-month period ended April 28, 2019. There were 132,000 share options granted during the six-month period ended April 28, 2019, with a weighted-average grant-date fair value of $3.31 per share. The Company received cash from option exercises of $0.4 million and $3.2 million for the three and six-month periods ended May 3, 2020, respectively, and $0.3 million and $0.8 million for the three and six-month periods ended April 28, 2019, respectively. As of May 3, 2020, the total unrecognized compensation cost related to unvested option awards was approximately $0.6 million. That cost is expected to be recognized over a weighted-average amortization period of 2.0 years.


The weighted-average inputs and risk-free rate of return ranges used to calculate the grant-date fair value of options issued during the six-month period ended April 28, 2019, are presented in the following table.

 
Six Months Ended
 
   
April 28, 2019
 
       
Volatility
   
33.1
%
         
Risk free rate of return
   
2.5-2.9
%
         
Dividend yield
   
0.0
%
         
Expected term
 
5.1 years
 


Information on outstanding and exercisable option awards as of May 3, 2020, is presented below.

Options
 
Shares
   
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life
 
Aggregate
Intrinsic
Value
 
                     
Outstanding at May 3, 2020
   
1,723,652
   
$
9.16
 
5.1 years
 
$
4,000
 
                           
Exercisable at May 3, 2020
   
1,433,324
   
$
9.07
 
4.6 years
 
$
3,494
 
v3.20.1
EARNINGS PER SHARE (Tables)
6 Months Ended
May 03, 2020
EARNINGS PER SHARE [Abstract]  
Calculation of Basic and Diluted Earnings Per Share

The calculation of basic and diluted earnings per share is presented below.

 
Three Months Ended
   
Six Months Ended
 
   
May 3,
2020
   
April 28,
2019
   
May 3,
2020
   
April 28
2019
 
                         
Net income attributable to Photronics, Inc. shareholders
 
$
6,284
   
$
8,479
   
$
16,584
   
$
13,746
 
                                 
Effect of dilutive securities:
                               
Interest expense on convertible notes, net of tax
   
-
     
349
     
-
     
845
 
                                 
Earnings used for diluted earnings per share
 
$
6,284
   
$
8,828
   
$
16,584
   
$
14,591
 
                                 
Weighted-average common shares computations:
                               
Weighted-average common shares used for basic earnings per share
   
64,937
     
66,261
     
65,246
     
66,422
 
Effect of dilutive securities:
                               
Share-based payment awards
   
480
     
438
     
687
     
451
 
Convertible notes
   
-
     
3,898
     
-
     
4,720
 
                                 
Potentially dilutive common shares
   
480
     
4,336
     
687
     
5,171
 
                                 
Weighted-average common shares used for diluted earnings per share
   
65,417
     
70,597
     
65,933
     
71,593
 
                                 
                                 
Basic earnings per share
 
$
0.10
   
$
0.13
   
$
0.25
   
$
0.21
 
Diluted earnings per share
 
$
0.10
   
$
0.13
   
$
0.25
   
$
0.20
 
Outstanding Securities Excluded from Calculation of Diluted Earnings or Loss Per Share

The table below shows the outstanding weighted-average share-based payment awards that were excluded from the calculation of diluted earnings per share because their exercise price exceeded the average market value of the common shares for the period or, under application of the treasury stock method, they were otherwise determined to be antidilutive.

 
Three Months Ended
   
Six Months Ended
 
   
May 3,
2020
   
April 28,
2019
   
May 3,
2020
   
April 28,
2019
 
                         
Share-based payment awards
   
1,009
     
1,204
     
591
     
1,134
 
                                 
Total potentially dilutive shares excluded
   
1,009
     
1,204
     
591
     
1,134
 
v3.20.1
LONG-TERM DEBT (Tables)
6 Months Ended
May 03, 2020
LONG-TERM DEBT [Abstract]  
Long-Term Debt

Long-term debt consists of the following:

 
May 3,
2020
   
October 31,
2019
 
             
             
Project Loans
 
$
34,452
   
$
34,490
 
Working Capital Loans (value added tax component)
   
9,144
     
9,539
 
                 
     
43,596
     
44,029
 
Current portion of long-term debt
   
(7,813
)
   
(2,142
)
                 
 Long-term debt
 
$
35,783
   
$
41,887
 
LONG-TERM DEBT [Abstract]  
Maturities of Long-term Debt

At May 3, 2020, maturities of our long-term debt over the next five fiscal years and thereafter were as follows:

2020 (remainder of)
 
$
1,755
 
2021
   
8,294
 
2022
   
12,417
 
2023
   
3,437
 
2024
   
6,582
 
Thereafter
   
11,111
 
 
 
$
43,596
 
Project Loans [Member]  
LONG-TERM DEBT [Abstract]  
Maturities of Long-term Debt

In November 2018, PDMCX was approved for credit of the equivalent of $50 million, subject to certain limitations related to PDMCX registered capital at the time of the initial approval, pursuant to which PDMCX has and will enter into separate loan agreements (“the Project Loans”) for intermittent borrowings. The Project Loans, which are denominated in Chinese renminbi (RMB), are being used to finance certain capital expenditures in China. PDMCX granted liens on its interest in land, building, and certain equipment, which had a combined carrying value of $94.1 million as of May 3, 2020, as collateral for the Project Loans. As of May 3, 2020, PDMCX had borrowed 243.4 million RMB ($34.5 million) against this approval. Payments on these borrowings are due semi-annually through December 2025; the initial payment is scheduled for June 2020. The table below presents, in U.S. dollars, the timing of future payments against the borrowings.

 
Fiscal Year
 
   
2020
   
2021
   
2022
   
2023
   
2024
   
2025
   
2026
 
                                           
Principal payments
 
$
1,274
   
$
6,369
   
$
5,679
   
$
3,437
   
$
6,582
   
$
6,299
   
$
4,812
 
Working Capital Loans [Member]  
LONG-TERM DEBT [Abstract]  
Maturities of Long-term Debt

In November 2018, PDMCX received approval for unsecured credit of the equivalent of $25.0 million, pursuant to which PDMCX may enter into separate loan agreements. Under this credit agreement (the “Working Capital Loans”), PDMCX can borrow up to 140.0 million RMB to pay value-added taxes (“VAT”), and up to 60.0 million RMB to fund operations; combined total borrowings are limited to the equivalent of $25.0 million. As of May 3, 2020, PDMCX had 64.6 million RMB ($9.1 million) outstanding against the approval to pay VAT. Payments on these borrowings are due semiannually, in increasing amounts, through January 2022. The table below presents, in U.S. dollars, the timing of future payments against these borrowings.

 
Fiscal Year
 
   
2020
   
2021
   
2022
 
                   
Principal payments
 
$
481
   
$
1,925
   
$
6,738
 
v3.20.1
RECENT ACCOUNTING PRONOUNCEMENTS (Policies)
6 Months Ended
May 03, 2020
RECENT ACCOUNTING PRONOUNCEMENTS [Abstract]  
Recent Accounting Pronouncements
Accounting Standards Updates Adopted


We adopted ASU 2016-02 and all subsequent amendments, collectively codified in ASC Topic 842 “Leases” (“Topic 842”), on November 1, 2019. The guidance requires modified retrospective adoption, either at the beginning of the earliest period presented or at the beginning of the period of adoption. We elected to apply the guidance at the beginning of the period of adoption and recorded, as of November 1, 2019, right-of-use (ROU) leased assets of $6.5 million. In conjunction with this, we recorded lease liabilities, which had been discounted at our incremental borrowing rates, of $6.5 million. Our adoption of Topic 842 did not affect our cash flows or our ability to comply with covenants under our credit agreement. Please see Note 7 for our leases disclosure.

Accounting Standards Updates to be Adopted


In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”, which provides optional expedients and exceptions to applying the guidance on contract modifications, hedge accounting, and other transactions, to simplify the accounting for transitioning from the London Interbank Offered Rate, and other interbank offered rates expected to be discontinued, to alternative reference rates. The guidance in this Update was effective upon its issuance; if elected, it is to be applied prospectively through December 31, 2022. We are currently evaluating the effect the potential adoption of this ASU will have on our consolidated financial statements.


In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses”, the main objective of which is to provide more useful information about expected credit losses on financial instruments and other commitments of an entity to extend credit. In support of this objective, the ASU replaces the incurred loss impairment methodology, found in current GAAP, with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. This ASU requires a cumulative-effect adjustment as of the beginning of the first reporting period in which the guidance is adopted. ASU 2016-13 is effective for Photronics in its first quarter of fiscal year 2021, with early adoption permitted beginning in the first quarter of fiscal year 2019. We have not early adopted and are currently evaluating the effect that this ASU will have on our consolidated financial statements.
v3.20.1
LEASES (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
May 03, 2020
May 03, 2020
Oct. 31, 2019
Lease Payments Under Non-cancellable Leases [Abstract]      
2020 $ 996 $ 996  
2021 1,802 1,802  
2022 1,686 1,686  
2023 787 787  
2024 444 444  
Thereafter 391 391  
Total Lease Payments 6,106 6,106  
Imputed Interest [1] (255) (255)  
Operating lease liabilities 5,851 5,851  
Lease, Cost [Abstract]      
Operating lease cost 633 1,797  
Short-term lease costs 102 212  
Variable lease costs 129 129  
Supplemental Cash Flow Information [Abstract]      
Operating cash flows used for operating leases 502 2,387  
ROU assets obtained in exchange for lease obligations $ 58 $ 340  
Weighted Average Lease Terms, Discount Rates and Leases Not Yet Commenced [Abstract]      
Weighted-average remaining lease term 3 years 8 months 12 days 3 years 8 months 12 days  
Weighted-average discount rate 2.41% 2.41%  
Rent expense under operating leases     $ 3,000
Future minimum lease payments under non-cancelable operating leases [Abstract]      
2020     1,885
2021     1,613
2022     1,535
2023     742
2024     424
Thereafter     377
Total future minimum payments due     6,576
Other Assets [Member]      
Leases [Abstract]      
Right-of-use assets, operating leases $ 6,500 $ 6,500  
Accrued Liabilities [Member]      
Lease Payments Under Non-cancellable Leases [Abstract]      
Operating lease liabilities 1,800 1,800  
Other Liabilities [Member]      
Lease Payments Under Non-cancellable Leases [Abstract]      
Operating lease liabilities $ 4,100 $ 4,100  
ASU 2016-02 [Member]      
Leases [Abstract]      
Right-of-use assets, operating leases     6,500
Lease Payments Under Non-cancellable Leases [Abstract]      
Operating lease liabilities     $ 6,500
[1] Imputed interest represents difference between undiscounted cash flows and discounted cash flows.
v3.20.1
CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME BY COMPONENT (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 03, 2020
Apr. 28, 2019
May 03, 2020
Apr. 28, 2019
CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME BY COMPONENT [Abstract]        
Other comprehensive income, tax $ 0 $ 0 $ 0 $ 0
Changes in Accumulated Other Comprehensive Income [Roll Forward]        
Beginning Balance     769,892  
Ending Balance 769,191   769,191  
Accumulated Other Comprehensive Income [Member]        
Changes in Accumulated Other Comprehensive Income [Roll Forward]        
Beginning Balance (11,742) 343 (9,005) (4,966)
Ending Balance (15,200) (6,828) (15,200) (6,828)
Foreign Currency Translation Adjustments [Member]        
Changes in Accumulated Other Comprehensive Income [Roll Forward]        
Beginning Balance (11,076) 971 (8,331) (4,328)
Ending Balance (14,535) (6,212) (14,535) (6,212)
Other [Member]        
Changes in Accumulated Other Comprehensive Income [Roll Forward]        
Beginning Balance (666) (628) (674) (638)
Ending Balance (665) (616) (665) (616)
AOCI Including Portion Attributable to Noncontrolling Interest [Member]        
Changes in Accumulated Other Comprehensive Income [Roll Forward]        
Other comprehensive (loss) income (2,404) (7,029) (3,951) (438)
Foreign Currency Translation Adjustments [Member]        
Changes in Accumulated Other Comprehensive Income [Roll Forward]        
Other comprehensive (loss) income (2,405) (7,054) (3,970) (482)
Other [Member]        
Changes in Accumulated Other Comprehensive Income [Roll Forward]        
Other comprehensive (loss) income 1 25 19 44
AOCI Attributable to Noncontrolling Interest [Member]        
Changes in Accumulated Other Comprehensive Income [Roll Forward]        
Less: other comprehensive income attributable to noncontrolling interests 1,054 142 2,244 1,424
Foreign Currency Translation Adjustments [Member]        
Changes in Accumulated Other Comprehensive Income [Roll Forward]        
Less: other comprehensive income attributable to noncontrolling interests 1,054 129 2,234 1,402
Other [Member]        
Changes in Accumulated Other Comprehensive Income [Roll Forward]        
Less: other comprehensive income attributable to noncontrolling interests $ 0 $ 13 $ 10 $ 22
v3.20.1
RECENT ACCOUNTING PRONOUNCEMENTS (Details) - USD ($)
$ in Thousands
May 03, 2020
Oct. 31, 2019
Accounting Standards Updates Adopted [Abstract]    
Lease liabilities $ 5,851  
ASU 2016-02 [Member]    
Accounting Standards Updates Adopted [Abstract]    
Right-of-use leased assets   $ 6,500
Lease liabilities   $ 6,500
v3.20.1
LONG-TERM DEBT
6 Months Ended
May 03, 2020
LONG-TERM DEBT [Abstract]  
LONG-TERM DEBT
NOTE 5 – LONG-TERM DEBT


Long-term debt consists of the following:

 
May 3,
2020
   
October 31,
2019
 
             
             
Project Loans
 
$
34,452
   
$
34,490
 
Working Capital Loans (value added tax component)
   
9,144
     
9,539
 
                 
     
43,596
     
44,029
 
Current portion of long-term debt
   
(7,813
)
   
(2,142
)
                 
 Long-term debt
 
$
35,783
   
$
41,887
 


At May 3, 2020, maturities of our long-term debt over the next five fiscal years and thereafter were as follows:

2020 (remainder of)
 
$
1,755
 
2021
   
8,294
 
2022
   
12,417
 
2023
   
3,437
 
2024
   
6,582
 
Thereafter
   
11,111
 
 
 
$
43,596
 


As of May 3, 2020 and October 31, 2019, the weighted-average interest rates of our short-term debt were 3.51% and 3.84%, respectively.

Project Loans


In November 2018, PDMCX was approved for credit of the equivalent of $50 million, subject to certain limitations related to PDMCX registered capital at the time of the initial approval, pursuant to which PDMCX has and will enter into separate loan agreements (“the Project Loans”) for intermittent borrowings. The Project Loans, which are denominated in Chinese renminbi (RMB), are being used to finance certain capital expenditures in China. PDMCX granted liens on its interest in land, building, and certain equipment, which had a combined carrying value of $94.1 million as of May 3, 2020, as collateral for the Project Loans. As of May 3, 2020, PDMCX had borrowed 243.4 million RMB ($34.5 million) against this approval. Payments on these borrowings are due semi-annually through December 2025; the initial payment is scheduled for June 2020. The table below presents, in U.S. dollars, the timing of future payments against the borrowings.

 
Fiscal Year
 
   
2020
   
2021
   
2022
   
2023
   
2024
   
2025
   
2026
 
                                           
Principal payments
 
$
1,274
   
$
6,369
   
$
5,679
   
$
3,437
   
$
6,582
   
$
6,299
   
$
4,812
 


The interest rates on the Project Loans are based on the benchmark lending rate of the People’s Bank of China (4.9% at May 3, 2020). Interest incurred on the loans will be reimbursed through incentives provided by the Xiamen Torch Hi-Tech Industrial Development Zone, which provide for such reimbursements up to a prescribed limit.


Working Capital Loans


In November 2018, PDMCX received approval for unsecured credit of the equivalent of $25.0 million, pursuant to which PDMCX may enter into separate loan agreements. Under this credit agreement (the “Working Capital Loans”), PDMCX can borrow up to 140.0 million RMB to pay value-added taxes (“VAT”), and up to 60.0 million RMB to fund operations; combined total borrowings are limited to the equivalent of $25.0 million. As of May 3, 2020, PDMCX had 64.6 million RMB ($9.1 million) outstanding against the approval to pay VAT. Payments on these borrowings are due semiannually, in increasing amounts, through January 2022. The table below presents, in U.S. dollars, the timing of future payments against these borrowings.

 
Fiscal Year
 
   
2020
   
2021
   
2022
 
                   
Principal payments
 
$
481
   
$
1,925
   
$
6,738
 


As of May 3, 2020, PDMCX had borrowed, in several transactions to fund operations, 44.8 million RMB ($6.3 million) against the approval, all of which was outstanding as of that date repayments are due one year from the borrowing dates.


The interest rates on borrowings to fund operations are approximately 4.37 to 4.60%, and interest rates on borrowings to pay VAT are approximately 4.53 to 4.73%; both rates are based on the RMB Loan Prime Rate of the National Interbank Funding Center, plus spreads that range from 25.75 to 67.75 basis points. Interest incurred on the loans will be reimbursed through incentives provided by the Xiamen Torch Hi-Tech Industrial Development Zone, which provide for such reimbursements up to a prescribed limit.

Equipment Loan


Effective July 2019, the Company entered into a Master Lease Agreement (“MLA”) which enables us to request advance payments or other funds to finance equipment to be leased or purchased in the U.S. In connection with this MLA, we were approved for financing of $35 million for the purchase of a high-end lithography tool. In the fourth quarter of fiscal 2019, the financing entity, upon our request, made an advance payment of $3.5 million to the equipment vendor on our behalf. Interest on this borrowing is payable monthly at thirty-day LIBOR plus 1% (1.79% at May 3, 2020), and will continue to accrue until the borrowing is repaid or, as allowed under the MLA, we enter into a lease for the equipment. We intend to enter into a lease agreement for the related equipment in fiscal year 2020; as such, we have classified this borrowing as current debt. All borrowings under the MLA are secured by the equipment to be leased or purchased.

Credit Agreement


In September 2018, we entered into a five-year amended and restated credit agreement (the “Credit Agreement”), which has a $50 million borrowing limit, with an expansion capacity to $100 million. The Credit Agreement is secured by substantially all of our assets located in the United States and common stock we own in certain foreign subsidiaries. The Credit Agreement includes minimum interest coverage ratio, total leverage ratio, and minimum unrestricted cash balance covenants (all of which we were in compliance with at May 3, 2020), and limits the amount of cash dividends, distributions, and redemptions we can pay on our common stock to an aggregate annual amount of $50 million. We had no outstanding borrowings against the Credit Agreement at May 3, 2020, and $50 million was available for borrowing. The interest rate on the Credit Agreement (1.37% at May 3, 2020) is based on our total leverage ratio at LIBOR plus a spread, as defined in the Credit Agreement.
v3.20.1
INCOME TAXES
6 Months Ended
May 03, 2020
INCOME TAXES [Abstract]  
INCOME TAXES
NOTE 9 - INCOME TAXES


We calculate our provision for income taxes at the end of each interim reporting period on the basis of an estimated annual effective tax rate adjusted for tax items that are discrete to each period.


The effective tax rate of 32.2% exceeds the U.S. statutory rate of 21.0% in the three-month period ended May 3, 2020, primarily due to the non-recognition of the tax benefit of losses that, in certain jurisdictions, have been offset by valuation allowances, which were partially offset by the benefit of tax holidays and investment credits in certain foreign jurisdictions.


The effective tax rate of 40.5% exceeds the U.S. statutory rate of 21.0% in the six-month period ended May 3, 2020, primarily due to the non-recognition of the tax benefit of losses that, in certain jurisdictions, have been offset by valuation allowances, and the establishment of a valuation allowance for a loss carryforward in a non-U.S. jurisdiction, which were partially offset by the benefits of tax holidays and investment credits in certain foreign jurisdictions.


Valuation allowances, in jurisdictions with historic losses, eliminate the current tax benefit of losses in these jurisdictions where, based on the weight of information available to us, we determined that it is more likely than not that the tax benefits will not be realized. In the three-month period ended February 2,2020, as a result of the reassessment of the aforementioned available information, we established a valuation allowance of $2.1 million against a non-U.S. based loss-carryforward deferred tax asset that is not more likely than not to be realized.


Unrecognized tax benefits related to uncertain tax positions were $1.8 million at May 3, 2020, and $1.9 million at October 31, 2019, substantially all of which, if recognized, would favorably impact the Company’s effective tax rate. Accrued interest and penalties related to unrecognized tax benefits was $0.2 million at May 3, 2020 and October 31, 2019. Although the timing of the expirations of statutes of limitations may be uncertain, as they can be dependent upon the settlement of tax audits, the Company believes that the amount of uncertain tax positions (including interest and penalties, and net of tax benefits) that may be resolved over the next twelve months is immaterial. Resolution of these uncertain tax positions may result from either or both the lapses of statutes of limitations and tax settlements. The Company is no longer subject to tax authority examinations in the U.S. and major foreign or state jurisdictions for years prior to fiscal year 2015.


We were granted a five-year tax holiday in Taiwan that expired on December 31, 2019. This tax holiday reduced foreign taxes by $0.1 million in the six-month period ended May 3, 2020, by $0.3 million and $1.1 million in the three and six-month periods ended April 28, 2019, respectively, with immaterial per share impacts in the six-month period ended May 3, 2020, and the three-month period ended April 28, 2019, and a one cent per share effect in the six-month period ended April 28, 2019.


The effective tax rate of 25.0% differs from the U.S. statutory rate of 21.0% in the three-month period ended April 28, 2019, primarily due to the elimination of tax benefits in jurisdictions, including the U.S., in which it is not more likely than not that the benefit will be realized; the effects of these eliminations were partially offset by the benefits of tax holidays and investment credits in certain foreign jurisdictions.


The effective tax rate of 20.9% differs from the U.S. statutory rate of 21.0% in the six-month period ended April 28, 2019, primarily due to the elimination of the tax benefits in jurisdictions, including the U.S., in which it is not more likely than not that the benefit will be realized; the effects of these eliminations were partially offset by the benefits of the settlement of a tax audit, as well as a tax holiday and investment credits in certain foreign jurisdictions.
v3.20.1
PDMCX JOINT VENTURE (Tables)
6 Months Ended
May 03, 2020
PDMCX JOINT VENTURE [Abstract]  
Carrying Amounts and Exposure to Loss Related to Assets and Liabilities

The carrying amounts of PDMCX assets and liabilities included in our condensed consolidated balance sheets are presented in the following table, together with our exposure to loss related to these assets and liabilities.

 
May 3, 2020
   
October 31, 2019
 
Classification
 
Carrying
Amount
   
Photronics
Interest
   
Carrying
Amount
   
Photronics
Interest
 
                         
Current assets
 
$
45,646
   
$
22,828
   
$
24,142
   
$
12,074
 
Non-current assets
   
104,972
     
52,496
     
114,015
     
57,019
 
                                 
Total assets
   
150,618
     
75,324
     
138,157
     
69,093
 
                                 
Current liabilities
   
28,785
     
14,395
     
16,889
     
8,446
 
Non-current liabilities
   
35,831
     
17,919
     
42,094
     
21,051
 
                                 
Total liabilities
   
64,616
     
32,314
     
58,983
     
29,497
 
                                 
Net assets
 
$
86,002
   
$
43,010
   
$
79,174
   
$
39,596
 
v3.20.1
FAIR VALUE MEASUREMENTS (Policies)
6 Months Ended
May 03, 2020
FAIR VALUE MEASUREMENTS [Abstract]  
Fair Value Financial Instruments

The accounting framework for determining fair value includes a hierarchy for ranking the quality and reliability of the information used to measure fair value, which enables the reader of the financial statements to assess the inputs used to develop those measurements. The fair value hierarchy consists of three tiers as follows: Level 1, defined as quoted market prices (unadjusted) in active markets for identical securities; Level 2, defined as inputs other than Level 1 that are observable, either directly or indirectly; and Level 3, defined as unobservable inputs that are not corroborated by market data.
v3.20.1
SHARE-BASED COMPENSATION (Tables)
6 Months Ended
May 03, 2020
SHARE-BASED COMPENSATION [Abstract]  
Assumptions Used to Calculate Weighted-Average Grant Date Fair Value of Options

The weighted-average inputs and risk-free rate of return ranges used to calculate the grant-date fair value of options issued during the six-month period ended April 28, 2019, are presented in the following table.

 
Six Months Ended
 
   
April 28, 2019
 
       
Volatility
   
33.1
%
         
Risk free rate of return
   
2.5-2.9
%
         
Dividend yield
   
0.0
%
         
Expected term
 
5.1 years
 
Information on Outstanding and Exercisable Option

Information on outstanding and exercisable option awards as of May 3, 2020, is presented below.

Options
 
Shares
   
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life
 
Aggregate
Intrinsic
Value
 
                     
Outstanding at May 3, 2020
   
1,723,652
   
$
9.16
 
5.1 years
 
$
4,000
 
                           
Exercisable at May 3, 2020
   
1,433,324
   
$
9.07
 
4.6 years
 
$
3,494
 
v3.20.1
SHARE-BASED COMPENSATION (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
May 03, 2020
Apr. 28, 2019
May 03, 2020
Apr. 28, 2019
Share-based Compensation [Abstract]        
Maximum number of shares of common stock that may be issued (in shares) 4,000,000   4,000,000  
Share-based compensation expense incurred $ 1,200 $ 900 $ 2,600 $ 2,000
Cash received from option exercises 400 300 3,200 800
Share-based compensation cost capitalized 0 0 0 0
Income tax benefits realized from stock option exercises 0 $ 0 $ 0 $ 0
Stock Options [Member]        
Share-based Compensation [Abstract]        
Contractual term     10 years  
Additional disclosures [Abstract]        
Share options granted (in shares)   0 0 132,000
Weighted-average grant date fair value of options granted (in dollars per share)       $ 3.31
Unrecognized compensation cost related to unvested option awards $ 600   $ 600  
Period for recognition of compensation cost not yet recognized     2 years  
Weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options [Abstract]        
Volatility       33.10%
Dividend yield       0.00%
Expected term       5 years 1 month 6 days
Outstanding and exercisable option awards [Roll Forward]        
Outstanding at end of period (in shares) 1,723,652   1,723,652  
Exercisable at end of period (in shares) 1,433,324   1,433,324  
Weighted-Average Exercise Price [Abstract]        
Weighted average exercise price, Outstanding at end of period (in dollars per share) $ 9.16   $ 9.16  
Weighted average exercise price, Exercisable at end of period (in dollars per share) $ 9.07   $ 9.07  
Weighted-Average Remaining Contractual Life [Abstract]        
Weighted average remaining contractual life, Outstanding at end of period     5 years 1 month 6 days  
Weighted average remaining contractual life, Exercisable at end of period     4 years 7 months 6 days  
Aggregate Intrinsic Value [Abstract]        
Aggregate intrinsic value, Outstanding at end of period $ 4,000   $ 4,000  
Aggregate intrinsic value, Exercisable at end of period $ 3,494   $ 3,494  
Stock Options [Member] | Minimum [Member]        
Share-based Compensation [Abstract]        
Award vesting period     1 year  
Weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options [Abstract]        
Risk free rate of return       2.50%
Stock Options [Member] | Maximum [Member]        
Share-based Compensation [Abstract]        
Award vesting period     4 years  
Weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options [Abstract]        
Risk free rate of return       2.90%
Restricted Stock [Member]        
Additional disclosures [Abstract]        
Period for recognition of compensation cost not yet recognized     3 years 1 month 6 days  
Restricted Stock [Abstract]        
Restricted stock awards granted (in shares) 5,000   527,000 435,000
Weighted average grant date fair value of restricted stock awards (in dollars per share) $ 9.90   $ 15.21 $ 9.80
Compensation cost not yet recognized related to unvested restricted stock awards $ 8,900   $ 8,900  
Number of shares of restricted stock outstanding (in shares) 854,866   854,866  
Restricted Stock [Member] | Minimum [Member]        
Share-based Compensation [Abstract]        
Award vesting period     1 year  
Restricted Stock [Member] | Maximum [Member]        
Share-based Compensation [Abstract]        
Award vesting period     4 years  
v3.20.1
FAIR VALUE MEASUREMENTS (Details) - USD ($)
$ in Thousands
May 03, 2020
Oct. 31, 2019
Fair Value, Assets and Liability [Abstract]    
Total assets $ 0 $ 0
Total liabilities $ 0 $ 0
v3.20.1
PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 03, 2020
Apr. 28, 2019
May 03, 2020
Apr. 28, 2019
Oct. 31, 2019
Property, plant and equipment [Abstract]          
Property, plant and equipment, gross $ 1,996,259   $ 1,996,259   $ 1,995,368
Accumulated depreciation and amortization (1,391,714)   (1,391,714)   (1,362,927)
Property, plant and equipment, net 604,545   604,545   632,441
Depreciation and amortization expense 22,100 $ 18,600 45,600 $ 36,200  
Land [Member]          
Property, plant and equipment [Abstract]          
Property, plant and equipment, gross 11,916   11,916   12,085
Buildings and Improvements [Member]          
Property, plant and equipment [Abstract]          
Property, plant and equipment, gross 172,689   172,689   172,340
Machinery and Equipment [Member]          
Property, plant and equipment [Abstract]          
Property, plant and equipment, gross 1,746,552   1,746,552   1,748,483
Leasehold Improvements [Member]          
Property, plant and equipment [Abstract]          
Property, plant and equipment, gross 20,344   20,344   19,921
Furniture, Fixtures and Office Equipment [Member]          
Property, plant and equipment [Abstract]          
Property, plant and equipment, gross 14,501   14,501   14,404
Construction in Progress [Member]          
Property, plant and equipment [Abstract]          
Property, plant and equipment, gross $ 30,257   $ 30,257   $ 28,135
v3.20.1
CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME BY COMPONENT (Tables)
6 Months Ended
May 03, 2020
CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME BY COMPONENT [Abstract]  
Changes in Accumulated Other Comprehensive Income by Component

The following tables set forth the changes in our accumulated other comprehensive income by component (net of tax of $0) for the three and six-month periods ended May 3, 2020 and April 28, 2019.

 
Three Months Ended May 3, 2020
 
   
Foreign Currency
Translation
Adjustments
   
Other
   
Total
 
                   
Balance at February 3, 2020
 
$
(11,076
)
 
$
(666
)
 
$
(11,742
)
Other comprehensive (loss) income
   
(2,405
)
   
1
     
(2,404
)
Less: other comprehensive income attributable to noncontrolling interests
   
1,054
     
-
     
1,054
 
                         
Balance at May 3, 2020
 
$
(14,535
)
 
$
(665
)
 
$
(15,200
)

 
Three Months Ended April 28, 2019
 
   
Foreign Currency
Translation
Adjustments
   
Other
   
Total
 
                   
                   
Balance at January 28, 2019
 
$
971
   
$
(628
)
 
$
343
 
Other comprehensive (loss) income
   
(7,054
)
   
25
     
(7,029
)
Less: other comprehensive income attributable to noncontrolling interests
   
129
     
13
     
142
 
                         
Balance at April 28, 2019
 
$
(6,212
)
 
$
(616
)
 
$
(6,828
)

 
Six Months Ended May 3, 2020
 
   
Foreign Currency
Translation
Adjustments
   
Other
   
Total
 
                   
Balance at November 1, 2019
 
$
(8,331
)
 
$
(674
)
 
$
(9,005
)
Other comprehensive (loss) income
   
(3,970
)
   
19
     
(3,951
)
Less: other comprehensive income attributable to noncontrolling interests
   
2,234
     
10
     
2,244
 
                         
Balance at May 3, 2020
 
$
(14,535
)
 
$
(665
)
 
$
(15,200
)

 
Six Months Ended April 28, 2019
 
   
Foreign Currency
Translation
Adjustments
   
Other
   
Total
 
                   
Balance at November 1, 2018
 
$
(4,328
)
 
$
(638
)
 
$
(4,966
)
Other comprehensive (loss) income
   
(482
)
   
44
     
(438
)
Less: other comprehensive income attributable to noncontrolling interests
   
1,402
     
22
     
1,424
 
                         
Balance at April 28, 2019
 
$
(6,212
)
 
$
(616
)
 
$
(6,828
)
v3.20.1
REVENUE, Contract Assets, Liabilities and Accounts Receivable (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 03, 2020
Apr. 28, 2019
May 03, 2020
Apr. 28, 2019
Oct. 31, 2019
Contract with Customer, Asset and Liability [Abstract]          
Contract assets $ 6,500   $ 6,500   $ 7,600
Contract liabilities current 10,700   10,700   $ 11,500
Contract liabilities non-current 5,000   5,000    
Impairment loss on contract assets     0 $ 0  
Provision for credit losses   $ 0   0  
Change in Contract with Customer, Liability [Abstract]          
Revenue from settlement of contract liabilities $ 900 $ 500 $ 1,800 $ 1,200  
Minimum [Member]          
Change in Contract with Customer, Liability [Abstract]          
Product invoice term     30 days    
Product Warranty [Abstract]          
Product warranty period     1 month    
Maximum [Member]          
Change in Contract with Customer, Liability [Abstract]          
Product invoice term     90 days    
Product Warranty [Abstract]          
Product warranty period     24 months    
IC [Member] | Minimum [Member]          
Remaining Performance Obligations [Abstract]          
Customer order, expected satisfaction period     1 day    
IC [Member] | Maximum [Member]          
Remaining Performance Obligations [Abstract]          
Customer order, expected satisfaction period     14 days    
FPD [Member] | Minimum [Member]          
Remaining Performance Obligations [Abstract]          
Customer order, expected satisfaction period     14 days    
FPD [Member] | Maximum [Member]          
Remaining Performance Obligations [Abstract]          
Customer order, expected satisfaction period     21 days    
v3.20.1
Condensed Consolidated Statements of Equity (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Non-Controlling Interests [Member]
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Non-Controlling Interests [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Balance at Oct. 31, 2018 $ 697 $ 555,606 $ 231,445 $ (23,111) $ (4,966) $ 144,898 $ 904,569              
Balance (ASU 2014-09 [Member]) at Oct. 31, 2018               $ 0 $ 0 $ 1,083 $ 0 $ 0 $ 121 $ 1,204
Balance (ASU 2016-16 [Member]) at Oct. 31, 2018               0 0 (1,130) 0 0 (3) (1,133)
Balance (in shares) at Oct. 31, 2018 69,700                          
Balance at Jan. 27, 2019 $ 699 557,188 236,665 (33,807) 343 152,082 913,170              
Balance (in shares) at Jan. 27, 2019 69,917                          
Balance at Oct. 31, 2018 $ 697 555,606 231,445 (23,111) (4,966) 144,898 904,569              
Balance (ASU 2014-09 [Member]) at Oct. 31, 2018               0 0 1,083 0 0 121 1,204
Balance (ASU 2016-16 [Member]) at Oct. 31, 2018               $ 0 $ 0 $ (1,130) $ 0 $ 0 $ (3) $ (1,133)
Balance (in shares) at Oct. 31, 2018 69,700                          
Net income $ 0 0 13,746 0 0 3,874 17,620              
Other comprehensive (loss) income 0 0 0 0 (1,862) 1,424 (438)              
Sale of common stock through employee stock option and purchase plans $ 1 792 0 0 0 0 793              
Sale of common stock through employee stock option and purchase plans (in shares) 136                          
Restricted stock awards vesting and expense $ 2 1,217 0 0 0 0 1,219              
Restricted stock awards vesting and expense (in shares) 148                          
Share-based compensation expense $ 0 744 0 0 0 0 744              
Contribution from noncontrolling interest 0 0 0 0 0 29,394 29,394              
Dividends to noncontrolling interest 0 0 0 0 0 (26,102) (26,102)              
Subsidiary dividend payable 0 0 0 0 0 (18,837) (18,837)              
Repurchase of common stock by subsidiary 0 0 0 0 0 (9) (9)              
Purchases of treasury stock 0 0 0 (10,696) 0 0 (10,696)              
Balance at Apr. 28, 2019 $ 700 558,359 245,144 (33,807) (6,828) 134,760 898,328              
Balance (in shares) at Apr. 28, 2019 69,984                          
Balance at Jan. 27, 2019 $ 699 557,188 236,665 (33,807) 343 152,082 913,170              
Balance (in shares) at Jan. 27, 2019 69,917                          
Net income $ 0 0 8,479 0 0 1,373 9,852              
Other comprehensive (loss) income 0 0 0 0 (7,171) 142 (7,029)              
Sale of common stock through employee stock option and purchase plans $ 1 271 0 0 0 0 272              
Sale of common stock through employee stock option and purchase plans (in shares) 41                          
Restricted stock awards vesting and expense $ 0 650 0 0 0 0 650              
Restricted stock awards vesting and expense (in shares) 26                          
Share-based compensation expense $ 0 250 0 0 0 0 250              
Subsidiary dividend payable 0 0 0 0 0 (18,837) (18,837)              
Balance at Apr. 28, 2019 $ 700 558,359 245,144 (33,807) (6,828) 134,760 898,328              
Balance (in shares) at Apr. 28, 2019 69,984                          
Balance at Oct. 31, 2019 $ 656 524,319 253,922 0 (9,005) 141,200 911,092              
Balance (in shares) at Oct. 31, 2019 65,595                          
Net income $ 0 0 16,584 0 0 2,316 18,900              
Other comprehensive (loss) income 0 0 0 0 (6,195) 2,244 (3,951)              
Sale of common stock through employee stock option and purchase plans $ 4 3,217 0 0 0 0 3,221              
Sale of common stock through employee stock option and purchase plans (in shares) 403                          
Restricted stock awards vesting and expense $ 2 1,827 0 0 0 0 1,829              
Restricted stock awards vesting and expense (in shares) 217                          
Share-based compensation expense $ 0 499 0 0 0 0 499              
Contribution from noncontrolling interest 0 0 0 0 0 7,600 7,600              
Repurchase of common stock by subsidiary 0 255 0 0 0 (893) (638)              
Purchases of treasury stock 0 0 0 (16,894) 0 0 (16,894)              
Balance at May. 03, 2020 $ 662 530,117 270,506 (16,894) (15,200) 152,467 921,658              
Balance (in shares) at May. 03, 2020 66,215                          
Balance at Feb. 02, 2020 $ 661 528,535 264,222 (11,000) (11,742) 142,125 912,801              
Balance (in shares) at Feb. 02, 2020 66,144                          
Net income $ 0 0 6,284 0 0 1,688 7,972              
Other comprehensive (loss) income 0 0 0 0 (3,458) 1,054 (2,404)              
Sale of common stock through employee stock option and purchase plans $ 1 363 0 0 0 0 364              
Sale of common stock through employee stock option and purchase plans (in shares) 45                          
Restricted stock awards vesting and expense $ 0 1,071 0 0 0 0 1,071              
Restricted stock awards vesting and expense (in shares) 26                          
Share-based compensation expense $ 0 148 0 0 0 0 148              
Contribution from noncontrolling interest 0 0 0 0 0 7,600 7,600              
Purchases of treasury stock 0 0 0 (5,894) 0 0 (5,894)              
Balance at May. 03, 2020 $ 662 $ 530,117 $ 270,506 $ (16,894) $ (15,200) $ 152,467 $ 921,658              
Balance (in shares) at May. 03, 2020 66,215                          
v3.20.1
Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - USD ($)
shares in Thousands, $ in Thousands
May 03, 2020
Oct. 31, 2019
Current assets:    
Accounts receivable, allowance $ 1,282 $ 1,334
Equity:    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 2,000 2,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 150,000 150,000
Common stock, shares issued (in shares) 66,215 65,595
Common stock, shares outstanding (in shares) 64,751 65,595
Treasury stock, shares (in shares) 1,464  
v3.20.1
INCOME TAXES (Policies)
6 Months Ended
May 03, 2020
INCOME TAXES [Abstract]  
Income Taxes

We calculate our provision for income taxes at the end of each interim reporting period on the basis of an estimated annual effective tax rate adjusted for tax items that are discrete to each period.


Unrecognized tax benefits related to uncertain tax positions were $1.8 million at May 3, 2020, and $1.9 million at October 31, 2019, substantially all of which, if recognized, would favorably impact the Company’s effective tax rate. Accrued interest and penalties related to unrecognized tax benefits was $0.2 million at May 3, 2020 and October 31, 2019. Although the timing of the expirations of statutes of limitations may be uncertain, as they can be dependent upon the settlement of tax audits, the Company believes that the amount of uncertain tax positions (including interest and penalties, and net of tax benefits) that may be resolved over the next twelve months is immaterial. Resolution of these uncertain tax positions may result from either or both the lapses of statutes of limitations and tax settlements. The Company is no longer subject to tax authority examinations in the U.S. and major foreign or state jurisdictions for years prior to fiscal year 2015.
v3.20.1
SHARE REPURCHASE PROGRAMS
6 Months Ended
May 03, 2020
SHARE REPURCHASE PROGRAMS [Abstract]  
SHARE REPURCHASE PROGRAMS
NOTE 13 – SHARE REPURCHASE PROGRAMS


In August 2019, the Company’s board of directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b5-1 of the Securities Act of 1933 (as amended). The company commenced repurchasing shares under this authorization on September 25, 2019. All of the 0.9 million shares repurchased under this authorization prior to November 1, 2019, were retired in fiscal 2019; the repurchase program was terminated on March 20, 2020. The table below presents information on this repurchase program.

 
Three Months Ended May 3, 2020
   
Six Months Ended May 3, 2020
   
From Inception Date of
September 25, 2019
 
                   
Number of shares repurchased
   
549
     
1,464
     
2,460
 
                         
Cost of shares repurchased
 
$
5,894
   
$
16,894
   
$
27,894
 
                         
Average price paid per share
 
$
10.75
   
$
11.54
   
$
11.34
 


In October 2018, the Company’s board of directors authorized the repurchase of up to $25 million of its common stock, to have been executed in open-market transactions or in accordance with a repurchase plan under Rule 10b5-1 of the Securities Act of 1933 (as amended). The share repurchase program commenced on October 22, 2018, and was terminated on February 1, 2019. All of the shares repurchased under this program were retired in fiscal 2019. The table below presents information on this repurchase program.

 
Three Months Ended
January 27, 2019
   
From Inception Date of
October 22, 2018
 
             
Number of shares repurchased
   
1,137
     
1,467
 
                 
Cost of shares repurchased
 
$
10,694
   
$
13,807
 
                 
Average price paid per share
 
$
9.40
   
$
9.41
 
v3.20.1
PDMCX JOINT VENTURE (Policies)
6 Months Ended
May 03, 2020
PDMCX JOINT VENTURE [Abstract]  
Variable Interest Entities

As required by the guidance in Topic 810 - “Consolidation” of the Accounting Standards Codification (“ASC”), we evaluated our involvement in PDMCX for the purpose of determining whether we should consolidate its results in our financial statements. The initial step of our evaluation was to determine whether PDMCX was a variable interest entity (“VIE”). Due to its lack of sufficient equity at risk to finance its activities without additional subordinated financial support, we determined that it was a VIE. Having made this determination, we then assessed whether we were the primary beneficiary of the VIE, and concluded that we were the primary beneficiary during the current and prior year reporting periods; thus, as required, the PDMCX financial results have been consolidated with those of Photronics. Our conclusion was based on the facts that we held a controlling financial interest in PDMCX (which resulted from our having the power to direct the activities that most significantly impacted its economic performance) and had the obligation to absorb losses and the right to receive benefits that could potentially be significant to PDMCX. Our conclusions that we had the power to direct the activities that most significantly affected the economic performance of PDMCX during the current and prior year reporting periods was based on our right to appoint the majority of its board of directors, which has, among others, the powers to manage the business (through its rights to appoint and evaluate PDMCX's management), incur indebtedness, enter into agreements and commitments, and acquire and dispose of PDMCX’s assets. In addition, as a result of the 50.01% variable interest we held during the current and prior-year periods, we had the obligation to absorb losses, and the right to receive benefits, that could potentially be significant to PDMCX.
v3.20.1
REVENUE (Tables)
6 Months Ended
May 03, 2020
REVENUE [Abstract]  
Disaggregation of Revenue

The following tables present our revenue for the three and six-month periods ended May 3, 2020 and April 28, 2019, disaggregated by product type, geographic origin, and timing of recognition. At the beginning of fiscal year 2020, we changed the threshold for the definition of high-end FPD, from G8 and above and active matrix organic light-emitting diode (AMOLED) display screens, to G10.5 and above, AMOLED, and low-temperature polysilicon display screens (LTPS), to reflect the overall advancement of technology in the FPD industry. Our definition of high-end IC products remains as 28 nanometer or smaller. The revenue by product type for the three and six-month periods ended April 28, 2019, presented below has been reclassified to conform to the current period presentation.

 
Three Months Ended
   
Six Months Ended
 
   
May 3, 2020
   
April 28, 2019
   
May 3, 2020
   
April 28, 2019
 
                         
Revenue by Product Type
                       
 IC
                       
High-end
 
$
38,267
   
$
38,429
   
$
79,308
   
$
72,995
 
Mainstream
   
58,579
     
60,158
     
124,516
     
120,471
 
Total IC
 
$
96,846
   
$
98,587
   
$
203,824
   
$
193,466
 
                                 
FPD
                               
High-end
 
$
31,809
   
$
22,051
   
$
71,579
   
$
37,401
 
Mainstream
   
14,119
     
10,942
     
27,107
     
25,424
 
Total FPD
 
$
45,928
   
$
32,993
   
$
98,686
   
$
62,825
 
   
$
142,774
   
$
131,580
   
$
302,510
   
$
256,291
 

 
Three Months Ended
   
Six Months Ended
 
   
May 3, 2020
   
April 28, 2019
   
May 3, 2020
   
April 28, 2019
 
                         
Revenue by Geographic Origin
                       
Taiwan
 
$
55,513
   
$
56,469
   
$
121,626
   
$
114,209
 
Korea
   
36,261
     
38,038
     
76,997
     
73,275
 
United States
   
24,857
     
26,742
     
49,925
     
49,215
 
China
   
17,486
     
1,467
     
37,386
     
1,730
 
Europe
   
8,331
     
8,435
     
15,874
     
16,788
 
Other
   
326
     
429
     
702
     
1,074
 
   
$
142,774
   
$
131,580
   
$
302,510
   
$
256,291
 
                                 
Revenue by Timing of Recognition
                               
Over time
 
$
126,071
   
$
123,853
   
$
263,905
   
$
244,699
 
At a point in time
   
16,703
     
7,727
     
38,605
     
11,592
 
   
$
142,774
   
$
131,580
   
$
302,510
   
$
256,291
 
v3.20.1
INVENTORIES (Tables)
6 Months Ended
May 03, 2020
INVENTORIES [Abstract]  
Inventories

Inventories are stated at the lower of cost, determined under the first-in, first-out ("FIFO") method, or net realizable value. Presented below are the components of inventory at the balance sheet dates:

 
May 3,
2020
   
October 31,
2019
 
             
Raw materials
 
$
55,110
   
$
46,027
 
Work in process
   
1,818
     
2,122
 
Finished goods
   
40
     
6
 
                 
   
$
56,968
   
$
48,155
 
v3.20.1
PROPERTY, PLANT AND EQUIPMENT
6 Months Ended
May 03, 2020
PROPERTY, PLANT AND EQUIPMENT [Abstract]  
PROPERTY, PLANT AND EQUIPMENT
NOTE 3 - PROPERTY, PLANT AND EQUIPMENT


Property, plant and equipment consists of the following:

 
May 3,
2020
   
October 31,
2019
 
             
Land
 
$
11,916
   
$
12,085
 
Buildings and improvements
   
172,689
     
172,340
 
Machinery and equipment
   
1,746,552
     
1,748,483
 
Leasehold improvements
   
20,344
     
19,921
 
Furniture, fixtures and office equipment
   
14,501
     
14,404
 
Construction in progress
   
30,257
     
28,135
 
                 
     
1,996,259
     
1,995,368
 
Accumulated depreciation and amortization
   
(1,391,714
)
   
(1,362,927
)
                 
   
$
604,545
   
$
632,441
 


Depreciation and amortization expense for property, plant and equipment was $22.1 million and $45.6 million for the three and six-month periods ended May 3, 2020 respectively, and $18.6 million and $36.2 million for the three and six-month periods ended April 28, 2019, respectively.
v3.20.1
LEASES
6 Months Ended
May 03, 2020
LEASES [Abstract]  
LEASES
NOTE 7 – LEASES


We adopted Accounting Standards Update (“ASU”) 2016-02 and all subsequent amendments, collectively codified in ASC Topic 842 “Leases” (“Topic 842”), on November 1, 2019. The guidance requires modified retrospective adoption, either at the beginning of the earliest period presented or at the beginning of the period of adoption. We elected to apply the guidance at the beginning of the period of adoption and recorded, as of November 1, 2019, right-of-use (ROU) leased assets of $6.5 million. In conjunction with this, we recorded lease liabilities, which had been discounted at our incremental borrowing rates, of $6.5 million.


The guidance allows a number of elections and practical expedients, of which we elected the following:

-
Election not to recognize short-term leases on the balance sheet.
-
Practical expedient to not separate lease and non-lease components in a contract.
-
Practical expedient “package” for transitioning to the new guidance:
-
Not reassessing whether any expired or existing contracts are, or contain, leases.
-
Not reassessing lease classification for any existing or expired leases.
-
Not reassessing initial direct costs for any existing leases.


Our involvement in lease arrangements has typically been as a lessee. We determine if an agreement is or contains a lease on the date of the lease agreement or commitment, if earlier. Our evaluation considers whether the arrangement includes an identified asset and whether it affords us the right to control the asset. Our having the right to control the identified asset is determined by whether we are entitled to substantially all of its economic benefits and can direct its use.


We recognize leases on our consolidated balance sheet when a lessor makes an asset underlying a lease having a term in excess of twelve months available for our use. The present value of lease payments over the term of the lease, which is determined using our incremental borrowing rate for collateralized loans at the commencement date of the lease, provides the basis for the initial measurement of ROU assets and their related lease liabilities. Variable lease payments, other than those that are dependent on an index or on a rate, are not included in the measurement of ROU assets and their related lease liabilities. Lease terms will include extension periods if the lease agreement includes an option to extend the lease that we are reasonably certain to exercise.


ROU assets underlying our leases include the land and facilities of some of our operating facilities, other real property, and machinery and equipment. As of May 3, 2020, we had ROU assets under operating leases of $6.5 million, included in “Other Assets”, and $1.8 and $4.1 million of lease liabilities, included in Accrued liabilities and Other liabilities, respectively. The following tables present lease payments under non-cancellable leases as of May 3, 2020.

 
 
Fiscal Year
                     
 
 
2020
   
2021
   
2022
   
2023
   
2024
   
Thereafter
   
Total Lease
Payments
   
Imputed
Interest*
   
Total
 
Lease payments
 
$
996
   
$
1,802
   
$
1,686
   
$
787
   
$
444
   
$
391
   
$
6,106
   
$
(255
)
 
$
5,851
 


*Imputed interest represents difference between undiscounted cash flows and discounted cash flows.



The following table presents lease costs for the three and six-month periods ended May 3, 2020.

 
Three Months Ended
   
Six Months Ended
 
   
May 3, 2020
   
May 3, 2020
 
             
Operating lease costs
 
$
633
   
$
1,797
 
Short-tern lease costs
 
$
102
   
$
212
 
Variable lease costs
 
$
129
   
$
129
 


Presented below is other information related to our operating leases.

Supplemental cash flows information:
           
   
Three Months Ended
   
Six Months Ended
 
   
May 3, 2020
   
May 3, 2020
 
             
Operating cash flows used for operating leases
 
$
502
   
$
2,387
 
ROU assets obtained in exchange for lease obligations
 
$
58
   
$
340
 

 
 
As of
 
 
 
May 3, 2020
 
 
     
Weighted-average remaining lease term
 
3.7 years
 
Weighted-average discount rate
   
2.41
%


Rent expense, as calculated under guidance in effect prior to our adoption of the new leases guidance, was $3.0 million in fiscal year 2019. At October 31, 2019, future minimum lease payments under non-cancelable operating leases with initial terms in excess of one year were as presented in the table below. The amounts are undiscounted and were calculated in accordance with guidance in effect prior to our adoption of the new leases guidance.

2020
 
$
1,885
 
2021
   
1,613
 
2022
   
1,535
 
2023
   
742
 
2024
   
424
 
Thereafter
   
377
 
   
$
6,576
 
v3.20.1
CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME BY COMPONENT
6 Months Ended
May 03, 2020
CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME BY COMPONENT [Abstract]  
CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME BY COMPONENT
NOTE 11 - CHANGES IN ACCUMULATED OTHER COMPREHENSIVE INCOME BY COMPONENT


The following tables set forth the changes in our accumulated other comprehensive income by component (net of tax of $0) for the three and six-month periods ended May 3, 2020 and April 28, 2019.

 
Three Months Ended May 3, 2020
 
   
Foreign Currency
Translation
Adjustments
   
Other
   
Total
 
                   
Balance at February 3, 2020
 
$
(11,076
)
 
$
(666
)
 
$
(11,742
)
Other comprehensive (loss) income
   
(2,405
)
   
1
     
(2,404
)
Less: other comprehensive income attributable to noncontrolling interests
   
1,054
     
-
     
1,054
 
                         
Balance at May 3, 2020
 
$
(14,535
)
 
$
(665
)
 
$
(15,200
)

 
Three Months Ended April 28, 2019
 
   
Foreign Currency
Translation
Adjustments
   
Other
   
Total
 
                   
                   
Balance at January 28, 2019
 
$
971
   
$
(628
)
 
$
343
 
Other comprehensive (loss) income
   
(7,054
)
   
25
     
(7,029
)
Less: other comprehensive income attributable to noncontrolling interests
   
129
     
13
     
142
 
                         
Balance at April 28, 2019
 
$
(6,212
)
 
$
(616
)
 
$
(6,828
)

 
Six Months Ended May 3, 2020
 
   
Foreign Currency
Translation
Adjustments
   
Other
   
Total
 
                   
Balance at November 1, 2019
 
$
(8,331
)
 
$
(674
)
 
$
(9,005
)
Other comprehensive (loss) income
   
(3,970
)
   
19
     
(3,951
)
Less: other comprehensive income attributable to noncontrolling interests
   
2,234
     
10
     
2,244
 
                         
Balance at May 3, 2020
 
$
(14,535
)
 
$
(665
)
 
$
(15,200
)

 
Six Months Ended April 28, 2019
 
   
Foreign Currency
Translation
Adjustments
   
Other
   
Total
 
                   
Balance at November 1, 2018
 
$
(4,328
)
 
$
(638
)
 
$
(4,966
)
Other comprehensive (loss) income
   
(482
)
   
44
     
(438
)
Less: other comprehensive income attributable to noncontrolling interests
   
1,402
     
22
     
1,424
 
                         
Balance at April 28, 2019
 
$
(6,212
)
 
$
(616
)
 
$
(6,828
)
v3.20.1
EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
May 03, 2020
Apr. 28, 2019
May 03, 2020
Apr. 28, 2019
Calculation of basic and diluted earnings per share [Abstract]        
Net income attributable to Photronics, Inc. shareholders $ 6,284 $ 8,479 $ 16,584 $ 13,746
Effect of dilutive securities [Abstract]        
Interest expense on convertible notes, net of tax 0 349 0 845
Earnings used for diluted earnings per share $ 6,284 $ 8,828 $ 16,584 $ 14,591
Weighted-average common shares computations [Abstract]        
Weighted-average common shares used for basic earnings per share (in shares) 64,937 66,261 65,246 66,422
Effect of dilutive securities [Abstract]        
Share-based payment awards (in shares) 480 438 687 451
Convertible notes (in shares) 0 3,898 0 4,720
Potentially dilutive common shares (in shares) 480 4,336 687 5,171
Weighted-average common shares used for diluted earnings per share (in shares) 65,417 70,597 65,933 71,593
Basic earnings per share (in dollars per share) $ 0.10 $ 0.13 $ 0.25 $ 0.21
Diluted earnings per share (in dollars per share) $ 0.10 $ 0.13 $ 0.25 $ 0.20
Antidilutive Securities [Abstract]        
Total potentially dilutive shares excluded (in shares) 1,009 1,204 591 1,134
Share-based Payment Awards [Member]        
Antidilutive Securities [Abstract]        
Total potentially dilutive shares excluded (in shares) 1,009 1,204 591 1,134
v3.20.1
COMMITMENTS AND CONTINGENCIES (Details)
$ in Thousands
6 Months Ended
May 03, 2020
USD ($)
Commitment and Contingencies [Abstract]  
Outstanding commitments for capital expenditure $ 138,000
Subsidiary [Member]  
Commitment and Contingencies [Abstract]  
Loss contingency damages sought 2,200
Fine amount recommended by prosecutor 30
Contingent loss accrued 30
Contingent loss not accrued 2,170
Subsidiary [Member] | Maximum [Member]  
Commitment and Contingencies [Abstract]  
Estimated range of contingent loss 2,200
Subsidiary [Member] | Minimum [Member]  
Commitment and Contingencies [Abstract]  
Estimated range of contingent loss $ 30
v3.20.1
PDMCX JOINT VENTURE, Carrying Amounts of Assets and Liabilities (Details) - USD ($)
$ in Thousands
May 03, 2020
Oct. 31, 2019
Carrying amounts of assets and liabilities [Abstract]    
Current assets $ 472,271 $ 427,527
Total assets 1,133,888 1,118,665
Current liabilities 153,372 151,954
Total liabilities 212,230 207,573
Carrying Amount [Member]    
Carrying amounts of assets and liabilities [Abstract]    
Current assets 45,646 24,142
Non-current assets 104,972 114,015
Total assets 150,618 138,157
Current liabilities 28,785 16,889
Non-current liabilities 35,831 42,094
Total liabilities 64,616 58,983
Net assets 86,002 79,174
Photronics Interest [Member]    
Carrying amounts of assets and liabilities [Abstract]    
Current assets 22,828 12,074
Non-current assets 52,496 57,019
Total assets 75,324 69,093
Current liabilities 14,395 8,446
Non-current liabilities 17,919 21,051
Total liabilities 32,314 29,497
Net assets $ 43,010 $ 39,596
v3.20.1
BASIS OF FINANCIAL STATEMENT PRESENTATION (Details)
6 Months Ended
May 03, 2020
Facility
Manufacturing Facilities [Abstract]  
Number of manufacturing facilities 11
Taiwan [Member]  
Manufacturing Facilities [Abstract]  
Number of manufacturing facilities 3
Korea [Member]  
Manufacturing Facilities [Abstract]  
Number of manufacturing facilities 1
United States [Member]  
Manufacturing Facilities [Abstract]  
Number of manufacturing facilities 3
Europe [Member]  
Manufacturing Facilities [Abstract]  
Number of manufacturing facilities 2
China [Member]  
Manufacturing Facilities [Abstract]  
Number of manufacturing facilities 2
v3.20.1
Condensed Consolidated Statements of Comprehensive Income (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 03, 2020
Apr. 28, 2019
May 03, 2020
Apr. 28, 2019
Condensed Consolidated Statements of Comprehensive Income (unaudited) [Abstract]        
Net income $ 7,972 $ 9,852 $ 18,900 $ 17,620
Other comprehensive income (loss), net of tax of $0:        
Foreign currency translation adjustments (2,405) (7,054) (3,970) (482)
Other 1 25 19 44
Net other comprehensive loss (2,404) (7,029) (3,951) (438)
Comprehensive income 5,568 2,823 14,949 17,182
Less: comprehensive income attributable to noncontrolling interests 2,742 1,515 4,560 5,298
Comprehensive income attributable to Photronics, Inc. shareholders $ 2,826 $ 1,308 $ 10,389 $ 11,884
v3.20.1
Document and Entity Information - shares
6 Months Ended
May 03, 2020
Jun. 08, 2020
Cover [Abstract]    
Entity Registrant Name PHOTRONICS INC  
Entity Central Index Key 0000810136  
Current Fiscal Year End Date --10-31  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Shell Company false  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Common Stock, Shares Outstanding   65,622,399
Document Type 10-Q  
Amendment Flag false  
Document Period End Date May 03, 2020  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q2  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 0-15451  
Entity Tax Identification Number 06-0854886  
Entity Incorporation, State or Country Code CT  
Entity Address, Address Line One 15 Secor Road  
Entity Address, City or Town Brookfield  
Entity Address, State or Province CT  
Entity Address, Postal Zip Code 06804  
City Area Code 203  
Local Phone Number 775-9000  
Title of 12(b) Security COMMON  
Trading Symbol PLAB  
Security Exchange Name NASDAQ  
v3.20.1
BASIS OF FINANCIAL STATEMENT PRESENTATION
6 Months Ended
May 03, 2020
BASIS OF FINANCIAL STATEMENT PRESENTATION [Abstract]  
BASIS OF FINANCIAL STATEMENT PRESENTATION
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION


Photronics, Inc. (“Photronics”, “the Company”, “we”, “our”, or “us”) is one of the world's leading manufacturers of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of semiconductors and flat-panel displays (“FPDs”), and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during the fabrication of integrated circuits (“ICs” or “semiconductors”), a variety of FPDs and, to a lesser extent, other types of electrical and optical components. We currently have eleven manufacturing facilities, which are located in Taiwan (3), Korea, the United States (3), Europe (2), and two recently constructed facilities in China. Our FPD facility in Hefei, China, commenced production in the second quarter of fiscal 2019 and our IC facility in Xiamen, China, commenced production in the third quarter of fiscal 2019.


The accompanying unaudited condensed consolidated financial statements (“the financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of management, adjustments, all of which are of a normal recurring nature, considered necessary for a fair presentation have been included. The financial statements include the accounts of Photronics, its wholly owned subsidiaries, and the majority-owned subsidiaries which it controls. All intercompany balances and transactions have been eliminated in consolidation.


The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect amounts reported in them. Estimates are based on historical experience and on various assumptions that are believed to be reasonable under the circumstances. Our estimates are based on the facts and circumstances available at the time they are made. Actual results we report may differ from such estimates. We review these estimates periodically and reflect any effects of revisions in the period in which they are determined.


Certain reclassifications of prior period amounts have been made to conform to the current period presentation. These reclassifications included separating, as its own line item, Foreign currency transaction (losses) gains, net, from Interest income and other income (expense), net, on the condensed consolidated statements of income, and separating Share-based compensation from Accounts payable, accrued liabilities, and other, in the condensed consolidated statements of cash flows.


Our business is typically impacted during the first, and sometimes the second, quarters of our fiscal year by the North American, European, and Asian holiday periods, as some customers reduce their development and buying activities during those periods. Operating results for the interim period are not necessarily indicative of the results that may be expected for the fiscal year ending October 31, 2020. For further information, refer to the consolidated financial statements, and notes thereto, included in our Annual Report on Form 10-K for the year ended October 31, 2019.
v3.20.1
RECENT ACCOUNTING PRONOUNCEMENTS
6 Months Ended
May 03, 2020
RECENT ACCOUNTING PRONOUNCEMENTS [Abstract]  
RECENT ACCOUNTING PRONOUNCEMENTS
NOTE 15 - RECENT ACCOUNTING PRONOUNCEMENTS

Accounting Standards Updates Adopted


We adopted ASU 2016-02 and all subsequent amendments, collectively codified in ASC Topic 842 “Leases” (“Topic 842”), on November 1, 2019. The guidance requires modified retrospective adoption, either at the beginning of the earliest period presented or at the beginning of the period of adoption. We elected to apply the guidance at the beginning of the period of adoption and recorded, as of November 1, 2019, right-of-use (ROU) leased assets of $6.5 million. In conjunction with this, we recorded lease liabilities, which had been discounted at our incremental borrowing rates, of $6.5 million. Our adoption of Topic 842 did not affect our cash flows or our ability to comply with covenants under our credit agreement. Please see Note 7 for our leases disclosure.

Accounting Standards Updates to be Adopted


In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”, which provides optional expedients and exceptions to applying the guidance on contract modifications, hedge accounting, and other transactions, to simplify the accounting for transitioning from the London Interbank Offered Rate, and other interbank offered rates expected to be discontinued, to alternative reference rates. The guidance in this Update was effective upon its issuance; if elected, it is to be applied prospectively through December 31, 2022. We are currently evaluating the effect the potential adoption of this ASU will have on our consolidated financial statements.


In June 2016, the FASB issued ASU 2016-13, “Measurement of Credit Losses”, the main objective of which is to provide more useful information about expected credit losses on financial instruments and other commitments of an entity to extend credit. In support of this objective, the ASU replaces the incurred loss impairment methodology, found in current GAAP, with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. This ASU requires a cumulative-effect adjustment as of the beginning of the first reporting period in which the guidance is adopted. ASU 2016-13 is effective for Photronics in its first quarter of fiscal year 2021, with early adoption permitted beginning in the first quarter of fiscal year 2019. We have not early adopted and are currently evaluating the effect that this ASU will have on our consolidated financial statements.
v3.20.1
LEASES (Policies)
6 Months Ended
May 03, 2020
LEASES [Abstract]  
Leases

We adopted Accounting Standards Update (“ASU”) 2016-02 and all subsequent amendments, collectively codified in ASC Topic 842 “Leases” (“Topic 842”), on November 1, 2019. The guidance requires modified retrospective adoption, either at the beginning of the earliest period presented or at the beginning of the period of adoption. We elected to apply the guidance at the beginning of the period of adoption and recorded, as of November 1, 2019, right-of-use (ROU) leased assets of $6.5 million. In conjunction with this, we recorded lease liabilities, which had been discounted at our incremental borrowing rates, of $6.5 million.


The guidance allows a number of elections and practical expedients, of which we elected the following:

-
Election not to recognize short-term leases on the balance sheet.
-
Practical expedient to not separate lease and non-lease components in a contract.
-
Practical expedient “package” for transitioning to the new guidance:
-
Not reassessing whether any expired or existing contracts are, or contain, leases.
-
Not reassessing lease classification for any existing or expired leases.
-
Not reassessing initial direct costs for any existing leases.


Our involvement in lease arrangements has typically been as a lessee. We determine if an agreement is or contains a lease on the date of the lease agreement or commitment, if earlier. Our evaluation considers whether the arrangement includes an identified asset and whether it affords us the right to control the asset. Our having the right to control the identified asset is determined by whether we are entitled to substantially all of its economic benefits and can direct its use.


We recognize leases on our consolidated balance sheet when a lessor makes an asset underlying a lease having a term in excess of twelve months available for our use. The present value of lease payments over the term of the lease, which is determined using our incremental borrowing rate for collateralized loans at the commencement date of the lease, provides the basis for the initial measurement of ROU assets and their related lease liabilities. Variable lease payments, other than those that are dependent on an index or on a rate, are not included in the measurement of ROU assets and their related lease liabilities. Lease terms will include extension periods if the lease agreement includes an option to extend the lease that we are reasonably certain to exercise.
v3.20.1
LONG-TERM DEBT (Details)
$ in Thousands, ¥ in Millions
1 Months Ended 6 Months Ended
Aug. 25, 2019
USD ($)
Jul. 28, 2019
USD ($)
May 03, 2020
CNY (¥)
May 03, 2020
USD ($)
Apr. 28, 2019
USD ($)
May 03, 2020
USD ($)
Oct. 31, 2019
USD ($)
Long-term debt [Abstract]              
Long-term debt           $ 43,596 $ 44,029
Current portion of long-term debt           (7,813) (2,142)
Long-term debt           $ 35,783 $ 41,887
Weighted-average interest rate of short -term debt     3.51%     3.51% 3.84%
Consolidated assets pledged           $ 1,133,888 $ 1,118,665
Proceeds from debt       $ 1,140 $ 39,633    
Maturities of Long-term Debt [Abstract]              
2020 (remainder of)           1,755  
2021           8,294  
2022           12,417  
2023           3,437  
2024           6,582  
Thereafter           11,111  
Project Loans [Member]              
Long-term debt [Abstract]              
Long-term debt           $ 34,452 34,490
Interest rate percentage     4.90%     4.90%  
Maturity date of debt     Dec. 31, 2025 Dec. 31, 2025      
Maximum borrowing capacity           $ 50,000  
Proceeds from credit facility     ¥ 243.4 $ 34,500      
Date of first required payment     Jun. 30, 2020 Jun. 30, 2020      
Maturities of Long-term Debt [Abstract]              
2020 (remainder of)           1,274  
2021           6,369  
2022           5,679  
2023           3,437  
2024           6,582  
2025           6,299  
2026           4,812  
Project Loans [Member] | Asset Pledged as Collateral [Member]              
Long-term debt [Abstract]              
Consolidated assets pledged           94,100  
Working Capital Loans [Member]              
Long-term debt [Abstract]              
Maturity date of debt     Jan. 31, 2022 Jan. 31, 2022      
Maximum borrowing capacity           25,000  
Maturities of Long-term Debt [Abstract]              
2020 (remainder of)           481  
2021           1,925  
2022           6,738  
Working Capital Loans [Member] | Minimum [Member]              
Long-term debt [Abstract]              
Basis spread on variable rate     0.2575% 0.2575%      
Working Capital Loans [Member] | Maximum [Member]              
Long-term debt [Abstract]              
Basis spread on variable rate     0.6775% 0.6775%      
Working Capital Loans (value added tax component) [Member]              
Long-term debt [Abstract]              
Long-term debt           9,144 $ 9,539
Maximum borrowing capacity | ¥     ¥ 140.0        
Amount outstanding under credit facility     ¥ 64.6     $ 9,100  
Working Capital Loans (value added tax component) [Member] | Minimum [Member]              
Long-term debt [Abstract]              
Interest rate percentage     4.53%     4.53%  
Working Capital Loans (value added tax component) [Member] | Maximum [Member]              
Long-term debt [Abstract]              
Interest rate percentage     4.73%     4.73%  
Working Capital Loans, Fund Operations [Member]              
Long-term debt [Abstract]              
Maximum borrowing capacity | ¥     ¥ 60.0        
Proceeds from credit facility     ¥ 44.8 $ 6,300      
Term of loan     1 year 1 year      
Working Capital Loans, Fund Operations [Member] | Minimum [Member]              
Long-term debt [Abstract]              
Interest rate percentage     4.37%     4.37%  
Working Capital Loans, Fund Operations [Member] | Maximum [Member]              
Long-term debt [Abstract]              
Interest rate percentage     4.60%     4.60%  
Amended and Restated Credit Agreement [Member]              
Long-term debt [Abstract]              
Maximum borrowing capacity           $ 100,000  
Term of loan     5 years 5 years      
Current borrowing capacity           50,000  
Cash limit for dividends, distributions and redemption on equity           50,000  
Amount outstanding under credit facility           0  
Available borrowing capacity           $ 50,000  
Effective interest rate     1.37%     1.37%  
Equipment Loan [Member]              
Long-term debt [Abstract]              
Maximum borrowing capacity   $ 35,000          
Proceeds from debt $ 3,500            
Equipment Loan [Member] | LIBOR [Member]              
Long-term debt [Abstract]              
Basis spread on variable rate   1.00%          
Term of variable rate   30 days          
Effective interest rate     1.79%     1.79%  
v3.20.1
INVENTORIES (Details) - USD ($)
$ in Thousands
May 03, 2020
Oct. 31, 2019
INVENTORIES [Abstract]    
Raw materials $ 55,110 $ 46,027
Work in process 1,818 2,122
Finished goods 40 6
Inventory $ 56,968 $ 48,155
v3.20.1
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
6 Months Ended
May 03, 2020
Apr. 28, 2019
Cash flows from operating activities:    
Net income $ 18,900 $ 17,620
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 47,896 38,515
Share-based compensation 2,576 1,962
Changes in assets and liabilities:    
Accounts receivable (13) (2,295)
Inventories (8,989) (9,447)
Other current assets (6,887) (6,114)
Accounts payable, accrued liabilities and other 7,840 (42,528)
Net cash provided by (used in) operating activities 61,323 (2,287)
Cash flows from investing activities:    
Purchases of property, plant and equipment (30,127) (140,436)
Government incentives 5,260 5,698
Other (139) (23)
Net cash used in investing activities (25,006) (134,761)
Cash flows from financing activities:    
Proceeds from debt 1,140 39,633
Contribution from noncontrolling interest 7,600 29,394
Purchases of treasury stock (16,894) (10,696)
Repayments of long-term debt (389) (61,220)
Proceeds from share-based arrangements 3,423 1,033
Dividends paid to noncontrolling interests 0 (26,102)
Other (251) (45)
Net cash used in financing activities (5,371) (28,003)
Effects of exchange rate changes on cash, cash equivalents, and restricted cash 475 2,843
Net increase (decrease) in cash, cash equivalents, and restricted cash 31,421 (162,208)
Cash, cash equivalents, and restricted cash at beginning of period 209,291 331,989
Cash, cash equivalents, and restricted cash at end of period 240,712 169,781
Supplemental disclosure of non-cash information:    
Accrual for property, plant and equipment purchased during the period 2,891 17,454
Accrual for property, plant and equipment purchased with funds receivable from government incentives 0 13,402
Subsidiary dividend payable $ 0 $ 18,837
v3.20.1
COMMITMENTS AND CONTINGENCIES
6 Months Ended
May 03, 2020
COMMITMENTS AND CONTINGENCIES [Abstract]  
COMMITMENTS AND CONTINGENCIES
NOTE 14 - COMMITMENTS AND CONTINGENCIES


As of May 3, 2020, the Company had commitments outstanding for capital expenditures of approximately $138 million, primarily for the purchase of high-end IC equipment. See Note 7 for information on our operating lease commitments.


The Company’s wholly owned subsidiary in South Korea has been involved in litigation regarding a 2016 informational tax filing for its non-South Korean bank accounts that was not timely made under a then recently issued presidential decree. A fine (based solely on the amount in such accounts) in the amount of $2.2 million was assessed against our subsidiary. Our subsidiary appealed the fine on the grounds that it was not required to make the tax filing, and such appeal was pursued up to the Supreme Court in South Korea. Under South Korean law, the tax authorities were entitled to pursue the matter in both civil and criminal courts simultaneously, with the proviso that any criminal fine imposed would act to dismiss any civil fine. The prosecutor recommended a fine of $0.03 million. The civil matter has subsequently been dismissed. Photronics was notified on March 12, 2020, that the Supreme Court rendered a decision against our subsidiary on the issue of whether our subsidiary was required to make the tax filing and remanded the case to the appellate court for determination of the fine. We are awaiting a trial date from the appellate court. Prior to the Supreme Court decision, the possibility of a fine had been deemed remote, as our initial assessment based on advice of local counsel and the subsequent judgments in the lower courts were all in our favor. Our estimate of the possible range of loss is $0.03 million to $2.2 million with the most likely amount being $0.03 million (based on the prosecutor’s recommendation). Accordingly, during the three-month period ended May 3, 2020, we accrued a contingent loss of $0.03 million with a charge to Selling, general and administrative expense in the consolidated statements of income. It is reasonably possible that the estimated loss will change in the near term. Our exposure to loss in excess of amounts accrued is $2.17 million. The imposition of the fine will not have a material impact on our financial position or financial performance.


We are subject to various other claims that arise in the ordinary course of business. We believe that our potential liability under such claims, individually or in the aggregate, will not have a material effect on the consolidated financial statements.
v3.20.1
REVENUE (Policies)
6 Months Ended
May 03, 2020
REVENUE [Abstract]  
Revenue

We recognize revenue when, or as, control of a good or service transfers to a customer, in an amount that reflects the consideration to which we expect to be entitled in exchange for transferring those goods or services. We account for an arrangement as a revenue contract when each party has approved and is committed to perform under the contract, the rights of the contracting parties regarding the goods or services to be transferred and the payment terms are identifiable, the arrangement has commercial substance, and collection of consideration is probable. Substantially all of our revenue comes from the sales of photomasks. We typically contract with our customers to sell sets of photomasks, which are comprised of multiple layers, the predominance of which we invoice as they ship to customers. As the photomasks are manufactured to customer specifications, they have no alternative use to us and, as our contracts generally provide us with the right to payment for work completed to date, we recognize revenue as we perform, or “over time,” on most of our contracts. We measure our performance to date using an input method, which is based on our estimated costs to complete the various manufacturing phases of a photomask. At the end of a reporting period, there will be a number of uncompleted revenue contracts on which we have performed; for any such contracts under which we are entitled to be compensated for our costs incurred plus a reasonable profit, we recognize revenue and a corresponding contract asset for such performance. We account for shipping and handling activities that we perform after a customer obtains control of a good as being activities to fulfill our promise to transfer the good to the customer, rather than as promised services, or performance obligations, under the contract.


As stated above, photomasks are manufactured to customer specifications in accordance with their proprietary designs; thus, they are individually unique. Due to their uniqueness and other factors, their transaction prices are individually established through negotiations with customers; consequently, our photomasks do not have standard or “list” prices. The transaction prices of the vast majority of our revenue contracts include only fixed amounts of consideration. In certain instances, such as when we offer a customer an early payment discount, an estimate of variable consideration would be included in the transaction price, but only to the extent that a significant reversal of revenue would not occur when the uncertainty related to the variability is resolved.

Contract Assets, Contract Liabilities, and Accounts Receivable


We recognize a contract asset when our performance under a contract precedes our receipt of consideration from a customer, or before payment is due, and our receipt of consideration is conditional upon factors other than the passage of time. Contract assets reflect our transfer of control to customers of photomasks that are in process or completed but not yet shipped. A receivable is recognized when we have an unconditional right to payment for our performance, which generally occurs when we ship the photomasks. Our contract assets primarily consist of a significant amount of our in-process production orders and fully manufactured photomasks which have not yet shipped, for which we have an enforceable right to collect consideration (including a reasonable profit) in the event the in-process orders are cancelled by customers. On an individual contract basis, we net contract assets with contract liabilities (deferred revenue) for financial reporting purposes. Our contract assets and liabilities are typically classified as current, as our production cycle and our lead times are both under one year. Contract assets of $6.5 million are included in “Other” current assets, and contract liabilities of $10.7 and $5.0 million are included in Accrued Liabilities and Other Liabilities, respectively, in our May 3, 2020 condensed consolidated balance sheet. Our October 31, 2019 condensed consolidated balance sheet includes contract assets of $7.6 million, included in “Other” current assets, and contract liabilities of $11.5 million, included in Accrued liabilities. We did not impair any contract assets during the six-month periods ended May 3, 2020 or April 28, 2019. We recognized $0.9 million and $1.8 million of revenue from the settlement of contract liabilities that existed at the beginning of the three and six-month periods ended May 3, 2020, and recognized $0.5 million and $1.2 million of revenue in the respective prior year periods, that related to the settlement of contract liabilities that existed at the beginning of those periods.


We generally record our accounts receivable at their billed amounts. All outstanding past due customer invoices are reviewed for collectibility during, and at the end of, every reporting period. To the extent we believe a loss on the collection of a customer invoice is probable, we record the loss and credit the allowance for doubtful accounts. In the event that an amount is determined to be uncollectible, we charge the allowance for doubtful accounts and derecognize the related receivable. Credit losses incurred on our accounts receivable during the three and six-month periods ended May 3, 2020, were immaterial, and we did not incur any credit losses on our accounts receivable during the three and six-month periods ended April 28, 2019.


Our invoice terms generally range from net thirty to ninety days, depending on both the geographic market in which the transaction occurs and our payment agreements with specific customers. In the event that our evaluation of a customer’s business prospects and financial condition indicate that the customer presents a collectibility risk, we modify terms of sale, which may require payment in advance of performance. We have elected the practical expedient allowed under ASC Topic 606 “Revenue from Contracts with Customers” (“Topic 606”) that permits us not to adjust a contract’s promised amount of consideration to reflect a financing component when the period between when we transfer control of goods or services to customers and when we are paid is one year or less.


In instances when we are paid in advance of our performance, we record a contract liability and, as allowed under the practical expedient in Topic 606, recognize interest expense only if the period between when we receive payment from the customer and the date when we expect to be entitled to the payment is greater than one year. Historically, advance payments we’ve received from customers have generally not preceded the completion of our performance obligations by more than one year.

Contract Costs


We pay commissions to third-party sales agents for certain sales that they obtain for us. However, the bases of the commissions are the transaction prices of the sales, which are completed in less than one year; thus, no relationship is established with a customer that will result in future business. Therefore, we would not recognize any portion of these sales commissions as costs of obtaining a contract, nor do we currently foresee other circumstances under which we would recognize such assets.

Remaining Performance Obligations


As we are typically required to fulfill customer orders within a short time period, our backlog of orders is generally not in excess of one to two weeks for IC photomasks and two to three weeks for FPD photomasks. As allowed under Topic 606, we have elected not to disclose our remaining performance obligations, which represent the costs associated with the completion of the manufacturing process of in-process photomasks related to contracts that have an original duration of one year or less.

Sales and Similar Taxes


We report our revenue net of any sales or similar taxes we collect on behalf of governmental entities.

Product Warranty


Our photomasks are sold under warranties that generally range from one to twenty-four months. We warrant that our photomasks conform to customer specifications, and will typically repair, replace, or issue a refund for, at our option, any photomasks that fail to do so. The warranties do not represent separate performance obligations in our revenue contracts. Historically, customer claims under warranty have been immaterial.
v3.20.1
Condensed Consolidated Statements of Income (unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
May 03, 2020
Apr. 28, 2019
May 03, 2020
Apr. 28, 2019
Condensed Consolidated Statements of Income (unaudited) [Abstract]        
Revenue $ 142,774 $ 131,580 $ 302,510 $ 256,291
Cost of goods sold 112,341 105,570 237,475 204,179
Gross profit 30,433 26,010 65,035 52,112
Operating expenses:        
Selling, general and administrative 13,267 13,269 27,486 27,061
Research and development 4,462 3,542 8,541 7,805
Total operating expenses 17,729 16,811 36,027 34,866
Operating income 12,704 9,199 29,008 17,246
Other income (expense):        
Foreign currency transaction (losses) gains, net (1,433) 3,961 3,304 5,052
Interest expense, net 775 (355) (1,023) (886)
Interest income and other income (expense), net (293) 325 464 873
Income before income taxes 11,753 13,130 31,753 22,285
Income tax provision 3,781 3,278 12,853 4,665
Net income 7,972 9,852 18,900 17,620
Net income attributable to noncontrolling interests 1,688 1,373 2,316 3,874
Net income attributable to Photronics, Inc. shareholders $ 6,284 $ 8,479 $ 16,584 $ 13,746
Earnings per share:        
Basic (in dollars per share) $ 0.10 $ 0.13 $ 0.25 $ 0.21
Diluted (in dollars per share) $ 0.10 $ 0.13 $ 0.25 $ 0.20
Weighted-average number of common shares outstanding:        
Basic (in shares) 64,937 66,261 65,246 66,422
Diluted (in shares) 65,417 70,597 65,933 71,593
v3.20.1
LEASES (Tables)
6 Months Ended
May 03, 2020
LEASES [Abstract]  
Lease Payments Under Non-cancelable Leases

ROU assets underlying our leases include the land and facilities of some of our operating facilities, other real property, and machinery and equipment. As of May 3, 2020, we had ROU assets under operating leases of $6.5 million, included in “Other Assets”, and $1.8 and $4.1 million of lease liabilities, included in Accrued liabilities and Other liabilities, respectively. The following tables present lease payments under non-cancellable leases as of May 3, 2020.

 
 
Fiscal Year
                     
 
 
2020
   
2021
   
2022
   
2023
   
2024
   
Thereafter
   
Total Lease
Payments
   
Imputed
Interest*
   
Total
 
Lease payments
 
$
996
   
$
1,802
   
$
1,686
   
$
787
   
$
444
   
$
391
   
$
6,106
   
$
(255
)
 
$
5,851
 


*Imputed interest represents difference between undiscounted cash flows and discounted cash flows.
Lease Cost

The following table presents lease costs for the three and six-month periods ended May 3, 2020.

 
Three Months Ended
   
Six Months Ended
 
   
May 3, 2020
   
May 3, 2020
 
             
Operating lease costs
 
$
633
   
$
1,797
 
Short-tern lease costs
 
$
102
   
$
212
 
Variable lease costs
 
$
129
   
$
129
 
Supplemental Information Related to Leases

Presented below is other information related to our operating leases.

Supplemental cash flows information:
           
   
Three Months Ended
   
Six Months Ended
 
   
May 3, 2020
   
May 3, 2020
 
             
Operating cash flows used for operating leases
 
$
502
   
$
2,387
 
ROU assets obtained in exchange for lease obligations
 
$
58
   
$
340
 
Weighted Average Lease Terms And Discount Rates Leases Not Yet Commenced
 
 
As of
 
 
 
May 3, 2020
 
 
     
Weighted-average remaining lease term
 
3.7 years
 
Weighted-average discount rate
   
2.41
%
Future Minimum Lease Payments Under Non-cancelable Operating Leases

Rent expense, as calculated under guidance in effect prior to our adoption of the new leases guidance, was $3.0 million in fiscal year 2019. At October 31, 2019, future minimum lease payments under non-cancelable operating leases with initial terms in excess of one year were as presented in the table below. The amounts are undiscounted and were calculated in accordance with guidance in effect prior to our adoption of the new leases guidance.

2020
 
$
1,885
 
2021
   
1,613
 
2022
   
1,535
 
2023
   
742
 
2024
   
424
 
Thereafter
   
377
 
   
$
6,576
 
v3.20.1
PROPERTY, PLANT AND EQUIPMENT (Tables)
6 Months Ended
May 03, 2020
PROPERTY, PLANT AND EQUIPMENT [Abstract]  
Property, Plant and Equipment

Property, plant and equipment consists of the following:

 
May 3,
2020
   
October 31,
2019
 
             
Land
 
$
11,916
   
$
12,085
 
Buildings and improvements
   
172,689
     
172,340
 
Machinery and equipment
   
1,746,552
     
1,748,483
 
Leasehold improvements
   
20,344
     
19,921
 
Furniture, fixtures and office equipment
   
14,501
     
14,404
 
Construction in progress
   
30,257
     
28,135
 
                 
     
1,996,259
     
1,995,368
 
Accumulated depreciation and amortization
   
(1,391,714
)
   
(1,362,927
)
                 
   
$
604,545
   
$
632,441
 
v3.20.1
EARNINGS PER SHARE
6 Months Ended
May 03, 2020
EARNINGS PER SHARE [Abstract]  
EARNINGS PER SHARE
NOTE 10 - EARNINGS PER SHARE


The calculation of basic and diluted earnings per share is presented below.

 
Three Months Ended
   
Six Months Ended
 
   
May 3,
2020
   
April 28,
2019
   
May 3,
2020
   
April 28
2019
 
                         
Net income attributable to Photronics, Inc. shareholders
 
$
6,284
   
$
8,479
   
$
16,584
   
$
13,746
 
                                 
Effect of dilutive securities:
                               
Interest expense on convertible notes, net of tax
   
-
     
349
     
-
     
845
 
                                 
Earnings used for diluted earnings per share
 
$
6,284
   
$
8,828
   
$
16,584
   
$
14,591
 
                                 
Weighted-average common shares computations:
                               
Weighted-average common shares used for basic earnings per share
   
64,937
     
66,261
     
65,246
     
66,422
 
Effect of dilutive securities:
                               
Share-based payment awards
   
480
     
438
     
687
     
451
 
Convertible notes
   
-
     
3,898
     
-
     
4,720
 
                                 
Potentially dilutive common shares
   
480
     
4,336
     
687
     
5,171
 
                                 
Weighted-average common shares used for diluted earnings per share
   
65,417
     
70,597
     
65,933
     
71,593
 
                                 
                                 
Basic earnings per share
 
$
0.10
   
$
0.13
   
$
0.25
   
$
0.21
 
Diluted earnings per share
 
$
0.10
   
$
0.13
   
$
0.25
   
$
0.20
 


The table below shows the outstanding weighted-average share-based payment awards that were excluded from the calculation of diluted earnings per share because their exercise price exceeded the average market value of the common shares for the period or, under application of the treasury stock method, they were otherwise determined to be antidilutive.

 
Three Months Ended
   
Six Months Ended
 
   
May 3,
2020
   
April 28,
2019
   
May 3,
2020
   
April 28,
2019
 
                         
Share-based payment awards
   
1,009
     
1,204
     
591
     
1,134
 
                                 
Total potentially dilutive shares excluded
   
1,009
     
1,204
     
591
     
1,134
 
v3.20.1
INVENTORIES
6 Months Ended
May 03, 2020
INVENTORIES [Abstract]  
INVENTORIES
NOTE 2 - INVENTORIES


Inventories are stated at the lower of cost, determined under the first-in, first-out ("FIFO") method, or net realizable value. Presented below are the components of inventory at the balance sheet dates:

 
May 3,
2020
   
October 31,
2019
 
             
Raw materials
 
$
55,110
   
$
46,027
 
Work in process
   
1,818
     
2,122
 
Finished goods
   
40
     
6
 
                 
   
$
56,968
   
$
48,155
 
v3.20.1
REVENUE
6 Months Ended
May 03, 2020
REVENUE [Abstract]  
REVENUE
NOTE 6 – REVENUE


We recognize revenue when, or as, control of a good or service transfers to a customer, in an amount that reflects the consideration to which we expect to be entitled in exchange for transferring those goods or services. We account for an arrangement as a revenue contract when each party has approved and is committed to perform under the contract, the rights of the contracting parties regarding the goods or services to be transferred and the payment terms are identifiable, the arrangement has commercial substance, and collection of consideration is probable. Substantially all of our revenue comes from the sales of photomasks. We typically contract with our customers to sell sets of photomasks, which are comprised of multiple layers, the predominance of which we invoice as they ship to customers. As the photomasks are manufactured to customer specifications, they have no alternative use to us and, as our contracts generally provide us with the right to payment for work completed to date, we recognize revenue as we perform, or “over time,” on most of our contracts. We measure our performance to date using an input method, which is based on our estimated costs to complete the various manufacturing phases of a photomask. At the end of a reporting period, there will be a number of uncompleted revenue contracts on which we have performed; for any such contracts under which we are entitled to be compensated for our costs incurred plus a reasonable profit, we recognize revenue and a corresponding contract asset for such performance. We account for shipping and handling activities that we perform after a customer obtains control of a good as being activities to fulfill our promise to transfer the good to the customer, rather than as promised services, or performance obligations, under the contract.


As stated above, photomasks are manufactured to customer specifications in accordance with their proprietary designs; thus, they are individually unique. Due to their uniqueness and other factors, their transaction prices are individually established through negotiations with customers; consequently, our photomasks do not have standard or “list” prices. The transaction prices of the vast majority of our revenue contracts include only fixed amounts of consideration. In certain instances, such as when we offer a customer an early payment discount, an estimate of variable consideration would be included in the transaction price, but only to the extent that a significant reversal of revenue would not occur when the uncertainty related to the variability is resolved.

Contract Assets, Contract Liabilities, and Accounts Receivable


We recognize a contract asset when our performance under a contract precedes our receipt of consideration from a customer, or before payment is due, and our receipt of consideration is conditional upon factors other than the passage of time. Contract assets reflect our transfer of control to customers of photomasks that are in process or completed but not yet shipped. A receivable is recognized when we have an unconditional right to payment for our performance, which generally occurs when we ship the photomasks. Our contract assets primarily consist of a significant amount of our in-process production orders and fully manufactured photomasks which have not yet shipped, for which we have an enforceable right to collect consideration (including a reasonable profit) in the event the in-process orders are cancelled by customers. On an individual contract basis, we net contract assets with contract liabilities (deferred revenue) for financial reporting purposes. Our contract assets and liabilities are typically classified as current, as our production cycle and our lead times are both under one year. Contract assets of $6.5 million are included in “Other” current assets, and contract liabilities of $10.7 and $5.0 million are included in Accrued Liabilities and Other Liabilities, respectively, in our May 3, 2020 condensed consolidated balance sheet. Our October 31, 2019 condensed consolidated balance sheet includes contract assets of $7.6 million, included in “Other” current assets, and contract liabilities of $11.5 million, included in Accrued liabilities. We did not impair any contract assets during the six-month periods ended May 3, 2020 or April 28, 2019. We recognized $0.9 million and $1.8 million of revenue from the settlement of contract liabilities that existed at the beginning of the three and six-month periods ended May 3, 2020, and recognized $0.5 million and $1.2 million of revenue in the respective prior year periods, that related to the settlement of contract liabilities that existed at the beginning of those periods.


We generally record our accounts receivable at their billed amounts. All outstanding past due customer invoices are reviewed for collectibility during, and at the end of, every reporting period. To the extent we believe a loss on the collection of a customer invoice is probable, we record the loss and credit the allowance for doubtful accounts. In the event that an amount is determined to be uncollectible, we charge the allowance for doubtful accounts and derecognize the related receivable. Credit losses incurred on our accounts receivable during the three and six-month periods ended May 3, 2020, were immaterial, and we did not incur any credit losses on our accounts receivable during the three and six-month periods ended April 28, 2019.


Our invoice terms generally range from net thirty to ninety days, depending on both the geographic market in which the transaction occurs and our payment agreements with specific customers. In the event that our evaluation of a customer’s business prospects and financial condition indicate that the customer presents a collectibility risk, we modify terms of sale, which may require payment in advance of performance. We have elected the practical expedient allowed under ASC Topic 606 “Revenue from Contracts with Customers” (“Topic 606”) that permits us not to adjust a contract’s promised amount of consideration to reflect a financing component when the period between when we transfer control of goods or services to customers and when we are paid is one year or less.


In instances when we are paid in advance of our performance, we record a contract liability and, as allowed under the practical expedient in Topic 606, recognize interest expense only if the period between when we receive payment from the customer and the date when we expect to be entitled to the payment is greater than one year. Historically, advance payments we’ve received from customers have generally not preceded the completion of our performance obligations by more than one year.

Disaggregation of Revenue


The following tables present our revenue for the three and six-month periods ended May 3, 2020 and April 28, 2019, disaggregated by product type, geographic origin, and timing of recognition. At the beginning of fiscal year 2020, we changed the threshold for the definition of high-end FPD, from G8 and above and active matrix organic light-emitting diode (AMOLED) display screens, to G10.5 and above, AMOLED, and low-temperature polysilicon display screens (LTPS), to reflect the overall advancement of technology in the FPD industry. Our definition of high-end IC products remains as 28 nanometer or smaller. The revenue by product type for the three and six-month periods ended April 28, 2019, presented below has been reclassified to conform to the current period presentation.

 
Three Months Ended
   
Six Months Ended
 
   
May 3, 2020
   
April 28, 2019
   
May 3, 2020
   
April 28, 2019
 
                         
Revenue by Product Type
                       
 IC
                       
High-end
 
$
38,267
   
$
38,429
   
$
79,308
   
$
72,995
 
Mainstream
   
58,579
     
60,158
     
124,516
     
120,471
 
Total IC
 
$
96,846
   
$
98,587
   
$
203,824
   
$
193,466
 
                                 
FPD
                               
High-end
 
$
31,809
   
$
22,051
   
$
71,579
   
$
37,401
 
Mainstream
   
14,119
     
10,942
     
27,107
     
25,424
 
Total FPD
 
$
45,928
   
$
32,993
   
$
98,686
   
$
62,825
 
   
$
142,774
   
$
131,580
   
$
302,510
   
$
256,291
 

 
Three Months Ended
   
Six Months Ended
 
   
May 3, 2020
   
April 28, 2019
   
May 3, 2020
   
April 28, 2019
 
                         
Revenue by Geographic Origin
                       
Taiwan
 
$
55,513
   
$
56,469
   
$
121,626
   
$
114,209
 
Korea
   
36,261
     
38,038
     
76,997
     
73,275
 
United States
   
24,857
     
26,742
     
49,925
     
49,215
 
China
   
17,486
     
1,467
     
37,386
     
1,730
 
Europe
   
8,331
     
8,435
     
15,874
     
16,788
 
Other
   
326
     
429
     
702
     
1,074
 
   
$
142,774
   
$
131,580
   
$
302,510
   
$
256,291
 
                                 
Revenue by Timing of Recognition
                               
Over time
 
$
126,071
   
$
123,853
   
$
263,905
   
$
244,699
 
At a point in time
   
16,703
     
7,727
     
38,605
     
11,592
 
   
$
142,774
   
$
131,580
   
$
302,510
   
$
256,291
 

Contract Costs


We pay commissions to third-party sales agents for certain sales that they obtain for us. However, the bases of the commissions are the transaction prices of the sales, which are completed in less than one year; thus, no relationship is established with a customer that will result in future business. Therefore, we would not recognize any portion of these sales commissions as costs of obtaining a contract, nor do we currently foresee other circumstances under which we would recognize such assets.

Remaining Performance Obligations


As we are typically required to fulfill customer orders within a short time period, our backlog of orders is generally not in excess of one to two weeks for IC photomasks and two to three weeks for FPD photomasks. As allowed under Topic 606, we have elected not to disclose our remaining performance obligations, which represent the costs associated with the completion of the manufacturing process of in-process photomasks related to contracts that have an original duration of one year or less.

Sales and Similar Taxes


We report our revenue net of any sales or similar taxes we collect on behalf of governmental entities.

Product Warranty


Our photomasks are sold under warranties that generally range from one to twenty-four months. We warrant that our photomasks conform to customer specifications, and will typically repair, replace, or issue a refund for, at our option, any photomasks that fail to do so. The warranties do not represent separate performance obligations in our revenue contracts. Historically, customer claims under warranty have been immaterial.
v3.20.1
INCOME TAXES (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
May 03, 2020
Feb. 02, 2020
Apr. 28, 2019
May 03, 2020
Apr. 28, 2019
Oct. 31, 2019
Effective Income and Statutory Tax Rate [Abstract]            
Effective tax rate 32.20%   25.00% 40.50% 20.90%  
U.S. statutory rate 21.00%   21.00% 21.00% 21.00%  
Tax Credit Carryforward [Abstract]            
Change in valuation allowance   $ 2.1        
Unrecognized Tax Benefits [Abstract]            
Unrecognized tax benefits $ 1.8     $ 1.8   $ 1.9
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued [Abstract]            
Accrued interest and penalties related to unrecognized tax benefits $ 0.2     $ 0.2   $ 0.2
Income Tax Examination [Abstract]            
Earliest open tax year       2015    
Taiwan Agency of the Ministry of Finance [Member]            
Income Tax Holiday [Abstract]            
Term of tax year holidays       5 years    
Income tax holiday termination date       December 31, 2019    
Dollar effect of income tax holiday     $ 0.3 $ 0.1 $ 1.1  
Per share effect of income tax holiday (in dollars per share)         $ 0.01  
v3.20.1
SHARE REPURCHASE PROGRAMS (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended 7 Months Ended
Oct. 31, 2018
May 03, 2020
Jan. 27, 2019
Jan. 27, 2019
May 03, 2020
Apr. 28, 2019
May 03, 2020
Aug. 31, 2019
Equity, Class of Treasury Stock [Line Items]                
Cost of shares repurchased   $ 5,894     $ 16,894 $ 10,696    
October 2018 Announced Program [Member]                
Equity, Class of Treasury Stock [Line Items]                
Stock repurchased authorized amount $ 25,000              
Stock repurchase program - commencement date         Oct. 22, 2018      
Stock repurchase program - termination date         Feb. 01, 2019      
Number of shares repurchased (in shares)     1,137 1,467        
Cost of shares repurchased     $ 10,694 $ 13,807        
Average price paid per share (in dollars per share)     $ 9.40 $ 9.41        
August 2019 Announced Program [Member]                
Equity, Class of Treasury Stock [Line Items]                
Stock repurchased authorized amount               $ 100,000
Stock repurchase program - commencement date         Sep. 25, 2019      
Stock repurchase program - termination date         Mar. 20, 2020      
Number of shares repurchased (in shares)   549     1,464   2,460  
Cost of shares repurchased   $ 5,894     $ 16,894   $ 27,894  
Average price paid per share (in dollars per share)   $ 10.75     $ 11.54   $ 11.34  
Shares repurchased and retired (in shares) 900